Studies on carbohydrate metabolism in Bifidobacterium : isolation, characterisation and regulation of a sucrose-utilisation gene cluster in Bifidobacterium lactis by Trindade, Marla
The copyright of this thesis vests in the author. No 
quotation from it or information derived from it is to be 
published without full acknowledgement of the source. 
The thesis is to be used for private study or non-
commercial research purposes only. 
Published by the University of Cape Town (UCT) in terms 










STUDIES ON CARBOHYDRATE METABOLISM IN 
BIFIDOBACTERIUM: ISOLATION, CHARACTERISATION AND 
REGULATION OF A SUCROSE-UTILISATION GENE CLUSTER 
IN BIFIDOBACTERIUM LACTIS 
by 
Marla Trindade 
A dissertation submitted in partial fulfilment of the requirements for the degree of 
Doctor of Philosophy in the Department of Molecular and Cellular Biology, 












CERTIFICATION OF SUPERVISOR 
In tenns of paragraph GP 8 of "General Rules for the degree of Doctor of Philosophy (ph.D.)" we, 
as supervisors of the candidate Marla Trindade, certify that we approve of the incorporation in this 
thesis of material that has already been published or submitted for publication. 
Dr. V. R. Abratt 
Department of Molecular and 
Cellular Biology 
University of Cape Town 
Dr. S. J. Reid 
Department of Molecular and 
Cellular Biology 
University of Cape Town 
Part of the work presented in this dissertation has been accepted for pUblication and will be 
published in Applied and Environmental Microbiology, January 2003, Volume 69, Part 1: 













A very special thanks to my supervisors, Dr. Val Abratt and Dr. Shez Reid, for their guidance, 
continued encouragement and advice, their unfailing support, and for proof-reading this thesis. I 
am also very grateful to them for the opportunity to attend the ruMS Conference in Paris this 
year. 
Thank you to all my fellow "Anaerobes", both past and present, for creating an enjoyable working 
environment, and for their help and valuable discussions throughout the years. In particular, I 
would like to thank Ana for her encouraging support, willing advice and help in the "running" of 
the lab. 
Thank you to the excellent technical and administrative assistance provided by Anne-Marie 
Clennel, Di de Villiers, Pei-yin Ma, Anke Fiedler and Juliet Hog. An extra special thanks to Di 
James for her sequencing services and for the use of her computer. 
On a more personal note, I would like to extend my gratitude to my family, for their fmancial and 
loving support and encouragement. Thank you to my mom for always believing in me and being 
so proud. To my husband, Ron, thank you for your unconditional love, support and patience, 
particularly during the many hours that you spent with me in the lab and during the difficult 
moments. I would like to thank God, that through Him all things are possible, and for blessing me 
with a wonderful, loving family and friends who have enabled me to accomplish this undertaking. 
I acknowledge and am grateful for financial assistance from the National Research Foundation 












ABSTRACT .................................................................................................................................. 2 
ABBREVIATIONS ............................................................................................................................ 4 
CHAPTER! General Introduction ................................................................................................ 7 
CHAPTER 2 Physiological Analysis of Carbohydrate Utilisation in Bifidobacterium .............. 60 
CHAPTER 3 Isolation of a Putative a.-Galactosidase from Bifidobacterium lactis ................... 81 
CHAPTER 4 Cloning, Sequencing and Characterisation of a Sucrose Utilisation ................... ! 01 
System from Bifidobacterium lactis ........................................................................ . 
CHAPTER 5 Transcriptional and Regulatory Analysis of the scr Gene Cluster ...................... 124 
CHAPTER 6 Final Conclusion .................................................................................................. 155 
APPENDICES .............................................................................................................................. 160 












Bifidobacteria are numerically important components of the human intestinal micro flora and they 
are considered to be health promoting and beneficial. Their saccharolytic nature enables them to 
be involved in a direct interaction with host metabolism. For these reasons, there is currently 
much interest in determining ways to increase the numbers of these bacteria in the human colon. 
This is being achieved by introducing the bifidobacteria by oral consumption (probiotics), 
stimulating the growth of resident bifidobacteria using non-digestible oligo saccharides 
(prebiotics), or a combination of these (synbiotics). Several prebiotic substrates have been 
identified which selectively stimulate the growth ofbifidobacteria, however further information is 
required with regards to the metabolism of these substrates by individual bifidobacterial species. 
The primary aim of the project was, therefore, to analyse carbohydrate metabolism for the 
identification of and/or the development of prebiotic substrates, and to provide a molecular 
characterisation for their utilisation. 
Several carbohydrates were tested for their ability to support the growth ofbifidobacteria as a sole 
carbohydrate source. The four bifidobacterial strains, B. breve, B. bifidum, B. longum and B. lactis 
were able to utilise a wide variety of substrates. Fructose-containing oligosaccharides, such as 
inulin, oligofructose and raffinose have been identified as bifidogenic, and all three have a sucrose 
bond in common. Growth experiments with B. lactis indicated that raffinose stimulated cell 
growth in comparison to glucose, while growth in oligo fructose was poor, and no growth occurred 
with inulin as a sole carbohydrate source. To better understand the genetic mechanisms by which 
B. lactis utilises fructose-containing oligosaccharides, the isolation of the genetic systems for the 
utilisation of raffmose and sucrose was undertaken. Several strategies were employed. For the 
raffinose utilisation genes, these included screening two B. lactis genebanks in Escherichia coli 
on raffinose and the histochemical substrate p-nitrophenyl-a·D-galactopyranoside, amplification 
of the a-galactosidase gene by peR using bifidobacterial gene-specific primers, construction and 
the subsequent screening of a genebank prepared with DNA which hybridised to a B. longum a-
galactosidase gene probe. A clone was identified which produced weak a-galactosidase activity in 
E. coli. Although several open reading frames were identified, none showed any sequence identity 
to an a-galactosidase or a related protein. Transcription of B. lactis mRNA hybridising to the 
insert DNA was induced when cells were grown in the presence of raffinose and could not be 
detected when cells were grown in the presence of glucose. However, a distinct transcript could 












A sucrose utilisation gene cluster of B. lactis was identified by complementation of a gene library 
in E. coli. Three genes, encoding a sucrose phosphorylase (scrP) , a sugar transporter (scrT) 
downstream of scrP, and a GalR-LacI transcriptional regulator (scrR) transcribed divergently 
from scrP, were identified by sequence analysis. The scrP gene was expressed constitutively from 
its own promoter in E. coli, and hydrolysed sucrose in a reaction that was dependent on the 
presence of phosphates. In B. lactis, total sucrase activity was induced by growth in the presence 
of sucrose, raffinose or oligofructose, and was repressed by glucose. RNA analysis of the scrP, 
scrR and scrT genes in B. lactis indicated that their expression was influenced by transcriptional 
regulation, and that all three genes were induced by growth in sucrose or raffinose and repressed 
by growth in glucose. As well as being affected by catabolite repression, the scr genes, or at least 
scrP, were also regulated by ScrR. Analysis of ScrP activity using scrR deletion constructs in E. 
coli indicated that ScrR functioned as a positive regulator, where ScrP activity was abolished 
when scr R was deleted. 
Primer extension analyses of the scrP-scrR divergent promoter region identified transcriptional 
start sites upstream of the scrP and scrR ATG start codons, immediately adjacent to palindromic 
sequences resembling regulator binding sites. These sequences also showed homology to the CRE 
(catabolite response element) consensus sequence to which the catabolite control protein CcpA 
binds. These binding sites are well positioned for the binding of repressors. A third palindromic 
sequence was identified adjacent to the scrP -35, and is well positioned for the binding of a 
positive regulator, possibly ScrR. Gel binding analyses were performed using B. lactis crude 
protein extract from cells grown in the presence of sucrose or glucose and the scrP-scrR promoter 
DNA fragment. A shift was observed with both extracts, which was inhibited when unlabelled 
promoter DNA was added as competitor. This could suggest that ScrP bound to the promoter 
fragment when sucrose-induced extract was used, and that another unidentified regulator protein 
bound to the promoter fragment when glucose-induced extract was used. 
From the results in this dissertation, and by analogy with previously studied sucrose utilisation 
systems, it is proposed that sucrose is not metabolised via a PTS mechanism in B. lactis. Rather, 
sucrose is transported into the cell in its native form by the ScrT permease and is hydrolysed by a 
sucrose phosphorylase (ScrP), yielding glucose-I-phosphate and fructose. The glucose-I-
phosphate would be converted by glucose-6-phosphate isomerase for its utilisation by the bifidus 
pathway of glucose fermentation. It was proposed that transcription of the scr genes is positively 













































: absorbance measured at a wavelength of 600 nm 
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: ampicillin resistance 
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1.1. INTRODUCTION TO BIFIDOBACTERIA 
Bifidobacteria are Gram-positive rods, non-spore fonning, non-motile, anaerobic organisms (212, 
260, 261). They are heterofennentative, producing both lactic and acetic acid as major end-
products of fermentation, and, therefore, many microbiologists consider them to be lactic acid 
bacteria, albeit a special case (284). This genus is among the three most prevalent bacterial genera 
in the human colon (198), constituting up to 25% of the total population in the intestinal tracts in 
adults and 95% in newborns (342). There is general agreement on the important role of the 
gastrointestinal micro flora in the health status of humans and animals (118). In accordance with 
this, bifidobacteria are considered to be probiotic organisms due to the health benefits that they 
provide to the human host. 
A brief introduction to the biology and general characteristics of bifidobacteria will be presented. 
This will be followed by an introduction to the intestinal flora and the role that they play in the 
human gut, with the focus on the health benefits associated with bifidobacteria. Carbohydrate 
metabolism in bifidobacteria and how this relates to their function in the gut will be reviewed, and 
will be followed by an introduction to bacterial raffmose and sucrose utilisation systems. 
1.1.1. Biology and General Characteristics of the Bifidobacteria 
The classification of the genus Bifidobacterium, a member of the family Actinomycetaceae, has 
been a source of controversy in the scientific community since its discovery. A strain isolated 
from faeces of breast-fed infants in 1899 by Tissier was named Bacillus bifidus (18). Later, in the 
early 1920s, it was classified as a member of the family Lactobacteriaceae by Orla-Jensen based 
on its morphology and physiology. This work was challenged in 1934 by Weiss and Rettger, who 
named it a variant of Lactobacillus acidophilus based on its serological and fermentative patterns 
(331). However, in 1936, OrIa-Jensen's work showed that these bacteria were a unique species 
and called them Bacterium bifidum, although they were termed L. bifidus in the fifth edition of 
Bergey's Manual in 1939 (18). Today the genus is classified into 32 different species, and they are 
not only part of the human microbial flora but also of various animals, including honeybees. 
Twelve of the species are of human origin (174). These organisms are also isolated from sewage 
or sewage-polluted surface waters and clinical material (314). 
Bifidobacteria are anaerobic microorganisms in that they are unable to grow on plates under 
aerobic conditions (261). However, the sensitivity to O2 is different among different strains and 











(212). In some strains, accumulation of H202 was found to be the principal reason for the 
requirement for anaerobic conditions. H202 causes a block in the fermentation pathway by 
inactivation of fructose-6-phosphate phosphoketolase, which is a key enzyme in the carbohydrate 
metabolism of this organism (discussed further in 1.3.2). Other strains of Bifidobacterium do not 
accumulate H202, and the presence of 02 is not lethal for these strains. It is concluded that 02 
prevents growth and fermentation of these strains by establishing too high an oxidation-reduction 
potential. 
1.1.1.1. Morphology 
The colony morphology of Bifidobacterium is characterised as smooth, glistening, convex 
elevation, entire edges, circular form, soft consistency and cream to white colour (261, 314). 
Originally, Tissier described bifidobacteria as curved rods and rods with ends split to give the 
characteristic Y -shape (Figure 1.1), which led to the designation of "bifid" (298). In addition, 
bizarre small branches and bulbous or swollen ends were seen. Hayward et al. (109) noted that in 
unfavourable culture media the organisms were so greatly branched that resemblance to rods was 
lost. Other organisms were unbranched but were swollen and irregular. As the strains become 
adapted to artificial culture by transfers, the branched and swollen forms become less frequent 
until rods predominate. Although bifidobacteria have a tendency to show morphological variation 
when grown in vitro, they are mostly rod-shaped in the natural habitat. As an explanation, it has 
been suggested that bifidobacteria probably have a more complicated pathway of cell wall 
synthesis compared to other organisms (212). 
Although the mechanism of induction of pleomorphism (branching) is not fully known, it appears 
that the presence of Ca2+ ions plays a principle role in its prevention (212). Whereas Ca2+ induces 
the bacilloid form, NaCI has been shown to induce the branched form. The addition of the amino 
acids alanine, aspartic acid, glutamic acid and serine, enables the organisms to convert to their 
bacilloid form. Therefore, by manipulating these amino acids and the Ca2+ and NaCI contents in 
the media, the strain of bifidobacteria can be maintained indefinitely in either a bifid or highly 
branched form. 
A comparison of the cell morphology of large numbers of strains grown anaerobically in stabs of 
trypticase phytone-yeast extract medium (TPY), showed that some of the bifidobacterial species 
had distinct cell shapes or rearrangements which might be of help in their recognition (261). 












Figure 1.1. Electron micrographs of Bifidobacterium bifidum. A: an unbranched phase. B: the bifid phase. Cells were 
fixed with glutaralydehyde-osmium tetroxide and stained with uranyl acetate-lead citrate. Abbreviations: (n): nuclear 
area, (db) dense bodies, (cw): a distinct cell wall (212). 
'B 
Figure 1.2. Morphology of Bifidobacterium. A: B. bifidum. B: B. longum. C: B. breve. D: B. animalis. Cells were 











1.1.1.2. Cell Wall Structure 
The principle cell wall component is peptidoglycan (murein) (290). This complex material 
consists of linear chains of a polysaccharide composed of molecules of N-acetylmuramic acid and 
N-acetylglucosamine alternating along the length of the chain. These chains are crosslinked by 
tetrapeptides consisting of alanine, glutamic acid, and ornithine or lysine, while links between 
adjacent tetrapeptides may consist of one or more of the amino acids glycine, serine, aspartic acid 
and threonine. The amino acid composition of the basic tetrapeptide can vary between species and 
lor strains of the same species, as can their sequence in the chain (Table 1.1). Strain differences 
can also arise from the substitution of ornithine by lysine, and the extent of crosslinkage between 
chains, i.e. crosslinks may arise between one, two or three amino acids in adjacent sequences. 









Type of peptidoglycan 
or murein 
Glucose 
Lys or Om-D-Asp + 
Om or Lys-D-Ser-D-Asp + 
Lys-Gly + 
Om or Lys-Ser-Ala-Thr-Ala + 
Om or Lys-Ser-Ala-Thr-Ala + 
Om: ornithine 
Ala: alanine 












Glucose, galactose and rhamnose are usual components of the cell wall structure, with qualitative 
and quantitative differences being observed with respect to species, strain and growth medium 
(Table 1.1) (290). The principal fatty acids are myristic, palmitic, palmitoleic and oleic, but the 
precise composition varies considerably with growth medium, the presence or absence of human 
milk and growth temperature. The phospholipids, such as phosphatidylglycerol and 
diphosphatidylglycerol are well represented, along with derivatives like 
alanylphosphatidylglycerol which are specific to bifidobacteria. Lipoteichoic acids, which appear 
to be essential for cell adhesion to the wall of the intestine, form links with the polysaccharide 











1.1.1.3. Genetic Aspects of Bijidobacteria 
The G+C content of Bifidobacterium DNA vanes from 55-67 mol%, and, therefore, these 
organisms are classified as having a high G+C content (212). The genome sizes for eight 
Bifidobacterium species were estimated by restriction analysis and pulse field gel electrophoresis 
to be an average of 1.8 Mb, and ranged from 1.5 to 2.1 Mb (198). 
The presence of plasmids has been demonstrated in the following bifidobacterial strains (125, 
275, 276, 277): B. breve and B. longum, which are found in the human intestine; B. asteroides, 
and B. indicum, found exclusively in the intestines of honeybees; and B. globosum, the most 
common in animals. Most of the plasmids remain cryptic. 
Most of the plasmid studies have been done on the B. longum B2577 plasmid pMBl, and it was 
the first to be sequenced (170, 234). Plasmid pMB 1 is approximately 1.9 kb in size, and contains 
two antibiotic resistance genes: AmpR and CmR. Sequence analysis revealed high degree of 
homology with plasmids from the Gram-positive, high GC organisms Corynebacterium 
glutamicum and Mycobacterium fortuitum, which are also members of the Actinomycetaceae 
family. Furthermore, two tandem genes present on pMB1 were highly homologous to those found 
in C. glutamicum, M fortuitum, and Neisseria gonorrhoeae plasmids. This suggests that this two-
gene operon is shared by a wide family of plasmids belonging not only to phylogenetically related 
bacteria, but also to unrelated species such as the gram-negative N gonorrhoeae. One of the 
ORFs identified showed significant similarity to ColE-type plasmid Rep proteins, and may be 
involved in plasmid replication. 
A second plasmid from B. longum, pKJ50, has been isolated and sequenced (205). Analysis of 
plasmid replication indicated that this occurs by a rolling-circle mechanism. pKJ 50 and a 
chloramphenicol resistance gene were cloned into pBR322, resulting in the Bifidobacterium-
E. coli shuttle vectors, pBK.J50F and pBKJ50R, capable of transforming B. animalis. Another 
B. longum-E. coli shuttle vector, pRM2, has been constructed and successfully introduced into 
B. longum (179). This vector is based on the pMBl replicon discussed above, and confers 
spectinomycin resistance. 
Up to now, no conjugation or transfection systems have been available for bifidobacteria. 
Transformation ofbifidobacteria is particularly difficult because of the cell wall composition, and 
the physical conditions are also affected by the medium composition and growth phase (235). 











strains have been published (8, 179, 235). Despite these advancements, there is still a shortage of 
genetic tools available for this genus, particularly cloning vectors, for genetic manipulations to be 
performed in bifidobacteria. However, due to the large industrial and medical importance of this 
organism, there is no doubt that this field will advance greatly in the next few years, specially 
with the recent sequencing of the B. longum NCC2705 genome (262). Suggestions have already 
been made as to how site-directed gene knockout strategies can be facilitated. 
1.2. FUNCTION OF BIFIDOBACTERIA AS PROBIOTICS 
1.2.1. The Intestinal Flora 
The intestinal tracts of all mammalian species that have been studied, appropriately harbour a 
complex collection of microorganisms, most of which are anaerobic bacterial species (292). These 
organisms are known as the intestinal micro flora. While the upper intestinal tract contains 
relatively few bacteria, numbers increase enormously in the colon (Figure 1.3) (118). The 
gastrointestinal tract of an adult human is estimated to harbour about 1014 viable bacterialg of 
intestinal contents (158), this is 10 times the total number of eukaryotic cells in all tissues in a 
human body. About 400 bacterial species belonging to more than 190 genera have been detected 
in human faeces, but 30 to 40 species constitute 99% of the collection in anyone human subject 
(118, 292). Only a few major groups dominate, all of which are strict anaerobes, such as 
Bacteroides, Eubacterium, Bifidobacterium and Peptostreptococcus (118). 
There is a wide variation of bacteria in the microflora among individuals, but, globally, the 
number of species and the population of bacteria are relatively stable in healthy adults. In spite of 
its stability, the intestinal microflora can be affected by a variety of factors. Host factors such as 
gastric acid, bile salts, and mucus in the intestinal wall can affect the composition of the 
microflora (183). In addition, diet, medication, infections, stress, ageing, and climate also 
contribute to the microflora composition. Bacterial interaCtions such as antagonism or symbiosis 
can also influence the contents of the microflora (65). 
Bifidobacteria are normal inhabitants of the human gastrointestinal tract throughout life, starting 
just days after birth (251). The digestive tract of newly-born infants rapidly becomes colonised by 
bacteria as the result of oral contamination from the vagina during birth (288). In breast-fed 
infants, this mixed population rapidly becomes dominated over the next 4 to 7 days by species of 











food is introduced into the diet, the intestinal microflora becomes more complex and diversified 
(344). By two years of age, the composition and metabolism of the child's micro flora resembles 
those of adults in many ways, and is more stable (lOO). Characteristic shifts in composition and 
functioning of the microflora may occur with ageing (l81). It has been reported that a small 
decrease in bifidobacteria, and an increase in clostridia, lactobacilli, streptococci, and 
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Figure 1.3. Microbial colonisation of the human gastrointestinal tract (118, 292). 




The importance of bacteria for human health and longevity was first hypothesised by Elie 
Metchnikoff at the beginning of the 20th century, who believed that the desirable effects to human 
health would only be expected if the gut microbes were substituted for yoghurt bacteria (cited in 
the review article by Holzapfel et ai, 118). Since then attempts have been made to modulate the 
indigenous intestinal flora by the use of live microbial adjuncts, now called probiotics. By 
definition, a probiotic is a live microbial feed supplement which beneficially affects the host 
animal by improving the properties ofthe indigenous microflora (252). 
Tissier's hypothesis almost 100 years ago that bifidobacteria might have health benefits was based 











throughout the life cycle, and that they are often the predominant microorganism in the gut of 
breast-fed infants. It has since been shown that breast-fed babies are less at risk for diarrhoeal 
disease than formula-fed infants (110). 
For a probiotic effect to be exerted, numerous ingested bifidobacteria must reach the site of action 
in the gut. A minimum of 106_107 viable organisms/g intestinal contents is recommended. In vivo· 
studies in adults and in infants have confirmed that some strains of bifidobacteria are able to 
survive passage through the gastrointestinal tract (1, 146). Marked strain differences exist in their 
ability to tolerate acid and bile salts, thus making survival an important criterion of selection 
(141). Once live bifidobacteria reach the site of action, they must be able to exert the desired 
effect; function is essential (254). 
Over 70 products are currently offered by which bifidobacteria can be administered. These 
include fermented milks, cottage cheese, buttermilk, frozen desserts, candy, beverages, cereals, 
infant formulas and pharmaceutical preparations (290). Products often contain B. bifidum, 
B. longum, B. lactis, B. breve, or B. in/antis; some use Bifidobacterium spp. (i.e. not yet classified) 
or B. animalis. Bifidobacteria may be fermented alone, but are commonly used in association with 
lactic acid bacteria for organoleptic or technological reasons, in particular, with Lactobacillus 
acidophilus and/or yoghurt cultures (Streptococcus thermophilus and Lactobacillus bu/garicus). 
The health benefits that are offered by bifidobacteria will be discussed briefly. 
1.2.2.1. Improvement of Lactose Digestion 
Dairy foods are an important source of high quality protein, riboflavin and calcium (297). 
However, 20 to 25% of the US population maldigest milk because of its lactose content (258). 
Lactose maldigestion is caused by a reduction in lactase (p-galactosidase) activity in the small 
intestine sometime after weaning. In these "lactase nonpersistent" individuals, unhydrolysed 
lactose passes into the large intestine, where it is fermented by the indigenous microflora into 
gases (H2, C~ and CO2) and short-chain fatty acids. The excessive gas production and the 
osmotic effects of excessive undigested lactose can cause gastrointestinal symptoms, including 
flatulence, abdominal pain, and diarrhoea. Lactose maldigesters may avoid milk and other dairy 
foods because of these symptoms, and thus potentially reduce their intake of some essential 
nutrients. When bifidobacteria are included in non-fermented milk, their consumption improves 











symptoms of flatulence. Bifidobacteria have a relatively high level of p-galactosidase activity 
(122, 167), which enables them to exert their positive effect. 
1.2.2.2. Improvement ill Gastrointestinal Transit 
In elderly people, mild constipation can be partially corrected through the consumption of milk 
fermented by bifidobacteria (274). The colonic transit times of woman have been shown to be 
significantly accelerated in the sigmoid colon after consuming fermented milk, particularly in 
those woman with slow initial time. This effect is not observed with traditional yoghurt (no 
bifidobacteria), thus showing the specificity of bifidobacteria for the increased colonic motility 
(99). 
1.2.2.3. Reduction of Risk of Cancer 
Indirect evidence in humans shows that consuming milk fermented by bifidobacteria leads to 
reduced levels of certain colonic enzymes (P-glucuronidase, nitroreductase, azoreductase, and 
glycoholic acid hydrolase), which are implicated in the conversion of procarcinogens to 
carcinogens such a nitrosamines or secondary bi!e salts (31). In addition, faecal putrefactive 
metabolites such as p-cresol, indole and ammonia were shown to be reduced when subjects 
consumed milk fermented by B. longum and S. thermophilus (288). Bifidobacteria inhibit the 
procarcinogens, nitrites and nitrosamines, through non-enzymatic and intracellular mechanisms 
(98). They also bind to heterocyclic amines (carcinogens formed during cooking of red meat), 
which, when bound, can then be eliminated in the faeces (199). 
Epidemiological studies have found that colon cancer risk is inversely related to the consumption 
of diets that include fermented milks (208). Research in rats indicated a significant decrease in 
colon tumour incidence and reduced number of tumours by the ingestion ofbifidobacteria. (279). 
Interest has more recently focused on a possible reduction of the risk of breast cancer. A recent in 
vitro report showed inhibition of growth of a human breast cancer cell line by milk fermented by 
bifidobacteria, thus demonstrating possible anticancer effects (19). 
1.2.2.4. Antimicrobial Activity 
The intestinal mucosa is an important organ of defence, providing a barrier against the antigens 
encountered by the enteric route, and most foreign antigens are excluded by the intestine's 












Infants and young children are particularly susceptible to the ill effects of diarrhoea. 
Gastroenteritis can be caused by a variety of pathogens including, rotavirus, E. coli and 
Campylobacter (250). Studies have shown that children aged between 3~36 months with persistent 
diarrhoea had decreased symptoms and increased weight gain when given a yoghurt diet 
consisting of Bifidobacterium and other lactic acid bacteria (30). Furthermore, it was found that 
infants fed a formula with added B. bifidum and S. thermophilus had less incidence of hospital-
I 
ind~ed diarrhoea and lower rates of rotavirus shedding compared to infants taking a standard 
I 
fOf11!1ula (241). The antagonistic effects against various pathogens, including E. coli (82, 93), 
I 
Shigella dysenteriae (178), and Yersinia enterocolitica (203) have also been investigated. 
Two possible mechanisms by which bifidobacteria could be exerting an effect are plausible, both 
involving the production of antimicrobial substances. The first is the production of acetic and 
lactic acid. These are toxic to certain pathogens and also create an acidic environment which 
prevents the growth of certain organisms. The second is the excretion of bacteriocins and peptides 
which have a broad spectrum of activity. B. bifidum produces a bacteriocin, bifidocin B, which 
shows inhibitory activity against Bacillus cereus, Enterococcus faecalis, Listeria innocua, 
Leuconostoc oenos, Micrococcus roseus and many others (342). Several Bifidobacterium strains 
also produce a proteinaceous factor which inhibits the adherence of some E. coli and other strains 
to the intestinal epithelium (82). Bifidobacteria and E. coli have high affinities for the GAl 
receptor, a neutral sphingoglycolipid found in the intestinal epithelium. Therefore, bifidobacteria 
not only competitively exclude E. coli by competing for the same binding sites, but also inhibit 
their binding by the production of a proteinaceous factor. Since the adhesion of pathogenic 
bacteria to host tissues is regarded as a prerequisite for colonisation-based infection, inhibition by 
bifidobacteria may help to prevent infection in the early stage of colonisation. 
1.2.2.5. Immunomodulating Effects 
Bifidobacteria can modulate various parameters of the immune system. In one report, blood 
samples of subjects consuming milk fermented by various cultures with added bifidobacteria and 
L. acidophilus, showed greater increase in humoral IgA response when subjects were given 
attenuated Salmonella typhi compared to the sera of subjects with no fermented milk intake (156). 
In a second study, B. bifidum added to fermented milk led to an increase in overall phagocytic 
activity against E. coli in peripheral blood. This increase was greater than that shown with 
fermented milk containing L. acidophilus but no Bifidobacterium (263). In addition, in vitro 











which serve as signals ,between cells during immune response) in blood mononuclear cells in the 
presence ofbifidobacteria (1). 
1.2.2.6. Contribution to Nutrition 
The diversity of bacteria permits the breakdown of essentially all substrates that enter the colon. 
Degradation of non-digested substrates by the micro flora, particularly of dietary carbohydrates 
(e.g. fibre, resistant starch, unabsorbed sugars) and endogenous substances such as mucus, lead to 
the production of gases (H2' CO2, Ca.), short-chain fatty acids (SCFA), lactic acid, branched 
chain fatty acids, ethanol, and ammonia (230). Products of degradation have nutritive functions, 
as in the case of SCF A, especially butyrate and lactic acid, which serve as energy substrates for 
colonocytes, liver cells, and peripheral tissues. Bifidobacteria are also capable of synthesising 
some B group vitamins (290) and a variety of amino acids (171) which can be beneficial to the 
consumer (181). 
The saccharolytic nature of bifidobacteria has induced much research interest in the science 
community for a number of reasons, one of which is their contribution to the host nutrition. The 
main focus is now on the development of pre- and synbiotics which will be discussed in further 
detail in the next section, which will deal with carbohydrate metabolism in bifidobacteria. 
1.3. CARBOHYDRATE METABOLISM IN BIFIDOBACTERIA 
Dietary carbohydrates that escape digestion by the host and micro flora in the upper 
gastrointestinal tract form the predominant substrates for bacterial growth in the colon (231). The 
environment in which bifidobacteria find themselves is, therefore, poor in mono- and 
disaccharides, and consists mainly of non-digestible oligo saccharides. These include 
oligosaccharides that contain fructose, glucose, xylose and galactose; resistant starch, which is not 
hydrolysed by pancreatic amylases but can be metabolised by bacterial enzymes; and non-starch 
polysaccharides, such as celluloses, hemicelluloses, pectins and gums (231). Host 
mucopolysaccharides and various proteins and peptides are also present (52). 
Bifidobacteria have been shown to utilise a great variety of carbohydrates as a carbon source (18). 
The substrate preferences are not only highly variable between different bifidobacterial species, 












(50, 249), including plant-derived dietary fibres, such as arabinogalactans and gums; and meat 
glycoproteins which originate from sloughed epithelial cells of the intestinal tract. Several 
glycosidases have been extracted and purified from bifidobacteria. These include neuraminidases, 
p-glucosidases, a-galactosidases, and p-galactosidase (18). In view of these organisms' ecological 
significance, it is surprising that virtually nothing is known about carbohydrate transport and 
metabolism in these organisms. 
1.3.1. Carbohydrate Transport Mechanisms 
Bacteria can potentially assimilate carbohydrates by a variety of mechanisms, either passively or 
by active mechanisms (27). Passive diffusion does not require any energy because bacterial 
membranes are selectively permeable to the solutes. Here, solute size is important in regulating 
the uptake of nutrients. Transmembrane protein complexes may facilitate diffusion by selectively 
recognising molecules that may be accumulated intracellularly, and this often occurs by the 
formation of a pore to effect uptake. 
Active transport systems are energy-dependant and. are usually ATP-driven (244). These include 
the periplasmic binding protein dependent system (PBPDS), where solute binding proteins in the 
periplasm transport carbohydrates in an unmodified state; the phosphoenolpyruvate (PEP)-
dependant group translocation (this will be discussed further in section 1.5.1.), which primarily 
operates in bacteria that use the glycolytic pathway of metabolism; and ion-linked transport 
systems (162). Three classes of ion-linked transport systems exist: symports, antiports, and 
uniports. Symports consist of a solute and coupling ion traversing the membrane in the same 
direction. Solute accumulation is energised by a transmembrane proton gradient. Antiports consist 
of the solute and coupling ion moving in opposite directions. The formation of a transmembrane 
gradient may then be used to drive the uptake of other solutes by symports. Uniport systems do 
not have a coupling ion and the driving force for uptake is provided by the charge on the substrate 
molecule itself (162). Many of these uptake processes are subject to control by either catabolite 
repression, catabolite inhibition or inducer exclusion mechanisms. 
Although the sugar uptake mechanisms in bifidobacteria are largely unknown, it has been shown 
that several Bifidobacterium species exhibit substrate preference with respect to sugar uptake (57, 
58). In one study (57), five monosaccharides were tested, and it was found that some of the 
substrates were co-utilised, whereas others were sequentially transported into the cells. The 
sequential uptake of the substrates suggested that catabolite regulatory mechanisms were 











galactose and mannose. However, the mechanisms involved have not been identified. With 
respect to transport mechanisms, the experiments with B. breve showed that glucose was not 
assimilated by facilitated diffusion, and that phosphorylation was involved in its transport (58). 
However, ATP rather than PEP was the source of the phosphate, and, therefore, it remains unclear 
if this was mediated by a PEP:PTS. On the other hand, arabinose uptake appeared to occur by 
facilitated diffusion. 
1.3.2. Glucose Fermentation 
Bifidobacteria degrade hexoses by a fructose-6-phosphate shunt rather than a glucose-6-phosphate 
shunt, as for the heterolactic lactobacilli, (18,290), and this is referred to as the bifidus pathway. 
This alternative phophoketolase pathway (Figure 1.4) appears to be specific to the genus 
Bifidobacterium and is characterised by the presence of fructose-6-phosphate phosphoketolase 
(F6PPK). F6PPK is present in all bifidobacterial species, and is used as a marker in the 
identification of this genus. Bifidobacterial cell extracts do not possess the glycolysis pathway or 
the hexosemonophosphate shunt pathway. This was established by the virtual absence of aldolase, 
an enzyme unique to glycolysis, and glucose-6-phosphate dehydrogenase, an enzyme associated 
with the hexosemonophosphate shunt. Some bifidobacterial species, however, do possess 
aldolase, but the physiological importance of this is not clear. There is no carbon dioxide 
production, confirming the absence of the hexosemonophosphate shunt. 
The end products of bifidobacterial glucose fermentation are acetate, lactate, formate and ethanol 
(18, 290). Ideally, the overall reaction would occur as follows: 
2 Glucose + 5 ADP + 5 Pi --., 3 acetate + 2 lactate + 5 ATP 
However, bifidobacteria have an alternative pathway, the phosphoroclastic reaction, that can 
convert pyruvate to ethanol and formate, and so some pyruvate is diverted from forming lactate to 
forming ethanol and formate (18). Different bifidobacterial species yield different relative 
amounts of acetate, lactate, ethanol, and formate under the same conditions. Moreover, the 
quantities of the fermentation products can be varied by varying the growth conditions, such as 
type and quantity of the carbon source. 
1.3.3. Galactose Fermentation 
There are two pathways for the catabolism of galactose in bifidobacteria: the classical Leloir 
pathway and the pyrophosphorylase pathway (Figure 1.5) (18). It is thought that the glucose-l-
phosphate generated can be converted to glucose-6-phosphate by a phosphoglucomutase, which 











in the two pathways have been isolated and characterised. Surprisingly, these enzymes are 
constitutively expressed. The enzyme that creates an alternative pathway for galactose metabolism 
is the UDP-galactose (glucose) pyrophosphorylase, catalysing the pyrophosphorolysis of both 
UDP-galactose and UDP-glucose. The two substrates are competitive inhibitors of each other. 
There is no information concerning possible mechanisms for which galactose-utilisation pathway 
is chosen in a given situation. Furthermore, it is not understood what the advantage is for the 
presence of two galactose-metabolising pathways. 
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Figure 1.4. The bifidus pathway for glucose fermentation. Enzymes involved are as follows: A: hexokinase, B: 
glucose-6-phosphate isomerase, C: fructose-6-phosphate phosphoketolase, D: transaldolase, E: transketolase, F: 
acetate kinase, G: ribose-5-phosphate isomerase, H: ribulose-5-phosphate epimerase, I: xylulose-5-phosphate 
phosphoketolase, J: fructokinase, K: glyceraldehyde-3-phosphate dehydrogenase. Enzymes not identified are the 
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Figure 1.5. The Leloir (A) and Pyrophosphorylase (B) pathways of galactose metabolism in bifidobacteria (18). 
1.3.4. Other Metabolic Pathways 
23 
It is generally accepted that bifidobacteria metabolise sugars via the bifidus shunt, and that 
glycolysis and the hexosemonophosphate shunt is not used (18,290). However, claims have been 
made that the glycolytic pathway exists in some bifidobacterial species, since hexokinase, 
glucokinase, and pyruvate kinase were detected in cell extracts (18). However, these enzymes 
have a function in the bifidus pathway (Figure 1.4), and therefore, the hypothesis that glycolysis is 
used by bifidobacteria is not warranted on the basis of the evidence presented. 
It has been reported that the glycolytic enzyme aldolase and the hexosemonophosphate shunt 
enzymes glucose-6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase were 
absent from bifidobacteria. However, all three of these enzymes are present in the rumen bacteria 
B. globosum and B. thermophilum (18). In the human species B. angulatum, B. catenulatum, and 
B. longum, the aldolase and 6-phosphogluconate dehydrogenase have been identified. The 











1.3.5. B. longum Genome Analysis and Carbohydrate Metabolism 
The full genome sequence of B. longum NCC2705 was recently published, and a bioinfOlmatics 
analysis was perfonned with respect to carbohydrate metabolism (262). This analysis revealed 
several physiological traits with respect to carbohydrate metabolism, which could explain firstly, 
the bacteria's ability to utilise a variety of complex carbohydrates, and secondly, how this might 
contribute to it being a probiotic organism. Some of the important points made which bear 
relevance to this study will be discussed briefly. 
It was found that >8.5% of the total predicted proteins were dedicated to carbohydrate transport 
and metabolism. This is 30% higher than what was found for E. coli, Enterococcus !aecium, 
Lactococcus lactis, Bacillus halodurans, and B. subtilis, thus indicating the important role that 
bifidobacteria play in carbohydrate metabolism in the human gut. More than 40 predicted glycosyl 
hydrolases were identified whose predicted substrates cover a wide range of di-, tri-, and higher 
order oligosaccharides. Based on sequence identity the following homologues were identified: 2 
xylanases, 9 arabinosidases, 2 a-galactosidases, neopullanase, isomaltase, maltase, inulinase, 4 ~­
galactosidases, 3 ~-glucosidases, 3 hexoaminidase.s and 3 a-mannosidases. Homologues of all 
enzymes needed for the fennentation of glucose, fructose or gluconate to lactate and acetate were 
shown to be present. This includes the characteristic F6PPK (section 1.3.2) and all the 
components of the fructose-6-phosphate shunt. Furthennore, homologues of enzymes needed to 
feed fructose, galactose, N-acetyl-glucosamine, N-acetyl-galactosamine, arabinose, xylose, ribose, 
sucrose, lactose, cellobiose, melibiose, gentobiose, maltose, isomaltase, raffinose and mannose 
into the fructose-6-phosphate shunt were identified. This substantiates the findings which reported 
the ability of B. longum to fennent a wide variety of carbohydrates (18, 50, 249, 290). Many of 
the glycosyl hydro lases were found to be organised in 7 clusters. Each cluster consisting of a 
LacI-type sugar-responsive repressor; an ABC-type oligosaccharide transporter; and 1-6 genes 
encoding various types of glycosyl hydro lases. 
Several unusual glycosyl hydro lases were identified, many showing identity to those from 
eukaryotes, strongly suggesting a special role in the adaptation of B. longum to its gastrointestinal 
niche (262). In further support of this, one of the carbohydrate clusters was found to contain genes 
which are more commonly found in eukaryotes, and are involved in the utilisation of 
glycoproteins. Glycoproteins are produced by epithelial cells of the colon, and its utilisation could 
possibly enhance colonisation of B. longum to the gastrointestinal tract. A significant number of 











human milk (74) and in plant polymers. They could be selective substrates for B. longum and its 
collection of unusual glycosyl hydrolases (262). 
Several of the clusters were found to have recently duplicated genes and adjacent insertion (IS) 
elements (262). This suggests that B. longum is under strong pressure to evolve the diversity of its 
metabolic capabilities so that it can cope with nutritional competition of varied substrates in the 
gastrointestinal tract (262). Furthermore, the carbohydrate utilisation gene clusters identified 
indicate that B. longum is well equipped with the machinery necessary for the utilisation of a 
diverse spectrum of substrates, either from the host's diet or perhaps from the host itself 
1.4. PREBIOTICS AND SYNBIOTICS 
As was discussed in section 1.2, bifidobacteria have been identified as probiotic organisms, and 
considerable research has been aimed at the delivery of these organisms to the human host. 
Bifidobacteria administered in foodstuffs have been shown to be able to pass the terminal ileum 
and are detected in the faeces, despite adverse physiochemical barriers in the gastrointestinal tract 
such as gastric acidity, bile production and rapid small intestinal transit (92, 211). However, they 
rapidly disappear from faeces when the oral dosing stops, indicating that they do not colonise the 
colon (32). With the realisation that bifidobacteria utilise a diverse range, as well as unusual 
carbohydrate substrates, and that diet could significantly alter the colonic flora, an alternative 
approach to modify colonic bacteria was developed which could overcome the difficulties 
associated with probiotics. In this approach, substrates which are indigestible by humans are used 
to selectively stimulate the growth and/or the activity of one or a limited number of colonic 
bacteria already resident in the gut (31). These non-digestible substrates, usually a carbohydrate, 
are termed prebiotics. 
Due to their health-promoting benefits, bifidobacteria have been identified as preferred target 
microorganisms for prebiotics (91). A number of oligo saccharides have been shown to selectively 
stimulate bifidobacteria, which when fed to humans, resulted in a significant increase in faecal 
bifidobacterial counts (Figure 1.6) (231). In addition, this increase in bifidobacteria was 











Standard Diet Inulin Diet 
65 
• Bifidobacteria • Fusobacteria 
D Bacteroides D Clostridia 
Figure 1.6. Shlfts in the distribution of faecal microflora in humans provided a diet with and without supplemental 
inulin (\93). 
F or a food to be classified as a prebiotic, certain criteria have to be met (231). Firstly, it must not 
be hydrolysed or absorbed in the upper part of the gastrointestinal tract. Secondly, it must be a 
selective substrate for one or a limited number of potentially beneficial bacteria commensal to the 
colon. Therefore, they must not be utilised by potentially harmful residents of the colon such as 
the enterobacteriaceae and clostridia. Thirdly, it must be able to alter the colonic flora, and as a 
consequence exert health benefits on the host. 
Several prebiotics have been identified which stimulate bifidobacteria, including the fructo-
oligosaccharides (46, 49), galacto-oligosaccharides (46, 49), soybean oligosaccharides (49, 247), 
oat ~-glucan and xylan (129). A schematic representation of these is shown in Figure 1.7. With 
regards to bifidobacteria, the most studied of these oligosaccharides are the fructo-
oligosaccharides inulin and oligofructose (92, 93, 94, 193, 228, 229, 231). These will be discussed 
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Figure 1.7. Properties of the classes of oligosaccharides that have been identified as prebiotics, showing those 
manufactured from A: lactose, B: sucrose, C: soybean, D: xylan. Abbreviations: Gal, galactose; Glu, glucose; Fru, 











As can be seen in FigllTe 1.7, oUgosaccharides can be manufactured enzymatically using mono-
and disaccharides by transglycosylation activity (49). Some bifidobacterial enzymes have been 
isolated, such as a ~-galactosidase (216), a-galactosidase (310) and a ~-glucosidase (194), which 
have been shown to carry out transglycosylation reactions. The possibility of synthesising 
bifidogenic prebiotic substrates using bifidobacterial enzymes is, therefore, receiving some 
interest. Studies thus far report the synthesis of oligosaccharides by transglycosylation activity 
and have looked at expression in E. coli for the possibility of mass production (194, 216, 310). 
Although some indication was given as to whether these synthesised oligosaccharides were able 
to support bifidobacterial growth (194, 216), suitable mixed culture fermentations and feeding 
trials have not been performed to indicate that they are bifidogenic. 
Recently, research has been aimed at the development of food products which contain 
combinations of the probiotic organism with prebiotic compounds. These products have been 
termed synbiotics (228). This combines the stimulatory effects by the body's own bacteria and 
new ones (135). Furthermore, the prebiotic acts to improve the survival, implantation, and growth 
of the newly added probiotic strains (193). Commercially available synbiotics include a yoghurt 
consisting of three probiotic strains and inulin; skimmed milk, enriched vitamins and 
micronutrients with chicory-fructo-oligosaccharides; and a product containing two probiotic 
strains and oligofructose (7). Recently, a synbiotic yoghurt containing resistant starch as the 
prebiotic and B. lactis LaftiTM B94 has been investigated (48). 
Due to the importance of fructose-containing oligosaccharides for the stimulation of 
bifidobacteria in the human gut, knowledge about the mechanisms by which these substrates are 
utilised by bifidobacteria is important. This would facilitate the development of novel prebiotic 
substrates and synbiotic products for biotechnological application. Bacterial mechanisms involved 
in the uptake and catabolism of the fructose-containing carbohydrates, raffinose and sucrose, will 
be reviewed, as this pertains to the research that was conducted and which will be presented in 
this dissertation. Firstly, raffinose utilisation will be discussed and this will be followed with an 
analysis of sucrose utilisation. However, before the two systems are described, some general 
aspects to carbohydrate utilisation, which are relevant to the discussion for both the sugars, will be 










1.5. GENERAL ASPECTS OF CARBOHYDRATE METABOLISM IN 
BACTERIA 
29 
The general aspects to carbohydrate utilisation which will be discussed include: the bacterial 
phosphoenolpyruvate-dependant (PEP) carbohydrate:phosphotransferase system (PTS) . and its 
regulation of non-PTS systems, in particular the involvement of HPrSer in regulation in Gram- . 
positive bacteria. This will be followed by a discussion on catabolite regulation in Gram-positive 
bacteria. 
1.5.1. The Carbohydrate Phosphotransferase System (PTS) 
The principle route for the transportation of carbohydrates in both Gram-positive and gram-
negative bacteria is the high-affinity, multi-component (pEP)-dependant PTS (210, 246). 
Concomitant with the translocation of the carbohydrate across the membrane is its 
phosphorylation. Regardless of the organism or the carbohydrate, all PTSs that have been 
identified catalyse the following overall process: 
Phosphoenolpyruvate(in) + Carbohydrate(out) -+ Pyruvate(in) + Carbohydrate-POn) 
The PTS is composed of two general energy-coupling proteins, Enzyme I, and HPr (histidine-
phosphorylatable protein) and several sugar-specific Enzyme II proteins (210, 223, 246). Enzyme 
II proteins typically consist of up to four protein domains EllA, Elm, EIlC, and EIlD, at least one 
of which is membrane-bound. Transport and phosphorylation of PTS sugars occurs as follows: a 
phosphoryl group donated by PEP is passed via EI, HPr, EIlASugar, EIIBSugar to the incoming sugar 
(Figure 1.8). The translocation of the sugar through the membrane is facilitated by the integral 
membrane domain, EIICSugar. 
EI proteins autophosphorylate a conserved histidyl residue with PEP as the phosphoryl donor. HPr 
proteins are phosphorylated by the phosphorylated form of EI at the conserved histidyl (His15) 
residue. In low-GC Gram-positive bacteria, HPr can also be phosphorylated at a conserved serine 
(Ser46) residue. The phospho group of HPrHis-P can be transferred to an Ell, whereas the 
phospho group ofHPrSer-P is removed by a phosphoprotein phosphatase and has been implicated 
in the regulation of several systems, and will discussed in section 1.5.2.1. The organisation of Ell 
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Figure 1.8. Organisation of the PTS components. Enzyme I and HPr are the general proteins for all PTSs. Ells 
contain two hydrophilic domains, IIA containing the first phosphorylation site (P-His), and lIB containing the second 
phosphorylation site. The hydrophobic IIC domain is membrane-bound. Two varieties exist for sucrose-specific Ell 
proteins corresponding to (I) those found in Streptococcus mutans, Pediococcus pentosaceus, and Lactococcus lactis 
where the EllA EIIB and EIIC domains are fused to form EIIBCAscr proteins and (2) those found in Bacillus subtilis, 
Staphylococcus xylosus, Vibrio alginolyticus, Clostridium beijerinckii and Klebsiella pneumoniae where only the 
EIIB and EIIC domains are fused to form EIIBCscr proteins. It should be noted that this is a simplified representation 
of PTS components and that different combinations of Ell protein domains specific for other sugars exist. 
Abbreviations: P-, phosphorylated form of the various proteins; Glc, glucose; PEP, phosphoenolpyruvate. (After 149 
and 210). 
1.5.2. Regulation by PTS 
The PTS also regulates the transport and metabolism of non-PTS carbohydrates (210, 243). This 
is triggered by the presence of a preferred carbon source in the growth medium, usually glucose, 
which inhibits the expression of proteins involved in the utilisation of alternative carbon sources. 
In Gram-positive bacteria, glucose has been shown to inhibit the uptake of both PTS and non-PTS 
sugars (inducer exclusion), and stimulates the dephosphorylation of intracellular sugar-phosphates 
and/or the efflux of the dephosphorylated sugar (inducer expulsion). These regulatory 











protein-protein interactjons between proteins/components of the PTS with non-PTS proteins (210, 
226). These have been studied extensively and for a review see references (210) and (243). For 
the purpose of this study, the mechanisms by which PTS components regulate non-PTS systems 
in Gram-positive bacteria will be discus~ed briefly, and all involve the HPr protein. 
1.5.2.1. Regulation Involving HPrSer in Gram-positive Bacteria 
As already mentioned, Gram-positive bacteria phosphorylate serine-46 in addition to histidyl-15 
on HPr. This is performed by an ATP-dependant HPr kinase and by phosphorylated-EI 
respectively (210). Whereas the phospho group ofHPrHis-P can be transferred to the various Ells, 
the phospho group of HPrSer-P is removed by a phosphoprotein phosphatase. HPrSer 
phosphorylation regulates different functions in different bacteria. In Lactobacillus brevis, 
HPrSer-P inhibits sugar:H+ symport permeases such as those specific for lactose and glucose 
(339, 341,). More specifically, HPrSer-P binds to the cytoplasmic surface of the permease to 
uncouple sugar transport from H+ cotransport. This converts the transport from an active system 
to a facilitated diffusion system (i.e. from a sugar:W symporter to a sugar uniporter). It is thought 
that other permeases are probably also targets ofthis type of regulation (341). 
In Lactococcus lactis, sugars are taken up by the PTS. It appears that HPrSer-P inhibits the PTS 
and stimulates the activity of, and possibly interacts with, a cytoplasmic sugar-P phosphatase that 
initiates the process of inducer expUlsion (210, 224, 340). The detailed mechanisms involved 
remain to be established. 
HPrSer-P is also involved in catabolite repression in Gram-positive bacteria. Catabolite repression 
is mediated by the CcpA protein, and this will be discussed in the next section. HPrSer-P is 
involved in CcpA-repression of both PTS and non-PTS genes for catabolic and transport proteins 
(62, 121, 226). The mechanism described thus far is as follows (243): in the presence of glucose, 
the HPrSer kinase is activated and phosphorylates HPr on ser-46. HPrSer-P, possibly together 
with a cytoplasmic metabolite, binds to and activates the CcpA protein, inducing a conformation 
that possesses high affinity for the CRE in the regulatory regions of affected genes (see 1.5.3.) 
This nUcleoprotein complex, possibly with other effector molecules, retards or blocks 
transcription initiation of catabolite-repressible operons. In some cases, the interaction between 
CcpA and HPrSer-P has been found to be stronger in the presence of glycolytic intermediates 











Heterofennentative lactic acid bacteria and bacteria that use carbohydrate pathways other than 
glycolysis seem to lack an intact PTS, and transport their carbohydrates by active transport 
energised by the proton-motive force (210, 232, 243, 246). In some of these organisms, such as 
L. brevis, and L. buchneri, HPr and an ATP-dependant protein kinase that phosphorylates HPr are 
present, but EI and Ell are absent (225). Furthennore, L. brevis exhibits metabolite-activated 
sugar expulsion that is independent of sugar-P hydrolysis, but involves HPrSer-P. It has since 
been revealed that incomplete PTSs may be characteristic of several prokaryotic genera (210). 
1.5.3. Catabolite Repression in Gram-positive Bacteria 
In gram-negative bacteria catabolite repression is mediated by cyclic AMP (cAMP) and the 
cAMP receptor protein (CRP) (163). CRP in complex with cAMP binds to a specific site in the 
promoter region of the affected genes, thereby activating transcription. In the low GC Gram-
positive bacteria, however, catabolite repression is mediated via a negative regulatory mechanism 
(120). 
Catabolite repression in the low GC Gram-positive bacteria is thought to involve the catabolite 
control protein (CcpA) (111, 120). CcpA is a transcnptional regulator belonging to the GaIR-LacI 
family (see 1.8.4), and binds to a cis-active palindromic DNA sequence in the vicinity of, or 
overlapping, the transcriptional start site of the affected gene (192, 329). This sequence is called 
the catabolite responsive element (CRE), and the consensus sequence ((T/A)GNAA(C/G)CGN 
(T/A)(T/A)NCA) has been proposed (121). Binding ofCcpA to the CRE is stimulated by HPr that 
has been phosphorylated at the serine residue (226). In Bacillus subtilis, Crh, an HPr-like protein 
has also been shown to stimulate CcpA binding (84). Besides its repressor function, CcpA also 
operates as an activator, and this is also mediated by binding to a CRE (160). 
The mechanisms involved in catabolite repression in the high GC Gram-positive bacteria are 
poorly understood. Catabolite repression is best characterised in Streptomyces coelicolor, and it 
has been suggested that serine phosphorylated HPr does not playa role in the high GC Gram-
positive bacteria (207). This was proposed since it appears that they lack both HPr serine kinase 
and HPr serine phosphatase. Several cis-acting regions containing either direct or indirect repeat 
sequences have been identified in Streptomyces which are involved in the negative regulation of 
catabolite repression-controlled promoters. None of these cis-acting regulatory sequences share 
any obvious sequence or structural similarity. Some trans-acting factors have also been implicated 
in catabolite repression in Streptomyces, however the precise roles of these proteins in mediating 











One of the trans-actillg proteins that is receiving more attention with regards to its role in 
catabolite repression is the glucose kinase GlkA, an enzyme which catalyses glucose 
phosphorylation and is essential for glucose metabolism in S. coelicolor (5, 6, 143). It has been 
proposed that GlkA has a regulatory role that is distinct from its catalytic function, since 
complementation of a glkA mutant with a heterologous glucose kinase, or activation of a cryptic 
glucose kinase, could restore glucose metabolism but not catabolite repression (5, 143). Sequence 
analysis of the glkA gene revealed that its product is a member of the ROK (repressor, orf, kinase) 
family of proteins, and is closely related to sugar kinases (6, 301). GlkA and other sugar kinases 
lack the N-terminal helix-tum-helix DNA binding domain found in transcriptional repressors, and 
therefore, their similarity likely reflects their sugar binding property. It has been suggested that 
kinases of this family would exert their regulatory function by the interaction with transcriptional 
factors (35, 301). A regulatory role for the glucose kinase in the low-GC Gram-positive bacteria, 
Bacillus megaterium and Staphylococcus xylosus, has also been proposed (319, 320). 
Furthermore, the S. xylosus GlkA contributed to catabolite repression as part of a non-PTS 
glucose utilisation system (75, 128). However, in S. xylosus, catabolite repression is mediated by 
CcpA and HPr (69, 123), and although GlkA participated in activation of CcpA, it was not able to 
trigger CcpA-mediated regulation independently from HPr kinase (128). Therefore, the role of 
GlkA in catabolite repression, particularly its involvement in the high GC Gram-positive bacteria, 
is yet to be clearly defined, and other proteins involved have probably yet to be discovered (207). 
Carbon catabolite repression is generally considered to be a phenomenon whereby a preferred 
carbon source in the medium, usually glucose, is sequentially metabolised before an alternative 
carbon source. This generally results in the repression of genes and operons, whose gene products 
are involved with the utilisation of the alternative carbon source. More recently, however, it has 
been suggested that catabolite repression serves as an autoregulatory device to keep sugar 
utilisation at a certain level, rather than to establish preferential utilisation of carbon sources (35). 
Autoregulation, therefore, enables bacteria to adjust sugar utilisation to their metabolic capacities, 
protecting cells from adverse effects which would result by the uptake of excess carbohydrate. 
The mechanisms involved allow bacteria to establish a hierarchy of sugar utilisation for the 











1.6. GENERAL ~SPECTS OF BACTERIAL RAFFINOSE METABOLISM 
Raffinose (galactose-a-I,6-sucrose) can be hydrolysed by a P-fructosidase giving rise to fructose 
and melibiose (galactose-a-I,6-glucose), or by an a-galactosidase resulting in galactose and 
sucrose (glucose-a-I,2-fructose). Melibiose and sucrose can then be further hydrolysed by a-
galactosidases and sucrases respectively. Generally, the latter hydrolysis which results in sucrose, 
is preferred, however, in the ethanologenic strains Klebsiella oxytoca M5Al, Erwinia 
chrysanthemi Be 16 and E. coli KO 11, the fructose is cleaved first (185). In this section, the focus 
will be on the uptake of raffinose and on the hydrolysis of the galactose bond to sucrose (in 
raffinose) and to glucose (in melibiose). 
1.6.1. Bacterial a-Galactosidase Enzymes 
The enzyme a-galactosidase catalyses the hydrolysis of a-I,6linked a-galactoside residues from 
simple oligosaccharides such as melibiose, raffinose, stachyose (galactose-a-I ,6-raffinose), and 
from polymeric galactomannans (a-galactosides a-I,6-linked to the backbone of P-I,4-linked D-
mannopyranose units). a-Galactosidases are used in industrial applications for the hydrolysis of 
raffinose from beet sugar syrups (136), hydrolysis of raffinose and stachyose from soybean milk 
(294), hydrolysis of hemic ell uloses for the pulp and paper industry (166), and for the modification 
of galactomannan to improve its gelling properties (37). High temperatures used during these 
processes have led, primarily, to the isolation of thermostable a-galactosidases from thermophilic 
bacteria (80, 177). a-Galactosidases also catalyse transgalactosylation, and therefore, are being 
isolated for the synthesis of novel compounds, particularly for the use as prebiotics (150, 310). 
Based on similarities in primary structure and hydrophobic cluster analyses, a-galactosidases 
have been grouped into three well conserved families in the general classification of glycosyl 
hydrolases (113). Those from bacteria have been grouped into families 4 and 36, while those from 
eukaryotes into family 27. The bacterial a-galactosidases from family 36 are larger than those in 
families 4 and 27, having a molecular weight of -80 kDa vs. the -50 kDa for the enzymes in the 
latter families (81). Only a limited degree of amino acid sequence identity occurs between the 
enzymes in families 36 and 27. The only shared consensus pattern [LIVMFY]-x(2)-[LNMFY]-x-
[LIVM]-D-[DS]-x-[WY], is near the N-terminal end of family 27 enzymes and within the central 
region of family 36 enzymes. Its presence indicates a similar reaction mechanism or a substrate 
binding site. The E. coli melibiase (meIA) represents family 4-type a-galactosidases, and is 











described is missing (1;;4). The E. coli melibiase requires NAD+ and manganese ions as a cofactor 
(38). Family 4-type a-galactosidases have also been identified in Klebsiella pneumoniae (103), 
Salmonella typhimurium (182), Enterobacter cloacae (196), Enterobacter aerogenes (197) and 
Rhizobium meliloti (83). 
Both intracellular and extracellular a-galactosidases have been isolated from bacteria. Some 
organisms, such as Bacteroides ovatus (90) and Trichoderma reesei (166) have been shown to 
possess more than one a-galactosidase. a-Galactosidase substrate specificities can vary, and can 
decrease with the number of sugar units present in the substrate (105, 106). In organisms where 
mUltiple enzymes exist, the type of a-galactosidase produced is dependent on the type of 
galactoside present in the medium (90, 166). 
1.6.2. Bacterial Uptake of Raffmose and Melibiose 
Unlike for sucrose transport (will be discussed in section 1.8.1.), raffinose transport systems 
isolated thus far do not depend on group translocation by PTS. Raffinose and its hydrolysis 
product, melibiose, can be taken up by bacterial cel~s via various membrane-associated perm eases 
that function via ion-linked transportation. These permeases can be grouped into two different 
types of mechanisms. The first type involves ABC transporters, while the second uptake system 
involves cation coupling. 
Periplasmic transport systems functioning as ABC (ATP-binding cassette) transporters are utilised 
by Streptococcus mutans (msmEFGK) (238), S. pneumoniae (rajEFG) (233) and R. meliloti 
(agpA) (83) for the transportation of raffinose and melibiose. These transporters are clustered 
together with other a-galactosidase genes. Periplasmic transport systems typically consist of a 
ligand-binding protein which is in the periplasm of gram-negative bacteria or tethered to the outer 
face of the cytoplasmic membrane of Gram-positive bacteria by covalently attached lipid, together 
with two different transmembrane proteins and at least one protein capable of binding and 
hydrolysing ATP (289). For R. meliloti, only the periplasmic ligand-binding protein has been 
identified (agpA), although an ORF (agpB) downstream of agpA could tum out to be another 
transport component (34, 83). In both the streptococci, the msmElrajE genes code for proteins that 
are likely to be anchored in the membrane and which have an ATP/GTP-binding site motif (233, 
238). They also have the msmFGlrajFG genes encoding for sugar transporters, and S. mutans but 
not S. pneumoniae, encodes a cytoplasmic protein (MsmK) which shows homology to members 
of the family of ATP-binding proteins (238). The streptococci raffinose utilisation systems will be 











The other three systems -of raffmose transport involve cation-coupled symporters. These are the 
raffinose utilisation RafB permease of E. coli (12), the LacY permease of the E. coli lac operon 
(236), and the melibiose utilisation MelB permeases from E. coli (215), K. pneumoniae (103), 
S. typhimurium (182), E. cloacae (196) and E. aerogenes (197). The secondary structures of these 
proteins, as predicted by hydropathy profiles, contain 12 hydrophobic segments thought to 
represent transmembrane a.-helical domains (Figure 1.9) (12, 29, 76, 103, 144, 182). The N- and 
C-termini are on the cytoplasmic side of the cytoplasmic membrane. Although the LacY permease 
is primarily involved in the uptake of ~-galactosides, it has been shown to transport raffinose and 
melibiose as well (45, 236). The RafB permease transports raffinose, melibiose and lactose (12). 
The melibiose permeases mediate transport of mono-, di- and trisaccharides (TMG and galactose, 
melibiose and lactose, and raffinose respectively) (153, 236,268). 
In many of the bacterial cotransport systems, H+ is the sole coupling cation. This has been shown 
for the E. coli LacY protein (332). The E. coli RafB permease exhibits striking similarities to the 
LacY protein (12). Furthermore, amino acids shown to participate in lactose-proton symport in the 
Lac Y are well conserved in RafB, and transport via RafB depends on the proton motive force. 
Interestingly, the melibiose permease of E. coli utilIses either W, Na+ or Lt as a coupling cation, 
depending on the substrate being transported (304). For melibiose transport, Na+ or H+ is utilised 
as a coupling ion, whereas Na+ or Li+ is used for TMG (methyl-l-thio-~-D-galactopyranoside) 
transport and Na +, W or Lt is utilised for methyl-a.-galactoside transport. The S. typhimurium 
melibiose permease utilises either Na+ or Li+, but not H+ (182), while in K. pneumoniae and 
E. aerogenes melibiose transport is not stimulated by Na + at all, but is stimulated by Lt (103, 
197). In E. cloacae, neither Na+ nor Lt stimulate transport, and only H+ can be used as the 
coupling cation (196). For the E. coli melibiose permease, four and eighteen amino acid residues 
have been identified which are involved in cation and substrate recognition respectively (132, 
338). All except one of the identified residues are also conserved in the S. typhimurium melibiose 
permease (Figure 1.9) (182). The carboxyl tail of the E. coli melibiose permease plays no direct 
role in substrate recognition or energy transduction, but rather the sugar/cation binding sites are 
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Figure 1.9. A membrane topology model of the melibiose permease (MeIB) of Salmonella typhimurium. Amino acid 
residues with no mark are identical in the S. typhimurium and E. coli permeases, encircled residues are conserved, and 
boxed residues are non-conserved (182). 
1.7. RAFFINOSE UTILSATION SYSTEMS IN BACTERIA 
1.7.1. Escherichia coli 
Raffinose and melibiose utilisation in E. coli is mediated via two different mechanisms: an 
inducible, plasmid-borne raj operon consisting of 4 genes, or by an inducible chromosomally-
linked mel operon consisting of 3 genes. Both of these systems will be discussed briefly. 
1.7.1.1. The E. coli ra/Operon 
Among the 39 Raf plasmids that have been independently isolated from E. coli, one, pRSD2, has 
been sequenced and analysed (12, 13). Originally, a 6.1 kb raj operon consisting of four genes 
was identified. These were, raJA, encoding an a-galactosidase; rajB, encoding a raffinose 
permease; rajD, encoding a sucrose hydrolase; and rajR, encoding a repressor (Figure 1.10). The 











located upstream of ratA and is transcribed from its own promoter. More recently, a fifth gene, 
rajY, encoding an outer membrane protein, has been identified 599 bp downstream from the 3' 
end of rajD (Figure 1.10) (306). The raj operon closely resembles the E. coli lac operon in overall 
organisation and mode of control. The differences pertain to substrate specificities of a- versus ~­
galactosidase and to sucrose hydrolase versus transacetylase (12). The closest resemblance is 
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Figure 1.10. Genetic organisation of the Escherichia coli rqf operon. The rqfABD promoter region is enlarged 
showing operators 0 1 and O2 (boxed), and the -10 and -35 sequences (underlined) (12, 13, 186,306). 
RafA, a-galactosidase, functions as a tetramer of identical 82 kDa subunits (12). It is distinct from 
the E. coli melA analogue (189) by cofactor requirement, stability and primary structure, but 
shows identity to two eukaryotic a-galactosidases (12, 266). RaID, sucrose hydrolase, is a 
homodimer of 55 kDa subunits, and has no counterpart in E. coli K12 (12). The cleavage of 
sucrose by RaID is an indispensable step in the catabolism of raffinose. Mutants in rajD grown in 
1 % raffmose accumulate sucrose, causing the cells to lyse after 3 divisions. Other E. coli K12 
hosts harbouring the same mutation could cope with excessive sucrose by exporting it via an 
unknown transport system. The rajB and rajD ORFs overlap by 1 bp, a configuration frequently 
accompanied by translation coupling. It is thought that this ensures sufficient synthesis of sucrose 












The membrane-bound RafB permease transports raffinose, melibiose and lactose. Although 
uptake is via a non-PTS, RafB is subject to regulation by the PTS. This PTS-mediated regulation 
involves binding of EWlucose (300). It is likely that this binding occurs at the central loop of RafB 
between transmembrane helices 6 and 7 by analogy to binding to the E. coli LacY (300,333). The 
RaN glycoporin downstream from rajD, was found to increase the uptake rates for maltose, 
sucrose and raffinose, and also permitted the diffusion of stachyose and maltodextrins (306). 
However, more recently, it has been shown that RaN does not contain a binding site for 
carbohydrates, and it has been suggested that it forms a general diffusion pore as apposed to a 
carbohydrate-specific porin (4). 
The raj operon transcription is negatively regulated by RafR and this repression is reversed by the 
addition of inducer, melibiose (13, 186). An N-terminal helix-tum-helix domain interacts with 
two nearly identical 18 bp palindromic operator sites, 0 1 and O2, which flank the -35 promoter 
box, with 02 located between the -35 and -10 boxes (Figure 1.10) (186). Although both operators 
bind RafR with equal affinities, O2 is more efficient in regulating promoter activity in vivo: RafR 
bound to 0)02 results in a 1200-fold repression, when bound to O2 alone results in 45% 
repression, whereas binding to 0 1 results in a 6% repression (183). Therefore, O2 is the dominant 
site crucial for controlling transcription initiation by RNA polymerase, whereas 0 1 has an 
accessory function. The affinity ofRafR for an operator site is lowered approximately 13~fold if 
the adjacent site has already been occupied by RafR. This is likely due to the steric hindrance 
between the RafR dimers bound to 0 1 and O2 which are only 3 bp apart. It has been suggested that 
this arrangement facilitates a single repressor molecule to oscillate between sites. 
1.7.1.2. The E. coli K-12 mel Operon 
The E. coli mel operon consists of three genes, melR, melA and meiB, which encode for a positive 
regulator of the AraClXylS family of transcriptional regulators, an a-galactosidase and a 
permease respectively (104, 325). The melA and melB genes are co-transcribed, and melR is 
transcribed divergently from its own promoter (Figure 1.11). 
Expression ofmelR and melAB is induced by melibiose and other a-D-galactosides (195), and this 
induction requires that melR be present either in cis or in trans (325). Regulator proteins 
belonging to the AraC/XylS family have conserved DNA-binding domains (85). These domains 
are about 100 amino acids long, and are usually located at the C-terminus of the protein. In some 
proteins, amino acids outside of the DNA-binding domain may be involved in dimerisation, 











suggested that MelR binds to the me/AB promoter to initiate transcription (326). In support of this, 
the me/AB promoter contains a poor -10 hexamer sequence, and lacks a -35 consensus sequence, 
which is typical of a promoter requiring an activator (202, 217). However, experimental evidence 
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Figure 1.11. Genetic organisation of the Escherichia coli K-12 mel operon. Boxed arrows indicate the gene, and thin 
arrows indicate transcriptional polarity and co-transcription of the melA and melB genes. 
In addition to MelR regulation, cAMP also seems to be involved in transcriptional regulation. 
Transcription from the me/R promoter, but not the me/AB promoter, is dependant on cAMP-CRP. 
A sequence showing homology to the cAMP-CRP binding consensus sequence (56) was 
identified from position -52 to -31 upstream of the me/R transcription site, where 10 out of the 14 
positions are homologous (325). cAMP-CRP is only able to bind to the me/R promoter in the 
presence of RNA polymerase. It has been suggested that cAMP-CRP and RNA polymerase make 
direct contact in open complexes and mutually tighten binding. This low affInity that the me/R 
promoter has for cAMP ensures that MelR is made only under extreme conditions, suggesting that 
melibiose is one of the "least preferred" substrates for E. coli. Although severnl me/AB genes have 
been isolated from other organisms, the regulatory gene has only been identified in E. coli, 
R. meli/oti and K pneumoniae (34, 103, 325). Regulatory analysis has not been conducted in 
K pneumoniae, while in R. meliloti it has been shown that the regulator (agpT) also functions as 
an AraC-like transcriptional activator (34). 
1. 7.2. Streptococcus pneumoniae and S. mutans 
These two organisms each have a cluster of genes bearing significant structural similarity to each 
other, with some of the genes showing high amino acid homology (233, 238). The S. mutans msm 












involved in the metabolism of multiple sugars (Figure 1.16) (238). It is responsible for the uptake 
of melibiose, raffmose and isomaltotriose and for the metabolism of raffmose, melibiose, sucrose 
and isomaltosaccharides. In the S. pneumoniae raf system, a 10.2 kb gene region also containing 8 
genes is required for the regulation and metabolism of raffmose alone (Figure 1.12) (233). Besides 
the substrate utilisation specificities, the differences between these two systems is that in the 
S. pneumoniae cluster the dexB (dextran glucosidase) and the msmK (ATP-binding protein) genes 
are absent, while the two genes, rajS and raj){, are only found in the pneumococcal gene cluster. 
Due to the similarities between the two systems, and considering that the S. pneumoniae system is 
specific for raffinose utilisation, only the S. pneumoniae system will be discussed further here. It 
should be noted however, that the utilisation of additional substrates by S. mutans could be due to 
the absence of the msmK and dexB genes in S. pneumoniae, and that besides this, the two systems 
possibly function by very similar mechanisms. The S. mutans msm system will be discussed 
further in section 1.9.3 with regards to sucrose utilisation. 
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Figure 1.12. Genetic organisation of the Streptococcus pneumoniae raj operon. Thin arrows indicate operons and 
transcriptional polarities. 
In the S. pneumoniae raf system, three transcripts are produced. The first transcript contains the 
rajS and rajR genes, encoding proteins which find homology to the B. subtilis biotin repressor 
protein (BirR) and to an AraClXylS family transcriptional regulator, respectively. Reading 
divergently from these is the aga gene encoding an a-galactosidase (Figure 1.12). Downstream of 
the aga is an operon of 5 genes: rafE, raff, rafG, gtfA and raj)(. The first three genes encode 
proteins with high homology to the S. mutans MsmE, MsmF and MsmG proteins respectively, 
and are likely to be involved in sugar binding and transportation, specifically of raffmose. The 
gtfA gene encodes a sucrose phosphorylase and is, therefore, likely to be involved in the 
catabolism of sucrose, the product from raffmose hydrolysis by the a-galactosidase. The last gene 











a-Galactosidase activity-is low in the presence of glucose and sucrose as a carbon source, and 
raffinose is the only sugar that induces activity. However, only sucrose, and not glucose, 
catabolite-represses aga induction when present in media containing raffinose. Furthennore, this 
repression is mediated by the sucrose PTS either directly or indirectly. With a CRE located 
upstream of the aga translational initiation codon, and the identification of a CcpA homologue in 
the S. pneumoniae genome, it is postulated that catabolite repression is mediated by the CcpA 
protein. However, inactivation of the gene has no effect on the regulation of aga expression. 
Therefore, catabolite repression is either mediated by the PTS directly, or by another regulatory 
protein. The two repressors identified; RafR and RafS, function as a positive and a negative 
regulator of the aga promoter respectively. An inverted repeat identified within the aga promoter 
shows high homology to the AraC binding region and could, therefore, function as the site for 
RafR binding. However, the mechanisms by which RafR and RafS regulation occurs, and the 
identity of the triggers for induction, remain unknown. 
1. 7 .3. Pediococcus pentosaceus 
Raffmose utilisation genes have been located on a plasmid, pSRQl, adjacent to a gene cluster 
containing genes for sucrose metabolism (see 1.9.5) (151). The raffinose regulon is thought to 
consist of 2 transcriptional units with opposite polarities (Figure 1.18) (149). The first contains 
rajP and agaR encoding a putative raffinose pennease and an a-galactosidase. The second 
contains the rajR gene which has homology to the S. mutans msmR activator located in the 
multiple sugar metabolism system (238). Further research will be required in order to discuss this 
system in more detail. 
1.8. GENERAL ASPECTS OF BACTERIAL SUCROSE METABOLISM 
It is thought that bacterial sucrose utilisation systems have evolved by modular evolution, where 
individual genes sharing a common origin became independently associated into regulons and 
operons (299). In most organisms the genes mediating sucrose uptake and hydrolysis are clustered 
together on the chromosome, fonning operons or regulons. Many of the sucrose utilisation 
systems that have been isolated thus far have certain features or components in common. These 
include: (i) a sucrose transport system, typically involving the PTS; (ii) enzymes that hydrolyse 
sucrose; (iii) ATP-dependent fructokinases and (iv) regulatory proteins, typically of the GaIR-











will be followed by a more detailed analysis of bacterial sucrose utilisation systems that have been 
characterised. Examples ofnon-PTS sucrose uptake and utilisation systems will also be presented. 
1.8.1. Sucrose Transport and the Phosphotransferase System 
A general introduction to the PEP-dependent PTS was given in section 1.5.1. The vast majority of 
bacteria take up the disaccharide via the sucrose-specific PTS. Sucrose-specific PTS genes have 
been isolated from several Gram-positive and gram-negative organisms, including Bacillus 
subtilis (77, 78, 88, 283), Streptococcus mutans (285, 286), Streptococcus sobrinus (43), 
Lactococcus lactis (295), Pediococcus pentosaceus (151), Klebsiella pneumoniae (14, 66, 127, 
299), Salmonella typhimurium, Staphylococcus xylosus (36,89,318), Vibrio alginolyticus (21, 22, 
269), Clostridium beijerinckii (222) and Erwinia amylovora (24). Typically, sucrose transported 
by the enzyme II proteins of the PTS yields intracellular sucrose-6-phosphate, which is cleaved by 
an intracellular invertase to yield glucose-6-phosphate and fructose (210). Fructose is further 
phosphorylated by an ATP-dependent fructokinase for metabolism via the glycolytic pathway. 
The organisation of Enzyme II protein domains v.aries, consisting of a single fused protein or 
fused and unfused domains. In the case of sucrose-specific Enzyme II proteins, two varieties exist. 
Those of S. mutans, P. pentosaceus, and S. sobrinus, the EllAScr EIIBScr and EIICScr domains are 
fused to form EIIBCA Ser proteins. Those of B. subtilis, V. alginolyticus, S. typhimurium, 
K. pneumoniae, Clostridium beijerinckii and S. xylosus, only the EIIBSer and EIICSer domains are 
fused, forming EIIBCScr proteins. In enteric bacteria, the EllA Gle protein allosterically controls the 
activities of target permeases, possibly by phosphorylation (209, 246). In cases where the EIIBScr 
proteins exist, evidence suggests that the EIIBSer subunit is phosphorylated by the EllA Gle domain 
(21, 152,280,287). 
Non-PTS sucrose uptake pathways involve facilitated diffusion or active ion-symport transport 
systems, followed by intracellular hydrolysis of unphosphorylated sucrose. Such systems have 
been described for Zymomonas mobilis (101), V. alginolyticus (130, 269), S. mutans (238) and 
E. coli (23). 
1.8.2. Enzymatic Sucrose Hydrolysis 
Sucrose hydrolysis is carried out by several glycosyl hydro lases belonging to different families, 
and in some bacteria more than one sucrose-hydrolysing activity is present. The ~­
fructofuranosidases belonging to family 32 are the largest group of these (112, 113, 114). They 











Some levanases and inulinases have increased specificity towards high molecular weight fructose 
polymers (P(2,6Hinked levans and P(2,1)-linked inulins). Some hydrolyse the low molecular 
weight fructose containing sugars such as raffinose and sucrose. In this group are the sucrose-6-
phosphate hydro lases, which hydrolyse both sucrose and sucrose-6-phosphate, but have a lower 
Km for the latter substrate (161, 267, 296). 
Many of the lactic acid bacteria employ glucosyltransferases (GTFs) and fructosyltransferases 
(FTFs) for the synthesis of high molecular weight glucans and fructans respectively from sucrose. 
These GTFs and FTFs also catalyse the hydrolysis of sucrose. The insoluble glucans and fructans 
produced are resistant to microbial degradation and are thought to provide an extracellular energy 
reserve. In the oral streptococci, they are believed to play a role in the colonisation of smooth 
dental surfaces, and therefore, in the formation of dental caries (188). Lactobacillus reuteri has 
also been found to produce large amounts of glucans and fructans from sucrose (311). A 
glucosyltransferase has recently been isolated from this organism (139), and interestingly, a 
levansucrase (311) and an inulosucrase (312) have also recently been isolated for the synthesis of 
two types of fructans, levan and inulin respectively., L. reuteri has been designated a probiotic and 
the glucans and fructans produced are considered to be prebiotics which contribute to human 
health (40). They also have been implicated in antitumoral (60), immunomodulating (263) and 
cholesterol-lowering activity (227). 
Sucrose phosphorylases catalyse the simultaneous hydrolysis and phosphorylation of sucrose 
using inorganic phosphate, and yields glucose-I-phosphate and fructose. Sucrose phosphorylases 
have been identified in only a few bacteria, and include S. mutans (238), Leuconostoc 
mesenteroides (137), Pseudomonas saccharophila (330), Pseudomonas putrefaciens and 
Agrobacterium vitis (79). 
1.8.3. Fructokinases Associated with Sucrose Metabolism 
Fructose resulting from sucrose hydrolysis must first be phosphorylated by kinases to be 
metabolised by glycolysis. Two families of kinases phosphorylate fructose, namely the 
ROKlhexokinases and the ribokinaselpjkB (28, 301). Fructokinases from both families catalyse 
the same reaction: ATP + fructose ~ ADP + fructose-6-phosphate. Both types of fructokinases 











1.8.4. GalR-LacI-Family Transcriptional Regulators 
Sucrose catabolic genes are predominantly regulated by the GaIR-LacI family transcriptional 
regulators. GalR-LacI proteins have an N-terminal helix-turn-helix DNA binding motif, and the 
remainder of the protein is involved in ligand binding, dimerisation, and in some cases, 
tetramerisation (191, 328). These proteins typically bind to operator sites containing palindromic 
nucleotide sequences in the promoter regions of the affected genes. The central bases. 
(M3NZCI/Gl 'Nz'T3'T4 ') are more highly conserved than the outer bases. The regulatory proteins 
bind to the operators as dimers, with each subunit binding a half site. 
Regulation of gene expression IS typically achieved by transcriptional repression where 
unliganded regulator dimers bind in the promoter regions. Ligand binding changes the 
conformation of the helix-turn-helix domain of the regulator and ultimately results in its 
dissociation from the DNA. In some cases however, the liganded form of the regulator binds its 
operator site, such as the PurR protein of E. coli (273). In addition, the catabolite 
repressor/activator (Cra) protein of enteric bacteria and the catabolite control protein (CcpA) of 
low-GC Gram-positive bacteria are able to effect both transcriptional repression and activation 
(160, 245). In these cases, the position of the operator site relative to the respective promoter 
appears to determine whether the regulator protein acts as a repressor or activator. 
1.9. SUCROSE UTILISATION SYSTEMS IN BACTERIA 
1.9.1. Bacillus subtilis 
Three pathways exist in B. subtilis which are involved in sucrose metabolism. The first, involves a 
non-specific levanase, SacC, which is encoded as the distal gene in a fructose inducible fructose-
PTS operon, and is, therefore, likely to be involved primarily in the metabolism of fructose 
polymers (142, 323). The second two are regulated by antitermination and these will be discussed 
further. 
The first pathway regulated by antitermination involves an extracellular levansucrase, SacB, 
which catalyses both the hydrolysis of sucrose and the synthesis of levans (283). The sacB gene 
was thought to be transcribed as a single unit since the region downstream of the gene contains a 
13 nt long dyad symmetry thought to be a strong rho-independent transcription terminator. It was 











downstream of the sacB gene (Figure 1.13) (204). The levB gene is in turn followed by another 
antitenninator structure and the yveA gene. sacB, levB and yveA are part of the same transcription 
unit. levB encodes a protein with similarity to the B. subtilis SacC described above, and is 
associated with the cell membrane acting in conjunction with SacB to degrade levan. The protein 
encoded by yveA displays all the features of a membrane protein, but its role remains unknown. 
The second pathway regulated by antitennination involves an EIIBCScr protein (SacP) and a 
sucrose-6-phosphate hydrolase (SacA) and they are encoded by the sacPA operon (77, 78, 282). 
Expression of the sacPA operon is induced by sucrose concentrations lower than ImM, while 
expression of sacB is fully induced by concentrations of sucrose higher than 30mM (282). sacPA 
expression is also subject to repression by glucose (II). 
Regulation in response to sucrose occurs predominantly by transcriptional antitennination at 
ribonucleotide anti terminator (RAT) sequences located in the leader regions of the sacB and 
sacPA operons (Figure 1.13) (51, 55). The transcriptional antitenninators SacT and SacY, are 
required for readthrough of the sacB and sacPA operons, respectively, by binding to the RAT 
sequences. SacY and SacT share strong identity to each other and to the E. coli BgIG 
antitenninator protein (55). The sacT gene lies upstream of the sacPA operon (Figure 1.13). The 
sacY gene is encoded as part of the sacXY operon where the predicted sacX protein finds identity 
to EIIBCscr_like proteins and to SacP (346). 
The RAT elements overlap the tenninator component in the leader regions (Figure 1.14) (I 5). 
Both the RAT and adjacent tenninator are predicted to fonn stem-loop structures. An activated 
fonn of SacT or Sac Y binds to the RNA chain preventing the fonnation of the tenninator, in 
which case full length transcripts are produced. In the absence of an activated tenninator protein, 
the tenninator structure fonns, reSUlting in early transcription tennination. 
The regulation of Sac Y and SacT antitennination has not been completely characterised. Analogy 
with antitennination by the E. coli BglG suggests that phosphorylation/dephosphorylation may 
playa role (240). This was supported by the finding that SacY can substitute for BglG in 
antitenninating transcription of the bgl operon in E. coli (124). Furthennore, phosphorylated and 
nonphosphorylated fonns of Sac Y have been identified, and the ratio between them was 
dependent on the external level of sucrose and the cellular levels of SacX. The phosphorylation of 
SacY is carried out by the SacX PTS pennease at a conserved His99 residue in the absence of 











PTS proteins (51). Th~refore, in the presence of sucrose, the dephosphorylated fonn of Sac Y is 
active and facilitates antitennination at the sacB RAT sequence. In the absence of sucrose, SacX 
phosphorylates SacY, thereby inactivating it and early tennination of the sacB occurs. 
Unlike SacY, an intact PTS is essential for SacT activity (11). It is thought that SacT is 
phosphorylated at two sites (11, 240). The one would be as for Sac Y, and would occur in response 
to sucrose concentration. The other site would act as an "activation" site and although the 
phosphoryl donor has not been clearly identified, it is likely to be phosphorylated by the PTS 
proteins, EI and HPr. In support of this, SacT has been shown to be phosphorylated by EI and HPr 
(10). However, the phosphorylation state of SacT did not affect its activity. Therefore, the precise 
role ofEI and HPr mediated phosphorylation remains unclear. 
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Figure 1.13. Genetic organisation of the Bacillus subtilis sacPA operon (A) and the unlinked sacB-levB-yveA and 
sacXT operons (B). Solid arrows indicate transcriptional polarity, and where it extends over more than I gene, co-
transcription occurs. Dashed lines and arrows indicate regulatory relationships: (I): SacT as an antiterminator active 
at the sacPA RAT, (2): the DegU/DegS signalling system which increases transcription off the sacXY and sacB-levB-
yveA promoters, (3): SacX as a negative regulator ofSacY and (4): SacY as an antiterminator of the sacB RAT. SacY 
and SacT also regulate sacXY transcription in response to sucrose. RAT: ribonucleotide antiterminator/terminator 
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Figure 1.14. Sequence (A) and structure (B) of the sacB and sacPA RAT elements and terminators. In both cases the 
terminator overlaps the RAT sequence. The sacB and sacP A RAT sequences differ in 3 positions, indicated in bold. 
Adjacent terminators are indicated by opposing arrows. (After 15 and 149). 
SacT and SacY are also involved in the induction of the sacXY operon in response to sucrose (51). 
The mechanisms involved are not clear since the RAT sequence identified ahead of the scaXY 
transcriptional start is 100 bp from the nearest transcriptional terminator. 
Transcriptional termination is not the only mechanism involved in the regulation of sucrose 
metabolism in B. subtilis. The DegU/DegS signalling system is involved in the induction of sacB 
and sacXY expression (Figure 1.13) (51, 278). Sucrose uptake is also regulated by inducer 
exclusion, where the EIIBScr domain of SacP is phosphorylated by the EllA Glucose domain of the 
EIICBA Glucose protein (287). 
1.9.2. Staphylococcus xylosus 
S. xylosus is a low-GC, Gram-positive, non-pathogenic bacterium isolated from human skin (265). 
Two genetic systems have been identified which are involved in sucrose metabolism. The first, 
consists of the malA gene, encoding an a-glucosidase that is needed for maltose-maltotriose 
catabolism (68). The second, involves a sucrose PTS (36, 89, 318). MalA however, plays a minor 
role in sucrose metabolism in S. xylosus, probably because sucrose-6-phosphate is yielded 











The PTS genes involyed In sucrose metabolism include: serA, encoding a EIIBC
Scr
; serR, 
encoding a GalR-LacI family regulatory protein; and serB, encoding a sucrose-6-phosphate 
hydrolase (Figure 1.15) (36, 89,318). The serR and serB genes are clustered, with the serR ORF 
termination codon 84 bp from the start codon of the serB ORF (36, 89). Despite their proximity, 
the two genes are independently transcribed. The serA gene is not associated with the serRand ser 
genes, and no additional sucrose utilisation genes are encoded close to the serA (318). 
There are 137 bp downstream of the serB gene in the published nucleotide sequence (accession 
no. X67744). Sequence analysis of this region indicated the presence of a truncated, 47 amino 
acid ORF. The deduced sequence showed identity to the N-terminal regions of ribokinase/pjkB 
family fructokinases, with the highest identity (45%) to the Clostridium aeetobutylieum ScrK 
(accession no. AAF35840.1). Furthermore, two domains conserved in the N-terminal regions of 
ribokinase/pjkB family fructokinases, (GEALID) and (GGAPCNV A) (28,334), were identified. It 
is, therefore, likely that a serK gene lies immediately downstream of serB, it would follow that the 
ser gene cluster consists ofthree, and not two, genes, namely serR, serB and serK. 
The serA, serR and serB genes have been disrupted in the S. xylosus genome (36, 89, 318). The 
serA and serB mutants were deficient in sucrose uptake and sucrose hydrolase activity 
respectively. The serR mutant expressed these activities constitutively, suggesting that ScrR 
functions as a negative regulator of serA and serB production (89). 
An imperfect palindromic sequence, OB, was identified +6 to +21 bp relative to the serB 
transcription start site, which was proposed to be the ScrR binding site (89). A 4 bp deletion of 
this site resulted in the constitutive expression of sucrose hydrolase activity. Furthermore, gel shift 
analyses demonstrated that a fusion of ScrR to the maltose-binding protein (MBP-ScrR) 
specifically bound to DNA fragments containing OB. This suggests that in the absence of sucrose, 
ScrR is bound to OB, preventing transcription of serB. Loss of binding in the OB mutant indicates 
that ScrR binds as a dimer. Neither glucose, fructose nor any of their metabolic intermediates 
affected the binding of ScrR. Sucrose also failed to have an effect. However, it was suggested that 
sucrose-6-phosphate would likely be the inducer molecule, given that sucrose would be present in 
this form as a result ofPTS-dependent transport. 
Evidence from the strain carrying the 4 bp deletion in OB suggests that this operator site also plays 
a role in glucose-mediated repression of serB, since glucose was unable to repress sucrose 











consensus sequence (discussed in section 1.5.3), raising the possibility that CcpA might also exert 
an effect at OB. Certainly, the CcpA has been cloned and characterised from S. xylosus and has 
been shown to mediate catabolite repression in this organism (69). 












Figure 1.15. Molecular organisation of the Staphylococcus xylosus suerose-PTS utilisation system. The serA, scrR 
and serB genes are independently transcribed and transcriptional polarity is indicated by the arrows. The dotted lines 
indicate the repression of the serA and serB transcription by ScrR at the OA1/OAl and OB operators respectively. In the 
presence of sucrose SerR is released from the operator sites and transcription proceeds. The 137 bp sequence after the 
published serB nucleotide sequence (Accession no. X67744) was analysed. A truncated ORF showing identity to 
ribokinase/pftB family fructokinases was observed, suggesting that a scrK gene could be located downstream of serB 
gene. --*---, indicates that the scrA gene is not linked to the serR, and scrB genes. 
The serA transcription is almost certainly also regulated by ScrR. Two 24 bp Os-like palindromes 
were identified in the serA promoter region (318). The one, OAb has three mismatches compared 
with OB, and overlaps the serA -10 promoter. The second, 0 A2, differs at two positions compared 
to OB and is located between positions + 11 and +24 downstream of the major transcriptional start. 
Gel mobility shift assays demonstrated that ScrR bound to the serA promoter region, but it was 
not established whether OAl or OA2 or both operator sites were involved (89). 
1.9.3. Streptococcus mutans and S. sobrinus 
The oral bacterium S. mutans has been implicated as the organism of greatest significance in the 
causation of dental caries, and the role of dietary sucrose in this is well documented (157). 
S. mutans possess a large number of enzymes which can act on sucrose (42). Extracellularly there 
are several glucosyltransferases (GTF) and fructosyltransferases which form polymers from one 
half of the disaccharide and release free monosaccharides (239). Under certain conditions, GTF 











while the remainder is metabolised intracellularly (157). Intracellular sucrose metabolism is 
mediated by at least two systems: a high affinity PTS-dependent system (285) and a low affinity 
multiple sugar metabolism (msm) system (238). In addition, a trehalose-PTS system has been 
shown to transport sucrose (213). Only the msm system and PTS-dependent system will be 
reviewed in the following discussion. 
The msm system is involved in the uptake and metabolism of several sugars, including raffinose, 
melibiose and isomaltosaccharides, and this is carried out by eight genes which are located on an 
11 kb region (Figure 1.16 A) (238). These are: msmR, encoding a positive effector protein; aga, 
encoding an a-galactosidase; msmE, encoding a sugar-binding lipoprotein; msmF and msmG, 
encoding integral membrane proteins; gtfA, encoding a sucrose phosphorylase; msmK, encoding 
an ATP-binding protein and dexB, encoding a dextran glucosidase. All the genes, except for 
msmR, are present in the same orientation and are co-transcribed (173). Expression of the genes is 
induced by raffinose and melibiose but not by isomaltose and isomaltotriose (238). 
The MsmE lipoprotein is thought to reside on the c~ll surface, where it binds target sugars, which 
are then transported by the membrane components MsmF and MsmG (173, 238). Transport and 
metabolism by msm is regulated by the PTS (54). As was discussed in section 1.5.2, PTS-
mediated regulation of non-PTS systems in Gram-positive bacteria involves the phosphorylation 
ofnon-PTS target proteins. Although the precise details have not been determined, it seems likely 
that a phosphoprotein specific to msm substrate-grown cells is involved and is phosphorylated by 
the PTS. At first, it was thought that sucrose was only generated intracellularly as a result of a-
galactosidase activity on raffinose (293). It would then be metabolised by the sucrose 
phosphorylase (GtfA). However, sucrose was found to block 70% of melibiose transport. This 
was further validated when sucrose uptake was increased in a sucrose PTS-deficient strain. 
However, the msm system only transports sucrose with a low affinity, and only plays a role in the 
presence of high concentrations of sucrose. 
The sucrose PTS on the other hand, is likely to facilitate the uptake of sucrose in low 
concentrations. The sucrose PTS regulon is encoded by the serK, serA, serB and serR genes 
(Figure 1.16 B) (107, 116, 161, 256, 257). The ser genes encode: a ROKlhexokinase family 
fructokinase (ScrK); and EIIBCA Scr protein (ScrA); a sucrose-6-phosphate hydrolase (ScrB) and a 
GalR-LacI family regulatory protein (ScrR). The serA and serK genes are independently 











phosphomannose isomerase gene (pmi) is located downstream of the serK, and disruption of the 
serK reduced pmi activity suggesting that these two genes are co-transcribed (257). 
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Figure 1.16. Genetic organisation of two sucrose utilisation ~lusters of Streptococcus mutans. A: the msm (multiple 
sugar metabolism) system, B: the sucrose-PTS. Thin arrows indicate transcriptional polarities and where it extends 
over more than one gene co-transcription has been inferred. 
Expression of serA and serB is induced by sucrose and repressed by glucose and fructose (116). In 
addition, maltose and sorbitol repressed serA activity to levels similar to what was observed for 
fructose. However, for serB, contradicting results have been reported for the effect of sorbitol and 
mannitol on expression (116, 286). Expression of the serA and serB genes was reduced under 
acidic growth conditions (PH 5.6) relative to neutral pH (116). Plaque bacteria are subjected to 
fluctuations in pH (157), and the fermentation of sugars would lead to lactic acid formation 
thereby decreasing the environmental pH. Therefore, this possibly plays a role as a feedback 
repression system, however further experimental evidence is required. 
The presence of the serR gene suggests an involvement ofits gene product in the regulation of the 
ser genes. Inactivation of serR resulted in the constitutive expression of serB, suggesting that 
ScrR functions as a negative regulator (116). Due to its identity to GalR-LacI-like proteins and the 
presence of a helix-tum-helix domain in the N-terminus, ScrR was investigated for its ability to 
bind to the serA-serB promoter region. A gel shift was observed with crude extract from cells 
expressing serR which was absent when crude extract from serR-mutant cells was used, and this 











binding protein or to tnmscarboxylase to the serB promoter could not be obtained. This could, 
however, be due to the fusion. Further experimental evidence is required to establish the exact 
mechanism by which ScrR interacts with the serA-serB promoter. 
A truncated sucrose PTS operon has also been cloned from S. sobrinus, and it is similar to the 
S. mutans system (43, 44). The serA and serB genes were identified, encoding an EIIBCAScr 
protein and a sucrose-6-phosphate hydrolase respectively, and they are arranged identically as in 
S. mutans. A truncated ORF was identified immediately downstream of the serB gene, encoding a 
helix-tum-helix motif similar to that of the S. mutans ScrR. This suggests that as in S. mutans, a 
gene encoding a regulatory protein lies adjacent to the serB gene in S. sobrinus. 
1.9.4. Laetoeoeeus laetis 
Sucrose utilisation in L. laetis is associated with resistance to and production of the antibiotic 
nisin (87). These traits are encoded by conjugative transposons, all of which are approximately 
70 kb in size and show a similar organisation (219). They differ with regard to the variant of nisin 
produced, either nisin A or nisin Z, and in their ability to conjugate to other L. laetis strains. Due 
to the 30% GC content of the transposons as opposed to the 38% GC content of the L. laetis 
genome, it has been proposed that the transposons originated outside of the genus Laetoeoecus. 
Sucrose utilisation genes have been isolated and studied from L. laetis NIZO R5 and L. laetis Kl, 
where they are encoded on Tn5276 and Tn5306 respectively. The majority of the analyses have 
been performed on the genes occurring on 1N5276, and this will be discussed further. 
Sucrose utilisation by L. laetis occurs via a typical sucrose PTS pathway (295). The product of 
translocation is sucrose-6-phosphate, which is cleaved by a sucrose-6-phosphate hydrolase to 
glucose-6-phosphate and fructose. Fructose is then converted to fructose-6-phosphate by an ATP-
dependent fructokinase. Four genes are involved in the utilisation of sucrose and are clustered 
together forming two transcriptional operons: saeAR and saeBK (Figure 1.17) (159, 221). A third 
transcript produced from a saeR promoter is also identified under sucrose-inducing conditions 
(159). saeA and saeR encode the sucrose-6-phosphate hydrolase and a GaIR-LacI family regulator 
respectively. Reading in the opposite direction to saeAR are the saeB and sacK genes encoding a 
PTS enzymell and a fructokinase respectively. sacAR, saeBK and saeR transcripts are only 
identified in cells grown in sucrose, and are not detected when glucose is used for growth, 
indicating firstly, that regulation occurs at the transcriptional level, and secondly, that glucose 






















Figure 1.17. Genetic and transcriptional organisation of the Tn5276-located sucrose gene cluster of Lactococcus 
laclis. Thin arrows indicate transcriptional polarities and where it extends over more than one gene co-transcription 
has been inferred (159). 
Inverted repeats were identified in the promoter regions of the saeA, saeB and saeR genes which 
could possibly function as the binding sites for factors involved in sucrose-specific regulation 
(159). Together with the presence of the saeR gene, it was postulated that saeAR and saeBK could 
be regulated by SacR, possibly by binding to the inverted repeats identified. In order to investigate 
the role of SacR in transcriptional control the saeR gene was disrupted. Northern analysis 
indicated that in the presence of glucose, saeAR and saeBK transcription became constitutive, and 
therefore, SacR functions as a repressor of transcription. Furthennore, the same mRNA levels of 
saeAR and saeBK were obtained from sucrose-grown cells indicating that SacR also mediates 
glucose repression. SacR-mediated substrate induction and negative autoregulation of saeR results 
in the efficient transcriptional control of the sae genes in response to variations in sucrose 
concentrations. Binding of SacR to the inverted repeats, however, still needs to be shown 
experimentally. 
1.9.5. Pediococcus pentosaceus and Lactobacillus plantarum 
Bacteria of the genus Pedioeoeeus do not utilise sucrose, with the exception of several strains 
which carry plasmids (96, 97, 187). One of these plasmids, pSRQl in P. pentosaeeus NRRL 
B-11465, contains the genes required for the utilisation of sucrose, raffinose and melibiose (151). 
There are thought to be two transcriptional units with opposite polarities (Figure 1.18) (149). The 
first contains the serB, serR and agl genes, encoding a sucrose hydrolase, a GalR-LacI family 
regulator and an a-glucosidase respectively. The second transcriptional unit is thought to involve 
the serA, agaS and serK genes, encoding a PTS EIIBCAScr, a putative a-galactosidase and a 











and these in tum, are flanked by IS elements similar to the E. coli IS30 and L. lactis IS981. This 
could suggest that the regulon is located on a transposon. Transcription of the two units is 
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Fignre 1.18. Organisation of the adjacent sucrose- and raffmose-utilisation genes from Pediococcus pentosaceus. 
Thin arrows indicate transcriptional polarities and where it extends over more than one gene co-transcription has been 
inferred (149, 151). 
Most Lactobacillus species utilise sucrose and they transport the sugar via the PTS (148). The 
sucrose utilisation locus in L. plan/arum was analysed using peR, Southern hybridisation and 
restriction mapping, revealing high similarity to the sucrose utilisation locus of P. pentosaceus 
pSRQ I (190). It contained the oppositely orientated scrA and scrBRagl operon, but not the agaS 
gene. The presence of the scrK gene was not determined. Sequencing of the scrB gene revealed 
98.6% identity to that of P. pentosaceus, whereas only 94.4% homology was observed between 
their 16S rRNA genes. This suggests horizontal transfer of the sucrose utilisation locus between 
the lactic acid bacteria. This will be discussed further in the next section. 
1.9.5.1. Similarities between the Sucrose PTS Regulons of Streptococci, L. lactis, 
P. pentosaceus and L. plantarum 
The PTS regulons of S. mutans, S. sobrinus, L. lactis, P. pentosaceus and L. plant arum share 
several features and these similarities suggest a common origin (190, 220). The shared features 
are discussed briefly below. For simplicity, the gene nomenclature, scr, will be used throughout, 
where scrA is the PTS Ell, scrB is the sucrose hydrolase, scrR is the regulator, and scrK is the 
fructokinase. 
In each system, the scrA and scrB genes are divergently transcribed and are separated by between 











transcribed with scrB. Jhis is not the case in L. lactis however, where the scrR is co-transcribed 
with scrA. The scrK is located downstream of, and in the same orientation as, scrA, except for in 
L. lactis. For P. pentosaceus and possibly L. plantarum, the scrK gene is not immediately 
downstream of scrA as in S. mutans, and in S. sobrinus a scrK gene has not been identified. 
In all the cases the scr A gene encodes an EImCA Ser protein. This differs from other PTS systems 
which are characterised by EImCScr proteins, such as those found in B. subtilis, S. xylosus, 
C. beijerinckii, S. typhimurium, K. pneumoniae and V. alginolyticus. In all the cases, the scrK 
encodes a fructokinase belonging to the ROKlhexokinase family. In other bacterial sucrose 
utilisation systems, the fructokinase is typically of the ribokinaselpjkB family. 
The fact that the L. lactis sucrose utilisation systems are located on conjugative transposons which 
have a GC content different to the L. lactis genome, and that the P. pentosaceus system is flanked 
by insertion sequences, makes it tempting to propose that the PTS regulons of S. mutans, 
S. sobrinus L. lactis, P. pentosaceus and L. plantarum share a common origin. However, for the 
streptococci it has not yet been determined if the sucrose utilisation system is encoded on a 
transposon. Further investigation is required to clearly establish whether these systems do in fact 
share a common origin. 
1.9.6. Escherichia coli 
Less than 50% of wild-type isolates of E. coli are sucrose positive (67), however, several sucrose-
metabolising strains have been isolated. In E. coli EC3132 and E. coli B-62, the sucrose catabolic 
genes are chromosomally encoded (23, 127,242), while in a third clinical isolate they are present 
on a transposon, Tn2555 (64). The most studied of these is the csc gene cluster (mnemonic for 
chromosomally encoded sucrose) in E. coli EC3132, which will be the focus in this discussion. 
In E. coli EC3132 sucrose is taken up by a non-PTS mechanism and is hydrolysed by an 
invertase/sucrose hydrolase and the released fructose is phosphorylated by a fructokinase (23, 
126). Four genes have been cloned and characterised (Figure 1.19). The cscK and cscB genes, 
encoding a ribokinase/pjkB family fructokinase and sucroselH+ symporter respectively are co-
transcribed. Reading divergently from cscKB is the cscA gene encoding the sucrose hydrolase. 












This sucrose utilisation system in E. coli EC3132 is unique in that it involves a sucrose!f-t 
symporter (CscB) (23, 126). CscB resembles permeases of the cluster 5 of the major facilitator 
superfamily (MFS), particularly with the lactose permease (LacY) from E. coli K-12. However, 
the transport activities ofCscB are significantly lower compared to LacY (126). Furthermore, the 
esc genes are poorly expressed and it seems to be, at least in part, due to the inefficient transport 
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Figure 1.19. Organisation of the chromosomally encoded sucrose utilisation regulon of Escherichia coli EC3132. 
Thin arrows indicate transcriptional polarities and where it extends over more than one gene co-transcription has been 
inferred (23, 126). 
CscR functions as a negative regulator of cscKB and cscA expression, and the presence of a Helix-
turn-Helix motif in the N-terminus suggests that it binds DNA. In the cscK and cscA promoter 
region, a palindromic motif (G6TsT~3A2CdG'IT'2T'3A'4A'sC'6) is present twice, most likely 
corresponding to the operators of the two genes (126). Analysis of a mutant exhibiting enhanced 
sucrose utilisation indicated that a T s-to-Cs transition in the left half of the putative cscK operator 
had occurred, further suggesting the involvement of CscR in regulation. However, further 
analyses need to be performed to characterise the interaction between CscR and the putative 
operators. In the esc promoter-operator region two segments sharing high identity with the 22-bp 
palindromic consensus sequence for a cAMP-CrpA binding site were identified. Expression of the 
esc genes in a Cya- mutant confirmed that both the cscK and cscA promoters were under the 
global control of cAMP-CrpA. 
The esc genes are integrated into the dsd gene cluster on the E. coli chromosome (126). A 
comparison of the esc coding region and adjacent genes from E. coli EC3132 with the genomic 
sequences of the E. coli K-12 and the sucrose-positive uropathogenic E. coli 0157:H7, revealed a 











presence of the argW ~ehe, coding for an arginine-specific tRNA, which served as an integration 
site for mobile genetic elements. A 21 bp repeat sequence was identified at the 3' end of argW 
which is a typical indicator for a site-specific integration of phage-like elements via tRNA-
encoding genes. The repeat identified in 0157:H7 was not annotated in a previous analysis of the 
0157 :H7 sequence, suggesting that the horizontal gene transfer and stable integration must have 
occurred relatively recently in evolutionary terms. This is further supported by the fact that the esc 
genes in EC3132 are poorly expressed and, therefore, have not yet optimally adapted. The B-62 
strain has a doubling time of 48 min on 0.2% sucrose (305), compared to the 20 hour doubling 
time for EC3132 (126). The cscKB operator of B-62 is almost identical to the sequence of 
EC3132 except that there is a C' 6-to-T' 6 transition in the right half of the palindrome. It has, 
therefore, been suggested that B-12 acquired an adaptation mutation to enable the cells to grow 
fast on relatively low concentrations of sucrose, and it therefore, likely inherited its esc genes 
before EC3132. Furthermore, it has been suggested that the esc genes do not belong to the set of 
housekeeping or backbone genes but rather belong to a group of optional genes that are highly 
mobile among the enteric bacteria. 
1.10. AIMS OF THIS STUDY 
Since bifidobacteria are saccharolytic, they play an important role in carbohydrate fermentation in 
the human colon. Taken together with the health benefits that they provide the human host, they 
are target organisms for the development of more successful probiotics and prebiotics. A variety 
of fructose-containing oligosaccharides, including inulin, oligo fructose and raffinose, has been 
reported to selectively stimulate the growth of bifidobacteria, and several are currently added to 
foodstuffs. Despite the considerable commercial and research interests in oligosaccharides and 
probiotic bacteria however, the genetic mechanisms by which these organisms metabolise 
carbohydrates remain virtually unexplored, and relatively little is known about which strains 
actually metabolise the prebiotic substrates that have been identified. Bifidobacteria are very 
diverse in their ability to utilise a wide variety of carbohydrates, and this diversity exists not only 
between species, but also between strains. Therefore, for the purpose of selecting suitable 
probiotic organisms, prebiotic substrates and possible synbiotic applications, it is important to 
establish the substrate requirements, specificities and carbohydrate utilisation mechanisms of 
individual bifidobacterial strains and species. This knowledge will enable the development of 











The main objective of this study was, therefore, to perform a molecular analysis of carbohydrate 
metabolism in these bacteria for the development of a suitable probiotic strain, and for the 
identification of prebiotic compounds which could selectively stimulate their growth in the human 
colon. Comparative studies were to be performed in the three type culture strains, B; breve, 
B. bifidum and B. longum and in the industrial strain, B. lactis. This would involve, firstly, the 
examination of the carbohydrate fermentation patterns of the four bifidobacteria. A molecular 
analysis of carbohydrate metabolism would be conducted for those carbohydrates identified as 
having the potential for the development as a prebiotic from the fermentation experiments 
performed. This would entail the cloning and characterisation of the genes involved in the 
utilisation of the carbohydrate, and examining their role in carbohydrate metabolism. The 
regulatory mechanisms involved would be analysed, both at the physiological and genetic leveL 
In this study, these analyses were performed in the industrial strain B. lactis, focussing on the 
carbohydrates raffinose and sucrose. 
Considerable insight into carbohydrate metabolism has been achieved by the recent release of the 
B. longum genome sequence, which will undoubtedly catalyse research in this field in 
bifidobacteria. It should be noted, however, that this information was not available at the time that 
the work presented in this thesis was initiated. Besides many 16S rRNA sequences, only six genes 
and two plasmids of the members of Bifidobacterium had been cloned and sequenced. In this 
report, the fmdings of the functional and regulatory studies will be placed in the context of the 
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The industrially-used B. lactis strain was isolated from a yoghurt starter culture using a genus-
specific 16S rRNA-targeted probe by colony hybridisation and PCR. Carbohydrate utilisation 
patterns of B. lactis, B. breve, B. longum, and B. bifidum were determined, where a variety of 
substrates were analysed for their ability to support bacterial growth as a sole carbohydrate 
source. B. lactis fermented the second most number of the carbohydrates tested, and it was 
selected for further analyses. Growth curves performed with B. lactis in media containing the 
prebiotic compounds raffinose and oligo fructose as well as sucrose, revealed that raffinose was 
the preferred substrate, and that growth in oligofructose was weak. 
Sucrase and a-galactosidase activities expressed in B. lactis were also investigated. Raffmose 
induced both sucrase and a-galactosidase activities, and sucrase activity was additionally induced 
by sucrose, and to a lesser extent by oligofructose. Both sucrase and a-galactosidase activities 
were repressed by the presence of glucose in the media, however this was more deleterious to a-
galactosidase production than it was for sucrase activity. Partial repression of both activities was 












Bifidobacteria play a very important role in carbohydrate fermentation in the colon since their 
saccharolytic nature enables them to utilise the different types of carbohydrate substrates that are 
potentially available to them in the intestinal environment. Since bifidobacteria provide the human 
host with health benefits (discussed in chapter 1), the prebiotic and synbiotic research approaches 
are receiving a great deal of attention. 
The effectiveness of a probiotic is determined by its ability to survive and compete in the colon 
for food (53), therefore, understanding carbohydrate utilisation by bifidobacteria is extremely 
important. Furthermore, the prebiotic and synbiotic approaches cannot be implemented until 
carbohydrate utilisation patterns of the organisms of interest are determined. 
A variety of fructose containing oligosaccharides, including inulin and oligofructose, have been 
reported to stimulate the growth of bifidobacteria (92, 94). Inulin is commonly found in plants 
such as artichoke, chicory, onion, leek, garlic and asparagus, with smaller amounts in cereal (91). 
It is a polymer of D-fructose linked by ~(2,1) bonds with an a(l,2) linked D-glucose at the 
terminal end of the molecule, and has a degree of polymerization of 2-60+ (229, 231, 322). 
Oligo fructose is produced commercially in one of two ways: either by partial enzymatic 
hydrolysis from chicory inulin using endoglycosidases (91), or by synthesis from sucrose using 
fungal fructofuranosidase (115). Its degree of polymerization is between 2 and 7 (229, 231, 322). 
Soybean is one of the genetically modified crops being adopted, particularly in developing 
countries where one-and-a-half million people suffer from hunger and malnutrition. South African 
farmers have recently begun planting transgenic soy. Soybean oligosaccharides could, therefore, 
become an important component of the African diet. Soybean oligosaccharides have also been 
shown to be prebiotics for bifidobacteria (49), and contain the oligo saccharides raffinose and 
stachyose, as well as sucrose, fructose and glucose. Raffinose and stachyose are both indigestible 
by humans and reach the colon intact. These substrates contain a(1,6)-linked galactose residues, 
and in raffinose it is linked to sucrose. 
The primary aim of the work presented in this chapter was to compare the fermentation patterns of 
the commercial B. lac tis strain to various other Bifidobacterium species with a view to its further 
development for biotechnological applications. In particular, the utilisation of inulin, oligofructose 
and raffinose by the bifidobacteria was of interest due to their prebiotic effects, and therefore, the 











enzymatic mechanisms required to utilise these carbohydrates, the production and regulation of 
sucrase and a.-galactosidase activity in response to different growth conditions was investigated in 
B.lactis. 
2.3. MATERIALS AND METHODS 
2.3.1. Bacterial Strains, Plasmids and Culture Conditions 
Bifidobacterium bifidum NCFB 2203, B. breve NCFB 2257, and B. longum NCFB 2259 were 
obtained from the NClMB culture collection, UK. Bifidobacterial cultures were propagated 
anaerobically at 37°C in an anaerobic chamber (Forma Scientific, Model 1024), in an atmosphere 
of 5% H2, 10% C02, and 85% N2. A comparative analysis of various growth media (Table 2.1) 
was performed (2.4.3) and BYG medium (Appendix B.1.3.) was selected for the culturing of the 
bifidobacteria. However, glycerol stocks were prepared from cells grown in BHl broth (Appendix 
B.1.1.) as previously described (253), and were stored at -70°C under the same anaerobic gas 
mixture as for growth. For the growth curves, and the sucrase assays, 1% (w/v) of each 
carbohydrate was substituted for glucose. 
Table 2.l. Various basal media used for the growth analysis of the bifidobacteria 
BGMedium BYGMedium BCGMedium BSGMedium 
Basic media Tryptone 10 BG medium + BGmedium+ BG medium + 
components a Yeast extract 2.5 Yeast extract 2.5 Casamino acids 0.2 ZnS04.7H20 0.025 
(grams/litre) Glucose 5 CaCh 0.015 
Tween 80 1 
Saltsb 
Reference 57, without 58 - 261 
peptone water 
a A complete description of the media components is described in the appendix. 












Escherichia coli JM109 (336) was used for all cloning purposes and was routinely cultured 
aerobically at 37°C in Luria-Bertani (LB) medium (253), containing ampicillin (Ap) (100 f.Lglml) 
when plasmid was present. The plasmid vector pBluescript SK (PSK) (Stratagene, La Jolla, 
California, USA) was used for cloning purposes. Further strain and plasmid details are supplied in 
Appendix A. 
2.3.2. Isolation of Bifulobacterium lactis 
One gram of a freeze-dried yoghurt starter culture (Darleon Distribution), containing a mixture of 
Bifidobacterium lactis together with Lactobacillus acidophilus, Lactobacillus casei, and 
Streptococcus thermophilus, was dissolved in 10 ml ofBHI broth and incubated anaerobically for 
18 hours. Serial dilutions were performed and plated in duplicate onto BHI agar and incubated 
aerobically and anaerobically. Single, well separated colonies growing only anaerobically were 
selected as putative B. lactis cells and were analysed further by colony hybridization. 
Bifidobacterium genus-specific primers were used to PCR a 16S rRNA DNA fragment from B. 
breve. The PCR fragment was DIG-labelled according to manufacturers' instructions (Boehringer 
Mannheim), and was used as a probe for colony hybridization (Boehringer Mannheim). Colonies 
showing a positive signal were analysed by PCR. PCR was performed as follows (50 f.LI): 5 f.LI 
buffer (supplied with the enzyme); 2.5 mM MgCh; 0.5 f.LM of each primer; 200 f.LM of each 
dNTP; 50 ng chromosomal DNA; and I U of Taq DNA polymerase (Supertherm). The PCR was 
carried out in a GeneAmp 9700 machine (Applied Biosystems). The amplification program 
consisted of one cycle of 96°C for 5 min, then 25 cycles of 96°C for 1 min, 66°C for 45 s, and 
72°C for 1 min, and finally one cycle of 72°C for 5 min. The reaction was cooled down to 4°C. 
The Bifidobacterium genus-specific 16S rRNA gene primers for PCR were: Forward 5'-CGC 
CAG GGT TIT CCC AGT CAC GAC GGG TGG TAA TGC CGG ATG-3' and Reverse 5'-
CAG GAA ACA GCT ATG ACC CAC CGT TAC ACC GGG AA-3'. The underlined sequence 
represents the Bifidobacterium genus-specific 16S rDNA sequence (146). The sequence in the 5' 
region is pSK-derived M13 forward and reverse primers respectively to facilitate sequencing. 
2.3.3. General DNA Manipulations 
Competent E. coli JMI09 cells were prepared using the rubidium chloride method (9). Plasmid 
DNA was extracted using the Nucleobond® AX KIT (Macherey-Nagel, Germany). T4ligase and 
restriction endonucleases were purchased from Amersham or Boehringer Mannheim and were 
used as specified by the manufacturer. DNA ligations were performed as previously described 











as described (253). DNA fragments were purified from the agarose gels using the High Pure PCR 
Product Purification kit (Roche). 
2.3.4. Nucleotide Sequence and Analysis 
DNA sequencing was done by the dideoxy-chain termination method (255), using the Thermo-
Sequenase Sequencing kit (USB) and Cy5 fluorescently labelled universal and reverse primers, as· 
per manufacturers' instructions. The sequencing reaction products were separated using the 
AlfExpress DNA sequencer (Pharmacia) and the nucleotide sequence obtained was analysed 
using the DNAMAN software package. Nucleotide and amino acid homology searches were 
carried out against the databases at NCBI, USA, using the BLAST programme (3). The B. lactis 
16S rRNA DNA sequence was submitted to Genbank and has been assigned the accession No. 
AY151397. 
2.3.5. Oxygen Tolerance Analyses 
Overnight BYG cultures of the bifidobacteria were diluted and plated onto BYG agar plates. 
Plates were incubated for 0, 1, 3, 4, 5, and 24 hours aerobically and then transferred to the 
anaerobic incubator for 2 days. The number of colony forming units after 2 days growth was 
recorded. 
2.3.6. Carbohydrate Fermentation Analysis of the Bifidobacteria 
BY agar containing 0.5% (w/v) of the sugars (arabinose, xylose, ribose, glucose, fructose, 
galactose, sorbitol, sucrose, lactose, maltose, cellobiose, melezitose, raffinose, trehalose, 
melibiose, mannitol, glucosamine, amylose, starch, glycogen, xylan, carboxymethyl cellulose 
(CMC), oligofructose, and inulin) was used. Phenol red (5% v/v of a 0.2% w/v solution) was 
added as a colourimetric pH indicator, the resazurin was omitted, and the media was adjusted to 
pH 7.6 with 6 N NaOH. A change of the colour of the media from orange to yellow indicated that 
acid had been produced via fermentation of the sugar. The utilisation of starch, xylan and 
cellulose was also tested in complete media (final concentrations of 0.1%, 0.5% or 1% w/v in 
BHI), and zones of utilisation were determined by staining with Gram's iodine (117) for starch, 
and Congo red (0.1 % w/v) for xylan and cellulose. Oligofructose (Raftilose P95) was supplied by 
Savannah Fine Chemicals (South Africa), soluble starch was supplied by BDH, and xylan by 











2.3.7. Bifidobacterium Chromosomal Extraction 
Bacterial cells grown to late-exponential-phase in 500 ml BYG medium containing 0.5% glycine 
were harvested by centrifugation (6 000 x g, 10 min at 4°C). The cells were washed twice in 
buffer (10 mM Tris-HCl pH 8.0, 10 mM NaCl, 1 mM EDTA), resuspended in 10 mllysozyme 
solution (25% sucrose, 0.1 M NaCl, 0.05 M Tris-HCl pH 8.0, 10 mg/mllysozyme) and incubated 
for two hours at room temperature. After incubation, 10 ml of buffer (10 mM Tris-HC1, 10 mM 
NaCl, 1 mM EDTA, pH 7.5) was added and the suspension gently mixed. Proteinase K 
(Boehringer Mannheim) was added to a final concentration of 100 l-1g/ml, and was incubated for 
one hour at room temperature with gentle mixing. SDS (final concentration of 2% w/v) and 0.5 
mg of RNAse (Sigma) were added and the mixture incubated at 37°C for 30 minutes. The 
resulting cell lysate was extracted three times with hot phenol (65°C), followed by three 
extractions with water-saturated ether. The DNA was precipitated with ethanol (253) and 
resuspended in 500 1-11 water. 
2.3.8. Processing of B. lactis Cells for Sucrase and a-Galactosidase Assays 
For sucrase assays, cell free extracts (CFEs) were prepared from 100 ml cultures grown to mid-
and late-logarithmic phase in BY medium containing the various carbohydrates, and were 
harvested by centrifugation (6000 x g, 10 min, 4°C). Cells were washed twice and resuspended in 
5 ml TAP buffer (100 mM Tris, 100 mM acetate, 64.2 mM Na2HP04, pH 6). Cells were disrupted 
by sonication (4°C) at 95 W for 6 min with 30 s cooling intervals (VirSonic Digital 475 Cell 
Disruptor), and cell debris was removed by centrifugation (15 000 x g, 20 min at 4°C). The 
supernatant was used as the CFE. 
a-Galactosidase assays were performed on three different preparations of the cells: crude lysate 
(total protein after sonication) (CL), cell free extract (CFE), and membrane fraction (MF) and 
were prepared as follows: mid-logarithmic phase cultures (100 ml) were harvested by 
centrifugation (6 000 x g, 10 min, 4°C), and were washed, and resuspended in 400 Jll of 20 mM 
sodium phosphate buffer (PH 6.5). Cells were sonicated as above, resulting in the CL fraction. 
The CL fraction was then centrifuged (14 000 x g, 20 min at 4°C), where the supernatant was used 
as the CFE. The remaining pellet which consisted of cell debris and the membrane fraction (MF) 











2.3.9. Enzyme Assays 
2.3.9.1. Sucrase Assays 
Sucrase assay conditions were determined from the characterization of ScrP activity experiments 
reported in Chapter 4. Sucrase activity was assayed in the following way: 15 III of 0.88 M sucrose 
was incubated with 35 III of the appropriate CFE dilution for 30 min at 60°C. The reaction was 
terminated with 150 III dinitrosalicylic acid reagent (DNS) (175), and boiled for 5 minutes. The 
amount of reaction product formed, was determined spectrophotometrically at 510 nm, using 
glucose (concentration range of 0.5-10 mM) as a standard. Sucrase activity was expressed as 
/lIDol reducing sugar produced per min per mg protein. 
2.3.9.2. a-Galactosidase Assays 
For the a-galactosidase assays, activity was determined by the rate of hydrolysis of p-nitrophenyl-
a-D-galactopyranoside (NpGal). A suitable enzyme assay was developed from four different 
protocols (81, 166,233, 310) and was performed as follows: 20 III of sample was incubated with 
180 III of NpGal (2.66 mM in 20 mM sodium phosphate buffer pH 6.5) at 37°C for 5 mins. The 
reaction was stopped by adding an equal volume of stop buffer (0.5 M glycineINaOH pH 9, 2 mM 
EDTA), and the volume was made up to 1 ml with water. The liberated p-nitrophenol was 
measured spectrophotometrically at 405 nm, which was also used as the standard (concentration 
range of 100 IlM to 1 mM). Protein concentrations were standardized Activity was expressed as 
/lIDol p-nitrophenol released per min per mg protein. 
2.3.10. Protein Assays 
Protein concentrations were determined using the method of Bradford (33), with bovine serum 
albumin as the standard (concentrations of 0.025 mg/ml to 0.1 mg/ml). The protein concentration 












2.4. RESULTS AND DISCUSSION 
2.4.1. Isolation of B. lactis 
The comparison of 16S rRNA sequences has been a reliable method for the classification and 
identification of bifidobacteria (169), even down to I-nucleotide difference (335). This technique 
is more rapid, simple and sensitive than previously used methods based on phenotypic 
characteristics and DNA-DNA homology. On this basis, genus-specific primers for 
Bifidobacterium were used for the isolation of B. lactis from a yoghurt starter culture, which also 
contained Lactobacillus acidophilus, La'ctobacillus casei, and Streptococcus thermophilus. 
Since B. lactis was the only obligate anaerobe species present, cells were incubated aerobically 
and anaerobically for the primary isolation of potential B. lactis cells (those cells which only grew 
anaerobically). Using the Bifidobacterium primers, a 0.55 kb rDNA fragment from B. breve was 
generated by PCR and was used as a probe to perform colony hybridizations on the putative 
B. lactis cells isolated. Colonies which hybridised to the probe were analysed by PCR using the 
same primers (Figure 2.1). PCR fragments were sub cloned into the EcoRV restriction enzyme site 
ofpSK yielding pLac2. The insert was sequenced using T7 and T3 universal primers and analysed 
using the BLAST search (3). Sequence analysis revealed sequence identity to bifidobacterial 16S 
rRNA (Table 2.2). A high sequence identity was also found to the B. animalis 16S rRNA gene. A 
report by Cai et al (39), where DNA-DNA hybridization between the type strains of B. lactis and 
B. animalis was done, concluded that they represent a single species. Furthermore, they concluded 
that the name B. lactis has no taxonomic standing and that it should be reclassified as B. animalis 
(39). However, since this report, other publications have used the name B. lactis. Furthermore, 
B. animalis is associated more with animals than with humans (261), and due to the human 
application aspects of this study, the name B. lactis was selected for future use in this work. 
2.4.2. Bifidobacterial Oxygen Tolerance 
One of the properties of a successful probiotic strain is that it maintains viability and activity in 
the carrier food before consumption (95). For an anaerobic organism, its tolerance to oxygen is of 
importance considering that the majority of food preparations containing probiotics are stored 
and/or prepared aerobically. Bifidobacteria, although anaerobic, have varying degrees of tolerance 
towards oxygen (18,39). We were interested in determining this in the four bifidobacterial strains, 
which in addition to facilitating the selection of a probiotic strain, it would also provide insight 
into the culturing and handling of the organisms in the laboratory. All the strains tested survived a 











times, and with each experiment the cell numbers for B. longum, B. lactis and B. bifidum did not 
decrease more than 10-fold, while B. breve cell numbers were reduced 4xl04-fold. From this type 
of experiment it appears that B. longum, B. lactis and B. bifidum can tolerate prolonged periods of 
exposure to oxygen, and would therefore make good probiotic candidates with respect to 
maintaining viability in the carrier foods. 
123456M 
+-- 0.55 kb 
Figure 2.1. peR analysis of putative B. lactis colonies using Bifidobacterium 16S rRNA primers. Lanes 1-3: Putative 
B. lactis isolates, Lane 4: B. breve 2257 positive control, Lane 5: E. coli 1M 109 negative control, Lane 6: no DNA, 
M: A DNA digested with PstI as molecular weight marker. 
Table 2.2. Sequence similarities of the B. lactis 16s rRNA DNA sequence in pLac2 to sequences 
in the database. 
Organism to which sequence similarity was found % Identity 
Bifidobacterium sp. (Accession no. X89111) 99% (523/524) 
B. lactis (Accession no. AB050136) 99% (523/524) 
B. lactis (Accession no. X89513) 99% (522/524) 
B. animalis (Accession no. AB050138) 99% (523/524) 
B. animalis (Accession no. D86185) 98% (520/526) 
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Figure 2.2. BifidobacteriaJ tolerance to aerobic incubation. Cells on BYG agar plates were exposed to aerobic incubation 
for the hours indicated and then incubated anaerobically for 2 d~ys. The experiment was repeated 3 times and the results 
for one of these is reported. The same trend was observed for each of the experiments. CPU: colony forming units. 
2.4.3. Analysis of the Bifidobacterial Carbohydrate Fermentation Patterns 
In order to analyse the fermentation patterns of the four bifidobacterial strains on various 
carbohydrates, a suitable basal medium containing a fermentation indicator was required. BG 
medium, a modified version of that used by Degnan e/ al (57), was selected. Growth was compared 
with BG medium containing either additional yeast extract (BYG), or casamino acids (BeG), or 
additional salts (BSG) (Table 2.1). Growth curves were performed with the four bifidobacterial 
strains in the media described and growth in BHI was used as a control (Figure 2.3). Although there 
were no major differences in the growth of the bifidobacterial strains with the various media, BYG 
was preferred by most, and was, therefore, selected as the media to be used throughout this study. 
This medium was also selected for the fermentation analyses, where the carbohydrates were 
substituted for the glucose (see 2.3.1). Phenol red was selected as the fermentation indicator (Figure 
2.4). 
Fermentation of a variety of carbohydrates as a sole carbohydrate source was tested (Table 2.3). 











B. bifidum. B. bifidum would perhaps not be the ideal target for industrial application due to its 
limited use of carbon sources, particularly the pre biotic substrates inulin, oligo fructose and 
raffinose. However, carbohydrate utilisation patterns between strains of a particular 
bifidobacterial species have been shown to vary considerably, particularly in B. bifidum (119). 
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Figure 2.3. Growth curves of the bifidobacteria grown in the media described in Table 2.1. and in BHI as a control 
medium. Growth was monitored by measuring absorbance at 600 nm (OD600nnJ at the times indicated. The values are 
the mean of three experiments. A: B. bifidum, B: B. breve, C: B. lactis, D: B. longum. Symbols: (+) BG, (_) BYG, 












Figure 2.4. Positive carbohydrate fermentations by B. breve grown on two different media. A. BY medium containing 
0.5% glucose. Acid production as a result offermentation reduces the pH to below 6.7 causing a change in the phenol red 
indicator from orange to yellow. B. Complete media (BHI) with 0.1 % starch. A zone of starch utilisation is detected when 
stained with Gram's iodine. 
It is interesting that some of the simple sugars, such as fructose, galactose could not be utilised by 
some of the strains, even though they were able to ferment the more complex substrates composed of 
these moieties, such as oligofructose and raffinose. This phenomenon appears to be common in many 
of the bifidobacterial strains (48, 119). Similarly, the thermophilic yoghurt bacteria S. thermophilus 
and Lactobacillus bulgaricus efficiently transport and hydrolyse lactose intracellularly, however, they 
only ferment the glucose portion oflactose, while the galactose is excreted (313). Simple sugars are 
metabolised by the human host, while the more complex carbohydrates reach the colon intact (249), 
thus, the latter probably represent the major source of carbon and energy for the gut bacteria. It would 
seem likely, therefore, that the substrate transport mechanisms of these organisms would be more 











Table 2.3. Carbohydra~e-fennentation patterns of the bifidobacteria. 
Substrate B. bifidum B. breve B.lactis B.longum 
Arabinose + 
Xylose +++ 
Ribose (+) + 
Glucose +++ +++ +++ +++ 
Fructose ++ ++ ++ 
Galactose ++ (+) 
Sorbitol + 
Mannitol ++ 
Glucosamine ++ +++ 
Sucrose ++ +++ + 
Lactose ++ +++ +++ +++ 
Melibiose + ++ + ++ 
Maltose ++ ++ ++ 
Cellobiose +++ 
Melezitose ++ 
Raffinose +++ +++ ++ 
Trehalose 
Amylose + 




Oligofructose ++ ++ ++ 
Inulin 
- No fennentation + Fennentation after 24 hours (+) Fennents slowly 
+a Was not fennented as a sole carbohydrate source, but was weakly utilised in complete media at 0.1 % (w/v) 
+b Was fennented as a sole carbohydrate source, and was utilised in complete medium at all concentrations 
+ab Was not fennented as a sole carbohydrate source, but was utilised in complete media at all concentrations 











As discussed in section 2.2, oligofructose has a DP below 7, while that of inulin is between 2 and 
60+ (229, 322). Therefore, the fact that B. lactis, B. breve and B. longum could utilise the fOImer 
but not the latter substrate, could indicate that the degree of polymerization affects the bacterial 
ability to utilise the prebiotic substrates. The B. longum and B. breve strains used in this study 
have previously been shown in the literature to utilise Rafiiline, which is 92-99% inulin with an 
average DP of 10-12 (92, 119, 322). Therefore, their inability to show growth on the inulin 
substrates used in this study was puzzling. Since the DP of inulin can vary significantly, it may be 
possible that our source of inulin has a DP greater than that of Rafiiline, and thus could be too 
complex for the organisms to utilise. In support of this, it has been reported that inulin with a DP 
> 10 was fermented half as quickly as molecules with a DP < 10 (231). 
Starch has recently been investigated for its ability to complement a bifidobacterial strain in a 
synbiotic yoghurt (48), and for its use in microencapsulation (47). In our analyses, only B. breve 
was able to utilise soluble starch as a sole carbohydrate source, however, the other strains were 
able to utilise starch to some extent when it was supplied in complete medium. Starch is 
hydrolysed by the combined action of several enzymes such as a-amylases, ~-amylases, 
glucoamylases, and other exo-l,4-glucanases (324). There are a few organisms from which 
activity of more than one of the enzymes has been detected, including from B. bifidum and 
B. pseudolongum (321). It is possible that B. breve similarly possesses more than one, considering 
that it was able to utilise soluble starch, amylose and glycogen as a sole carbohydrate source. In 
comparison, the other strains could only utilise the soluble starch, suggesting a less diverse 
genetic ability to hydrolyse this substrate. Interestingly, B. longum showed weak amylase activity 
when grown in complete media containing soluble starch (Table 2.3). Sequence analysis of the 
B. longum NCC2705 genome indicated that ~- and a-amylases are absent (262). Furthermore, it is 
generally considered that B. longum cannot utilise this substrate (260, 261, 290). However, some 
strains have been shown to hydrolyse Hi-Maize™ (48), and therefore must possess the required 
enzymes. It appears, therefore, that the B. longum strain used in this study similarly possesses, 
albeit weak, enzymatic activity towards starch, once again illustrating the variation in 
carbohydrate utilisation patterns between bifidobacterial strains. 
2.4.4. Sucrase and a-Galactosidase Activity in B. lactis 
B. lactis was selected for further analyses for a number of reasons. It is the probiotic used most 
industrially and, unlike many of the bifidobacterial strains tested, it has been shown to survive 
well in the conditions stimulating the human stomach (48), an important factor for the selection of 











organism due to its recent discovery (174), and, therefore, a greater knowledge is required for this 
organism to be developed further for biotechnological applications. It was also the second best 
utiliser of the carbohydrates tested (Table 2.3), including oligofructose and raffmose. Due to the 
importance of these substrates as prebiotics, we were interested in isolating and studying the 
genetic mechanisms by which B. lactis utilised them. Three key enzyme activities are required for 
their utilisation: sucrase, fructanase, and a-galactosidase. Since B. lactis could not utilize fructose, 
only a-galactosidase and sucrase activity was investigated in response to growth in the presence 
of various carbohydrates. The isolation of these genetic systems was undertaken and will be 
presented in chapters 3 and 4 respectively. 
2.4.4.1. B. lacUs Growth Curves 
Growth curves were performed to determine an appropriate growth stage and time point at which 
sucrase and a-galactosidase enzyme activities could be assayed. In order to establish how these 
activities were regulated, B. lactis growth curves were performed in the presence of 1% (w/v) of 
the following carbohydrates: glucose, sucrose, glucose plus sucrose, raffinose and oligofructose 
(Figure 2.5). Raffinose and sucrose were the carbon sources most preferred by B. lactis, giving 
maximum cell yields as well as maximum growth rates, in comparison to glucose. Growth in 
oligofructose was poor. These results should be of particular interest in the viewpoint of future 
prebiotic development. It appears that raffinose-containing substrates might be better candidates 
for the growth stimulation of B. lactis. Soybean oligosaccharides (SBO) have been shown to 
stimulate the growth of bifidobacteria while being poorly fermented by other genera of the 
microflora (l08, 247). Furthermore, raffinose has been shown to be more rapidly and efficiently 
assimilated by bifidobacteria compared to other non-digestible oligo saccharides, including 
fructose-oligomers (129). However, the raffinose and stachyose present in SBO may be 
responsible for flatulence after fermentation (259), and therefore, their use as prebiotics would 
need to take this into consideration. 
2.4.4.2. Regulation of Sucrase Activity in B. lacUs 
Sucrase activity was assayed in B. lactis cultures grown to mid- and late-logarithmic phase in BY 
medium containing sucrose, glucose, glucose plus sucrose, raffinose or oligofructose (Figure 2.6). 
Sucrase activity in the different conditions did not differ greatly between mid- and late-log 
cultures. Similar activities were recorded for cultures grown in glucose and in glucose plus 
sucrose. Taking activity in glucose as the basal level, sucrase activity was induced 2-fold in the 
presence of sucrose or raffinose, and 1.4-fold in oligofructose in comparison with it. It is clear that 










growth curves performed for B. lactis (see 2.4.4.1 and Figure 2.5), it was suggested that growth in 
the presence of sucrose was preferred in comparison to glucose. It is, therefore, surprising that 
glucose reduced sucrose utilisation. Perhaps glucose was in fact the preferred carbon source, and 
that growth in the presence of glucose was inhibited by strong acidification. The fact that sucrase 
activity did not increase in late-log cultures grown in glucose plus sucrose, suggests that the 
sucrose was not co-utilised by the cells. However, the growth curves suggest the contrast, since 
growth was higher in the presence of glucose plus sucrose compared to in glucose alone (Figure 
2.5), indicating that sucrose was co-utilised. It could be argued that in the presence of glucose plus 
sucrose, constitutive systems would utilise the sucrose, thereby allowing the simultaneous 
utilisation of both sugars, and the resulting activity would be the same as that seen when grown in 
glucose. Future experiments would need to be performed where the concentration of the sugars in 
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Figure 2.5. Growth curves of B. lactis grown in BY medium containing 1% (w/v) of each of the various sugars. 
Growth was monitored by measuring the absorbance at 600 nm (OD600) at the times indicated. Symbols: (.) Glucose, 
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Figure 2.6. Sucrase activity from B. lacus cells grown in the presence of various carbohydrates to mid-log (@ and late-
log (0). Results are an average of three experiments, with the bars indicating the standard deviation from the mean. 
2.4.4.3. Regulation of a-Galactosidase Activity in B. lactis 
a-Galactosidase activity was measured from B. lactis cells grown to mid-logarithmic phase In 
BY medium containing glucose, raffinose, or glucose plus raffinose. Growth in galactose was very 
poor, reaching a maximum OD600 of 0.15, and was, therefore, not included in the study. The 
assays were initially conducted separately on the CFE and MF fractions (see 2.3.8), but the 
activity was found to be approximately the same for both. It could be possible that more than one 
enzyme conferring a-galactosidase activity exists in B. lactis. Although in B. adolescentis and 
B. longum CRL849 only one a-galactosidase was purified (86, 150, 310), some organisms are 
known to produce several, such as Bacteroides ovatus (90) and Trichoderma reesei (166). In fact, 
sequence analysis of the B. longum NCC2705 genome revealed the presence of two 
a-galactosidase genes (BL0177 and BL1518) (262). Alternatively, the enzyme might non-
specifically associate with the membrane. In B. ovatus for example, it was found that after 
sonication and centrifugation, only 49% of total a-galactosidase activity remained in the CFE, 
compared with 95% of the marker enzyme (90). Although activity was released from the pelleted 











membrane. It is possible that this may also be the case in B. lactis. Nonetheless, activity was 
assayed on crude lysate, representing a combination of the CFE and MF fractions. The results 
(Figure 2.7) showed a 20-fold induction in the presence of raffmose in comparison to glucose, 
while in glucose plus raffinose this induction was reduced to 16-fold. The reduced activity in the 
presence of glucose plus raffinose indicates that a-galactosidase activity is regulated by catabolite 
repression, and has similarly been reported for Bifidobacteriurn adolescentis (150). Raffinose was 
suggested to be the carbon source preferred by B. lactis for growth compared to glucose (see 
section 2.4.4.1 and Figure 2.5), therefore, repression of raffinose utilisation by glucose would not 
be expected. As was discussed in section 2.4.4.2, perhaps glucose is the preferred carbon source. 
The significant induction seen in the presence of glucose plus raffinose implies that both sugars 
were utilised by B. lactis, however, the mechanisms involved are not known. 
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Figure 2.7. a-Galactosidase activity measured from B. lactis cells grown to mid-log in the presence of various 
carbohydrates. G: glucose, R: raffinose. Activity is represented as the mean of three experiments, with the bars 
indicating the standard deviation from the meau. 
2.5. CONCLUSIONS 
The carbohydrate utilisation patterns of B. lactis, B. breve, B. longurn, and B. bifid urn were 
determined, where a variety of substrates were analysed for their ability to support bacterial 











bifidobacteria (261), but are being replaced by more rapid and reliable methods such as ribotyping 
(172), pulse-gel electrophoresis and 16s rRNA sequencing (169,335). 
This fermentation study has given a useful indication of the carbohydrate utilisation patterns of 
these bifidobacteria, and has certainly illustrated the importance of such information for the 
selection of suitable probiotics and prebiotics for future biotechnological applications. However, 
considering that these conditions do not mimic those encountered in the colon, it is important that 
these interpretations be made in conjunction with growth rate and overall cell yield analyses. 
Hopkins et al (119) showed that high maximum specific growth rates occurred with some 
bifidobacterial strains on certain carbon sources, even though the overall growth was poor. The 
rate at which an organism can grow on a particular carbon source will influence its ability to 
compete with other bacteria in the colon (119). Furthermore, bacteria divert a greater proportion 
of energy into the maintenance of cellular functions as the residence time in the gut progresses. 
Time is, therefore, an important factor for the production of bacterial cell mass from 
carbohydrates, indicating a substrate's efficacy if its utilisation results in a high growth rate. 
Another disadvantage to this type of analysis is that the organism's inability to ferment a 
particular substrate does not necessarily mean that they do not possess the machinery to do so. In 
a previous study, B. breve was found that although it could not utilise arabinose as a sole carbon 
source, the sugar was co-utilised with glucose when present as a mixture (58). The enzymes 
needed for its metabolism were present and the sugar could be used to provide energy. This 
further strengthens why in vitro analyses are not strongly supported, since the conditions that the 
organisms encounter in the colon are different, and therefore, different profiles could be obtained 
in "the real world". 
However, these carbohydrate utilisation analyses could be used to supply the groundwork from 
which in vivo experiments can then be developed. One can get an idea of which strains are the 
most diverse in their ability to utilise a range of carbohydrates. One can also determine the class 
of carbohydrate that is preferred, for example, starches or fructan-containing substrates. Detecting 
diet-induced changes in bacterial types and numbers in vivo has been difficult however, and 
sometimes, contradictory (31, 247). An alternative method is to measure metabolic products and 
activities related to the microflora in order to assess diet-related effects (247). An analysis of 
fermentation patterns, could therefore, aid in selecting appropriate enzymatic markers to allow 
conclusions to be made as to the likely consequences for the health of the host. With so many 
aspects of fermentation analyses to consider, the rate at which prebiotics are being developed and 










The bifidobacterial population present in the microflora of adult humans has been shown to vary 
between individuals, and undergoes fluctuations with time (172). Taken together with the variable 
fermentation patterns within a bifidobacterial strain, one can understand why the synbiotic 
approach is the latest concept being researched and developed. In this way, a particular probiotic 
strain (or combination of strains) could be selected for its/their specific health benefits, and be 
administered in its/their specific prebiotic to enable the passage through the gut and the 
colonisation thereafter. This method combines the advantages offered by pro- and prebiotics, 
whilst overcoming some of the disadvantages associated with them. 
Growth curves performed with B. lactis in raffinose, oligofructose and sucrose, revealed that 
raffinose was the preferred substrate, and that growth in oligofructose was weak (Figure 2.5). 
Taken with the failure to utilise inulin as a sole carbon source (Table 2.3), the fructo-
oligo saccharides would not make choice prebiotics if B. lactis was to be considered for the 
synbiotic application, whereas soybean oligo saccharides could provide a more suitable alternative. 
Sucrase activity in B. lactis was found to be partially repressed when cultured in the presence of 
glucose (Figure 2.6), while activity in glucose plus sucrose did not improve, even though it 
supported better growth (Figure 2.5). The activity detected possibly represents the action of a 
number of systems regulated at different levels and possibly by different mechanisms. Although 
catabolite repression appears to regulate sucrase activity to some extent in B. lactis, it has never 
been addressed in this genus, and therefore, the mechanisms involved remain completely 
unknown. A more detailed analysis of sucrose utilisation by B. lactis is discussed in chapter 5, 
where the genetic regulation of the sucrase system isolated was analysed. a-Galactosidase activity 
in B. lactis appears to be similarly regulated by catabolite repression. Activity was induced by 
growth in the presence of raffinose, while being minimally produced in the presence of glucose 
(Figure 2.7). The induction that occurred during growth in glucose plus raffinose possibly 
indicates that the sugars are co-utilised, however conclusions to the mechanisms involved are not 
known. 
In order to further understand the genetic mechanisms employed by B. lactis for the utilisation of 
the prebiotics oligofructose and raffinose, the isolation of these genetic systems was undertaken. 
To achieve this, the cloning and characterisation of the a-galactosidase and sucrase genes was 
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The isolation of the B. lacUs raffinose utilisation genes was attempted using several strategies: (i) 
screening of two B. lactis genebanks on raffinose and the histochemical substrate p-nitrophenyl-
a-D-galactopyranoside, (ii) amplification of the a-galactosidase from B. lactis by peR using 
primers designed to conserved regions of the B. longum and B. adolescentis genes, (iii). 
construction and the subsequent screening of a B. lactis genebank prepared with DNA which 
hybridised to a B. longum a-galactosidase gene probe. Screening of the genebanks on the 
substrate p-nitrophenyl-a-D-galactopyranoside resulted in the isolation of three clones which 
displayed weak a-galactosidase activity. From restriction analysis, only one of these clones, 
p4B 11, could contain a functional gene, and it was analysed further. Sequence analysis revealed 7 
putative ORFs, none of which showed identity to other a-galactosidases or related proteins. Insert 
DNA from p4B 11 was hybridised to RNA from B. lactis cells in a slot blot experiment, and a 
signal could only be detected from cells which had been grown in the presence of raffinose and 
not glucose. However, a transcript could not be identified. Protein from E. coli cells with p4Bll 
was analysed by SDS-PAGE, but a distinct prot~in band which could be responsible for the 













Although inulin and oligo fructose are the carbohydrates considered to be the most effective 
prebiotics for bifidobacteria (92, 94), galactose- and raffmose-containing oligo saccharides also 
selectively stimulate the growth of bifidobacteria (49, 247). As was discussed in chapter 2, soya 
could become a significant component in the African diet, and its high content of raffinose, which 
is indigestible by humans, could play an important role in the stimulation of bifidobacteria in the 
gut. Certainly for B. lactis, raffinose was the preferred carbon source in comparison to glucose 
and oligofructose (Figure 2.5). 
Raffinose contains a(l,6)-linked galactose residues linked to sucrose, requiring two catabolic 
enzymes for its hydrolysis: an a-galactosidase and a sucrase. As was reviewed in chapter 1, the 
two raffinose catabolic genes are organised in close proximity on the chromosome in Escherichia 
coli, Streptococcus mutans, S. pneumoniae and in Pediococcus pentosaceus (12, 151, 233,238). 
In both the streptococci the a-galactosidase is associated with, and found in, close proximity to a 
sucrose phosphorylase. Besides hydrolytic activity,. the a-galactosidase from B. adolescentis was 
shown to have transglycosylation activity, where a-galacto-oligosaccharides were produced from 
melibiose and stachyose (310). These oligosaccharides could potentially be used as bifidobacterial 
growth promoting factors. 
The fact that raffinose was the carbon source preferred by B. lactis, together with the prebiotic 
potential of this carbohydrate, its utilisation by B. lactis was of interest to us. Furthermore, the 
bifidobacterial enzymatic synthesis of growth promoting factors for biotechnological applications 
could be investigated if an a-galactosidase with transglycosylation activity was isolated. In order 
to achieve this, the raffinose-utilisation genes were to be isolated and characterised. 
Raffinose utilisation genes have been isolated by screening gene libraries on raffinose, sucrose 
and histochemical substrates for clones conferring a positive phenotype on E. coli (12, 81, 166, 
238, 310). Raffinose utilisation genes have also been isolated by PCR (80, 233), and with the 
B. adolescentis and B. longum a-galactosidase sequences available (83, 310), this could be an 
alternative strategy. This approach, however, would require "chromosome walking" to obtain the 
entire gene sequence and to determine the presence of additional genes. Considering that in E. coli 
and S. pneumoniae the raffinose utilisation genes are organised in clusters comprising five and 











of several genes. The, steps taken to isolate the raffinose utilisation genes from B. lactis are 
presented and discussed in this chapter. 
3.3. MATERIALS AND METHODS 
3.3.1. Bacterial Strains, Plasmids and Culture Conditions 
Bifidobacterium lactis, isolated in chapter 2, was propagated in BYG medium as described in 
2.3.1. Where applicable, 1% (w/v) of raffinose was substituted for glucose. 
E. coli JM109 (336) was- used for all cloning purposes and was routinely cultured aerobically at 
37°C in Luria-Bertani (LB) medium (253). Ampicillin (Ap) (100 /lglml) was added to media for 
the growth of cells containing plasmid. MacConkey base medium (Difco Laboratories) and M9 
minimal medium (176) supplemented with Ap and 1 % (w/v) raffinose, was used to assess 
carbohydrate fermentation phenotypes. 
The following plasmids were used for subc10ning and sequencing: Ml3-derived Bluescript SK 
plasmid (PSK) (Stratagene, La Jolla, California, USA), pEcoR251 (343), pMTI04 (327), and 
pGem®-T Easy (promega). Further strain and plasmid details are given in Appendix A. 
3.3.2. General DNA Manipulations 
Extraction of plasmid DNA, preparation of E. coli JM! 09 cells, DNA ligations, gel 
electrophoresis and other general manipulations are described in section 2.3.3. 
3.3.3. B. lactis Chromosomal DNA Extraction 
B. /actis chromosomal DNA was extracted as described in section 2.3.7. 
3.3.4. Construction of Genebanks 
Two size-selected B. /actis genebanks were prepared. The first was prepared with 5-10 kb Sau3A-
digested DNA fragments, and will be referred to as the Sau3A genebank. The second was 
prepared with 6-9 kb Bamill-digested DNA fragments which hybridised to the 1.4 kb u-











The Sau3A genebank 'Yas prepared as follows. B. lactis chromosomal DNA was partially digested 
with Sau3A restriction endonuclease and subjected to agarose gel electrophoresis. DNA fragments 
of between 5 and 10 kb were excised from the gel and recovered using the High Pure PCR 
Product Purification kit (Roche). The fragments were ligated into the Bgill restriction site of the 
positive selection vector pEcoR251 and transfonned into E. coli JMI09. The genebank consisted 
of approximately 3 500 clones divided into 7 pools. 
The BamHI genebank was prepared as follows. B. lactis chromosomal DNA was digested to 
completion with BamHI restriction endonuclease. Two-thirds of the digested DNA was 
electrophoresed on one half of an agarose gel, while the other one-third was run on the second 
half for Southern hybridisation (see 3.3.7. ). The DNA fragments (7-8 kb) which hybridised to the 
B. longum a-galactosidase probe were purified from the gel and ligated into pEcoR251 that had 
been digested with BglII restriction enzyme. Ligated DNA was used to transfonn E. coli JMI09 
competent cells. 
3.3.5. Screening of the B. lactis Genebanks 
E. coli JMI09 cells transfonned with the B. lactis genebanks were screened for two different 
phenotypes: raffinose utilisation and a-galactosidase enzyme production. For raffinose utilisation, 
transfonnants were incubated on M9 minimal and MacConkey agar plates containing raffinose. 
E. coli transfonned with pMTI04 was plated on the same medium to ensure that it in fact was 
unable to utilise raffinose. E. coli cells harbouring the control plasmid did not give growth on the 
raffinose minimal medium, however, on raffinose MacConkey agar all colonies were slightly 
pink, suggesting that some background activity could be detected from E. coli. 
Transfonnants were screened for a-galactosidase activity following a method described by 
Fridjonsson et al (81) which uses p-nitrophenyl-a-D-galactopyranoside (NpGal) as the substrate. 
E. coli JMI09 was transfonned with 2 J.l.1 DNA from each pool of the Sau3A and BamHI 
genebanks and 200 J.l.1 aliquots of the transfonnation mix (each containing approximately 100 
recombinants) were grown in 5 ml ofLB medium containing ampicillin. Once turbid, 4 ml of cells 
were washed and resuspended in 100 J.l.1 lysis buffer (lysozyme 4 mg/mI, 25 mM EDT A, 0.1 % 
Triton X-IOO, pH 8) and incubated for 30 min at 37°C. To this, 350 ~l of 0.1 mM potassium 
phosphate buffer (PH 6.5) containing the substrate p-nitrophenyl-a-D-galactopyranoside (NpGal) 
(0.8 mg/ml) was added and the suspension was incubated for 15 h at 55°C. The enzyme reaction 











measured spectrophotometrically at 405 run. This procedure was also conducted on E. coli cells 
transformed with pMTI04 plasmid DNA as a negative control. The culture belonging to the 
aliquot displaying the highest hydrolysing activity was divided into 13 sub-pools and each part 
was again grown in 5 ml of LB medium containing ampicillin, and the same procedure was 
repeated. The culture exhibiting the highest a-galactosidase activity after the second screening 
was diluted and plated on Luria agar. Single colonies were selected and analysed for a-
galactosidase activity in the same way. 
3.3.6. PCR of the a-Galactosidase from Bifidobacteria 
PCR amplification of the a-galactosidase gene was performed on B. lactis and B. longum 
chromosomal DNA in the following reaction (50 I.d): 5 Jll buffer; 2.5 mM MgC}z; 0.5 JlM of each 
primer; 200 JlM of each dNTP; 50 ng chromosomal DNA; and 1 U of Taq DNA polymerase 
(Supertherm). The PCR was carried out in a GeneAmp 9700 machine (Applied Biosystems). The 
amplification program consisted of one cycle of 96°C for 5 min, then 25 cycles of 96°C for 1 min, 
54°C for 45 s, and 72°C for 1 min, and finally one cycle of 72°C for 5 min. The reaction was 
cooled down to 4°C. The primers were designed .to a conserved region of the B. longum and 
B. adolescentis a-galactosidase genes (Figure 3.4): GalF 5' -GAG ATC CTC ACC ACC ACC G-
3' and GalR 5' -CTG CGT GAA GCG GTA GAT CG-3'. 
3.3.7. Southern and Colony Hybridisation 
For Southern hybridisation, DNA was digested with BamHI restriction enzyme, subjected to 
agarose gel electrophoresis and transferred via the capillary alkali transfer procedure to a Hybond-
W nylon membrane (253). For colony hybridisation, DNA from colonies was transferred to nylon 
membrane according to the manufacturers' instructions (Roche). Fragments to be used as probes 
were non-radioactively labelled by the random-primed method using the Digoxigenin labelling 
and detection kit (Roche). Hybridisation and detection procedures were performed according to 
the manufacturers' instructions. Hybridisations performed with the 1.4 kb a-galactosidase 
fragment from B. longum were done using low stringency conditions described by the 
manufacturer and temperatures between 48°C and 55°C were used. 
3.3.8. Nucleotide Sequence and Analysis 











3.3.9. a-Galactosidas~ Assays 
a-Galactosidase assays were perfonned on E. coli JM109 crude lysate (CL) as described in 
section 2.3.9.2. 
3.3.10. Protein Assays 
Protein concentrations were detennined as described in section 2.3.10. 
3.3.11. Total RNA Extraction 
Total RNA was isolated from 50 ml mid-logarithmic phase cultures of B. lacHs and E. coli based 
on a protocol for Gram-positive bacteria (17). Cells were harvested by centrifugation (6 000 g, 10 
min, 4°C) and immediately resuspended in 2 ml of buffer (20 mM sodium acetate pH 5.5, 1 mM 
EDTA). Two hundred microliters of 10% SDS and 2 ml of water-equilibrated phenollchlorofonn 
(1:1) were added and tubes were incubated for 10 min at 70°C. The phases were separated by 
centrifugation and the aqueous phase was extracted twice more with water-equilibrated 
phenollchlorofonn. RNA was then precipitated from the aqueous phase with 1110 volume of 3 M 
sodium acetate (PH 5.5), and 2.5 volumes of ethanol. After 30 min at -70°C, RNA was pelleted 
(14000 g, 15 min, 4°C), and resuspended in 180 J.lI of water. A DNAse step was perfonned as 
follows. RNAse-free DNAse (30 U) and 20 J.lI of DNAse buffer (200 mM sodium acetate pH 4.5, 
100 mM MgCh, 100 mM NaCl) were added to the resuspended RNA and incubated for 30 min at 
room temperature. Twenty microliters of 0.25 mM EDT A was added to inactivate the enzyme. 
followed by an extraction with phenollchlorofonn and then with an equal volume of 
chlorofonnlisoamyl alcohol (24:1). RNA was precipitated as before and resuspended in 40 J.lI of 
water. 
3.3.12. Northern Hybridisation and RNA Slot Blot Analysis 
For Northern hybridisation, RNA was separated on fonnaldehyde gels (253) and was capillary 
transferred to positively charged nylon membrane (Roche), using lOX SSC as a transfer medium 
(253). RNA slot blots were perfonned in duplicate as described (253) using the Hoeffer Scientific 
apparatus. Hybridisation and detection of the DIG-labelled DNA probes was perfonned according 
to the manufacturers' instructions. The 4.2 kb HindIII-BamHI fragment from p4B 11 was used as 
the experimental probe and the B. lactis 16S rDNA probe constructed in chapter 2 (2.3.2) was 











3.3.13. SDS Polyacrylamide Gel Electrophoresis 
E. coli proteins to be analysed by SOS-PAGE were isolated as follows. Overnight cultures (2 ml) 
were microfuged and the resulting cell pellet resuspended in disruption mix (0.125 M Tris pH 7.6, 
10% p-mercaptoethanol, 10% SOS, 10% sucrose, 0.01 % bromophenol blue). The suspension was 
vortexed for 5 mins and boiled for 10 mins. This procedure was repeated, and the· protein 
suspension was then placed on ice. For electrophoresis, 10-20 III of protein was separated on 10% 
SOS polyacrylamide gels as described previously (145) using the Mighty Small apparatus 
(Hoeffer Scientific Instruments). Molecular weight markers were obtained from Amersham 
Pharmacia. 
3.4. RESULTS 
3.4.1. Screening for Raffinose Metabolic Genes by Complementation. 
Raffinose utilisation genes have been isolated by screening on raffinose or sucrose (1, 12). 
Screening on sucrose was performed and is presented in chapter 4, while the screening on 
raffinose is described here. E. coli JM109 cells are unable to grow in minimal medium containing 
raffinose, and were, therefore, transformed with the B. lactis Sau3A genebank, and the 
transformants were screened on minimal medium and MacConkey agar containing raffinose. 
Raffinose-positive colonies were not obtained. Failure to isolate genes involved in the metabolism 
of raffinose in this way could be due to size limitation of the genebank. The E. coli raJ operon 
consists of 5 structural genes containing approximately 8.4 kb of nucleotide sequence (12), while 
the S. pneumoniae system is comprised of 8 structural genes present on a 10.2 kb region (233). It 
is, therefore, possible that the B. lactis genes are similarly organised on a large region of the 
chromosome, and that they are not all present on a single ONA fragment in the genebank. 
Alternatively, it could be possible that the genes involved in raffmose utilisation are not clustered 
together in B. lactis. It was, therefore, decided to isolate a gene coding for a single, assayable 
enzyme, the a-galactosidase. 
3.4.2. Isolation of the a-Galactosidase Gene by PCR 
The a-galactosidase gene has previously been cloned and sequenced from B. longum and 
B. adolescentis (150, 310) and primers (GalF and GalR) were designed to conserved regions in 











DNA did not yield the expected 1.4 kb product, even with variations in annealing temperatures, 
concentration of MgClz, and DNA Taq polymerase. The high GC DNA content of these 
organisms likely impairs the ability of Taq DNA polymerase to efficiently amplify DNA 
fragments due to formation of secondary structures. Difficulty with PCR was encountered 
throughout the work reported in this thesis, and has similarly been experienced with 
Corynebacterium glutamicum as well (1. Kensley, personal conununication). Products specific for 
the amplification of high GC DNA are available, such as the High GC PCR Kit (Roche), which 
could be used in future amplifications. 
Since B. longum was a strain that we had in our collection, it was decided to isolate the a-
galactosidase gene from it by PCR with the primers designed, and the resulting DNA fragment 
would serve as a probe for hybridisation to B. lactis chromosomal DNA. A 1.4 kb fragment was 
MW 1 2 
1.4 kb ----+ 
Figure 3.1. Amplification of the a-galactosidase gene from B. longum NCFB 2259 with the GalF and GalR primers. 
Lane I: PCR from undigested chromosomal DNA, Lane 2: PCR from chromosomal DNA digested with SacI, StuI, 
and Kpnl. 
obtained by PCR (Figure 3.l) and it was subcloned into the SmaI restriction site of the pSK 
plasmid vector. A 0.65 kb EcoRI restriction fragment present in the published sequence of the 
B. longum a-galactosidase gene (accession no. AF160969) was used to identify clones which 
potentially contained the expected sequence. Sequence analysis of one of these clones (pLacZ8, 
previously named pLonGal8) revealed that a 1.4 kb region of the p-galactosidase gene had been 
subcloned instead of the a-galactosidase gene, also indicating that 6 out of 19 and 6 out of 20 
bases of the GalF and GalR primers respectively annealed to the B. longum p-galactosidase DNA 
sequence in the PCR reaction (Figure 3.2). The partially cloned B. longum p-galactosidase 











(accession no. AJ224434) protein sequences, and the aligrunent of these proteins is shown in 
Figure 3.3. ~-galactosidases from B. bifidum and B. infantis have been shown to have 
transgalactosylase activity (184), and therefore these proteins could also be applied for the 
production of novel prebiotics for bifidobacteria. It would, therefore, be interesting to determine if 
the cloned ~-galactosidase from B. longum could similarly be able to carry out this activity. 
* * * * ** 
GalF primer 5'-GAGATCCTCACCACCACCG- 3' 
1 ATGACAGACGTCACACATGTCGATCGCGCATCGCAGGCTTGGCTGACCGAC ....... . 
1 M T D V T H V D R A S Q AWL T D 
474 D V F RAM Y K H V H D 
1422 ................. CTGCACAAGGCGCGGTACATGTTCGTGCACGTGCTG ...... . 
3' -GCTAGATGGCGGAATGCGTC- 5' GalR primer 
* * * *** 
Figure 3.2. Alignment of the a-galactosidase PCR primers with the cloned B. longum NCBF 2257 ~-galactosidase 
DNA sequence from pLacZ8. The GalF and GalR primer sequences are shown in red. Primer bases which could have 
annealed are indicated by an asterisk. The top row shows the coding sequence, while the anti-sense sequence is shown 
on the bottom row. 
Although it was not certain that the a-galactosidase gene was being amplified, a strategy was 
employed to eliminate the ~-galactosidase gene product from the peR reaction. The chromosomal 
DNA to be used as template was digested with restriction enzymes present within the 
~-galactosidase gene of B. longum, which would not digest within the 1.4 kb fragment of the 
B. longum a-galactosidase gene to be amplified. From the analysis of the preliminary sequence 
obtained from the cloned ~-galactosidase (pLacZ8), the enzymes Sad, StuI, and KpnI were 
selected. PCR performed on digested DNA resulted in the same 1.4 kb fragment as for undigested 
DNA (Figure 3.l). The PCR products were subcloned in pGem-T Easy vector. One clone, pGal8, 
containing the expected 0.65 kb EcoRI fragment was analysed further. Sequence analysis of the 
insert DNA revealed that the a-galactosidase gene had been successfully cloned. Figure 3.4 
illustrates the amino acid sequence aligrunent of the bifidobacterial a-galactosidases that have 
been isolated. The cloned a-galactosidase from B. longum found 99% sequence identity at the 
protein level to the published B. longum VMKB44 a-galactosidase sequence (accession no. 
AF160969). Furthermore, an a-galactosidase (BL1518) from the B. longum NCC2705 sequenced 
genome was found and it was 100% identical to that of B. longum VMKB44. The four non-











Figure 3.4, are most likely a result of Taq DNA polymerase errors. Although such mismatch 
mutations are commonly associated with peR, the frequency with which it occurred within the 
pGal8 sequence is alanningly higher than the expected error rate of 10-5 to 10-4 per nucleotide 
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Figure 3.3. Multiple sequence alignment of the cloned B. longum ~-galactosidase (BlonORF) to bifidobacterial LacZ 
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Figure 3.4. Multiple sequence alignment of the cloned B. longum NCFB 2257 a-galactosidase (BlonORF) to others 
isolated from bifidobacteria BadoAGA: B. adolescenlis (accession no. AF124596), BlonlAGA: B. longum VMKB44 
(accession no. AF160969), Blon2AGA: B, longum NCC2705 (BL1518). The asterisks indicate the amino acids that 
are different for BlonORF in comparison to the BlonlAGA and Blon2AGA protein sequences. 
3.4.3. Southern Hybridisation of the B. longum a-Galactosidase Gene to B. lactis 
The 1.4 kb a-galactosidase DNA fragment isolated from B. longum could now be used to isolate 
the gene from B. lactis by hybridisation and the subsequent construction of a mini-genebank. The 
1.4 kb ApaI-SacI fragment from pGal8 was prepared for southern hybridisation to B. lac tis and 











B.longum (122), therefore, hybridisation was performed under low stringency conditions. The 1.4 






Figure 3.5. Southern hybridisation of the B. longum a-galactosidase probe. Lane I: B. lac/is chromosomal DNA 
digested with BamHI, Lane 2: B. longum chromosomal DNA digested with BamHI, Lane 3: pMTl04 plasmid DNA, 
Lane 4: pGal8 plasmid DNA digested with ApaI and Sad. The 1.4 kb ApaI-Sad fragment from pGal8 was used as 
the probe. 
A B. lactis genebank was constructed in E. coli with BamHI-digested DNA fragments of 6-9 kb in 
size which included the DNA fragment that hybridised to the a-galactosidase probe. Colony 
hybridisation was performed using the same probe for the identification of E. coli transformants 
containing the B. lactis a-galactosidase gene. Of the 850 colonies screened, several hybridised 
weakly, but only one contained an insert of approximately 7 kb. This clone however, failed to 
give a-galactosidase activity. 
3.4.4. Isolation of a Putative a-Galactosidase from B. lactis by Complementation 
The two B. lactis genebanks were screened for a-galactosidase activity by assaying for the 
liberation of p-nitrophenol as described in the methods (3.3 .5. ). Of the 13 pools, 7 showed a 
yellow colour development distinguishable from the other pools and from the cells transformed 
with the control plasmid pMTl 04. The pool displaying the highest activity was selected for a new 
round of screening. This time, 10 portions of 13 developed the yellow colour. In the next round, 
single colonies were analysed for the release of the p-nitrophenol and 3 gave a positive 











revealed that they contamed different inserts of 3.7, 1.8, and 0.2 kb respectively. The isolation of 
3 plasmids containing inserts different from each other could suggest that the a.-galactosidase 
activity in E. coli was not as a result of a cloned a.-galactosidase gene. This is discussed further in 
the conclusions. 
Since p4B 11 displayed the highest activity in the screening process, and since the insert sizes in 
pHI and pH2 were too small to contain a full length a.-galactosidase gene, further analyses were 
only performed on p4B 11. a.-Galactosidase assays performed on cell lysate from E. coli JMI09 
cells with p4B11 were found to have an activity of 0.0215 ± 0.0025 Jlmollminlmg protein. In 
B. lactis, an activity of 1.145 ± 0.48 Jlmollminlmg protein was obtained when cells were grown in 
the presence of raffinose, and was reduced to 0.048 ± 0.028 Jlmollminlmg protein in the presence 
of glucose (section 2.4.4.3, chapter 2). The activity in E. coli with p4Bli was 2-fold lower than 
the repressed activity obtained from B. lactis cells, indicating a very weak, and probably also 
repressed expression ofthe B. lactis gene in E. coli in LB medium. Especially considering that the 
construct is in multi copy in E. coli. In contrast, the B. adolescentis a.-galactosidase, which also 
showed catabolite repression in the presence of glucose, gave activity in E. coli cultured in LB 
medium comparable to that in B. adolescentis (310). 
In order to locate the activity on the insert, the 2.6 kb Pst! and 2.3 kb HindfII-EcoRl fragments 
were subcloned from p4B 11 into the BgnI site of pEcoR251, in both orientations for each of the 
fragments, yielding pTspl, pTsp2 and pHE3, pHE5 respectively (Figure 3.6). The four clones 
were analysed for a.-galactosidase activity, but none was detected. Since the a.-galactosidase 
genes can vary between 2.1 to 2.4 kb in size, it was possible that the gene responsible for the 
activity had been truncated when the two fragments were subcloned. The sequence of p4B 11 was, 
therefore analysed. 
3.4.5. Southern Blot Analysis of the p4Bll Insert 
Before continuing with the analysis of this clone, a Southern blot was performed to confirm that 
B. lactis DNA had indeed been cloned. The 0.8 kb EcoRl fragment from p4B 11 was hybridised to 
B. lactis chromosomal DNA digested with either EcoRl or BamHI restriction enzymes (Figure 
3.7). The probe hybridised to a 0.8 kb EcoRl genomic fragment confirming that the p4B 11 insert 
DNA did originate from B. lactis. The probe also hybridised to an approximately 11.5 kb genomic 











kb in size (3.3.4.), it waS anticipated that the insert DNA from p4BII would not be present in this 
genebank. 
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Figure 3.6. Restriction map ofp4BI1 showing the ORFs that were located by sequence analysis. The 2.6 kb PstI and 
2.3 kb HindIII-EcoRI fragments were subcloned in both orientations in pEcoR251 in the BglU restriction site. The 
filled box and arrow on p4B 11 indicate the position and direction of the A. promoter (PI.) present on the pEcoR251 
vector. Sizes are shown in kb. Bg/S: BgHJJSau3A. 
3.4.6. Sequence Analysis ofp4Bll 
Since the activity could not be localised to a smaller fragment of the insert DNA, the entire 3.7 kb 
insert was sequenced. Several open reading frames were located on the insert (Figure 3.6), but 
only ORF3 showed any significant sequence identity to sequences in the database. This truncated 
ORF showed 35-38% sequence identity at the protein level to putative methylases from various 
bacteria (Table 3.1). The DNA sequence for ORF3 was used to search the B. longum sequenced 
genome, and found identity to a hypothetical protein with a possible methylase domain (BL0328), 
and an alignment of the protein sequences is shown in Figure 3.8. Analysis of the sequence 
adjacent to the B. longum putative methylase did not reveal a similar genetic arrangement as for 











other ORFs located on-p4Bll and the B. longum genome was not identified. The subclone pTspl 
contains ORFs 5,6 and 7 in the same orientation relative to the A promoter present on the vector 
(Figure 3.6), while on pTsp2 ORF 1 is in the same orientation as the promoter. In the subclone 
pHE3, ORF 4 is in the same orientation as the promoter, while on pHE5 ORFs 2 and 3 are in the 
same orientation as the promoter. Since none of the ORFs are truncated in these subclones, if 
activity was being generated by one of these ORFs, it should have been detected in cells 
harbouring one of the four subclones. It is possible that due to sequencing errors the correct ORF 
was not identified. In this case, it could be possible that the ORF responsible for the a-
galactosidase activity was truncated when the insert from p4B 11 was subcloned, and this would 
explain the loss of activity observed. 
1 2 3 4 
llkb--
O.8kb---- • -
Figure 3.7. Southern hybrldisation of the 0.8 kb EcoRl fragment from p4B II to B. lacUs chromosomal DNA. Lane I: 
p4Bll DNA digested with EcoRl, Lane 2: pEcoR251 DNA digested with EcoRl, Lane 3: B. lactis chromosomal 
DNA digested with EcoRl, Lane 4: B. lactis chromosomal DNA digested with BamHI. 
Table 3.1. Percent identity and similarity of the deduced B. lactis ORF3 amino acid sequence to 
bacterial methylases. 
Homologous Protein Accession Number % Identity % Similarity 
Streptomyces coelicolor putative DNA AL034447 38 54 
methylase 
Bacillus anthracis putative RNA NC 003995 36 51 
methylase 













3.4.7. Transcriptional Regulation of B. lactis RNA Coding for Insert DNA from p4Bll 
Since the activity generated by p4Bl1 could not be assigned to one of the ORFs by sequence 
identity or by localisation, and since it was confinned by southern blot analysis that the insert 
DNA did originate from B. lac/is, RNA analysis was undertaken. We wanted to determine if a 
transcript relating to the insert DNA from p4Bl1 was produced in B. lac/is, and detennine if it 
was similarly regulated by catabolite repression, as was observed for a-galactosidase activity 
(chapter 2). Furthennore, by detennining the transcript size, the ORF responsible for the activity 
could possibly be identified. Since there was no indication as to where the activity was localised, 
the 4.3 kb HindIII-BamHI fragment from p4Bll was used as a probe. RNA slot blots were 
perfonned using RNA extracted from B. lac/is cultures grown in the presence of 1 % (w/v) 
raffmose or glucose (Figure 3.9). RNA from E. coli JM109 with p4Bll and pMT104 was also 
included. For B. lac/is, a signal was detected from cultures grown in the presence of raffinose, but 
was absent when grown in the presence of glucose. This suggests firstly, that whatever gene is 
present on p4Bll, is regulated by catabolite repression in B. lactis, and secondly, that the activity 
generated by the clone in E. coli is not likely to be spurious. A positive signal was also detected 
with RNA from E. coli with p4Bl1. Although the P!obe contains 0.7 kb of vector sequence, RNA 
from E. coli with pMTl04 did not hybridise to the probe, suggesting that the signal obtained was 
due to mRNA transcribed from the insert DNA. In order to detennine the transcript sizes, 
Northern hybridisation was perfonned with RNA as for the slot blots, however, transcripts were 



















Figure 3.8. Multiple sequence alignment of the B. lactis ORF3 from p4B 11 with a probable methylase from 











3.4.8. Analysis of Protein Production from E. coli (p4Bll) 
Since the transcript responsible for a-galactosidase activity could not be identified, it was decided 
to analyse the proteins produced by E. coli cells with p4B 11. If a distinct band could be identified, 
MALDI-TOF (matrix assisted laser desorption ionisation-time of flight) mass spectrometry could 
be performed to facilitate the identification of the protein. SDS-PAGE was performed using total 
protein from E. coli JM109 containing the plasmids p4BII and pMT104 (Figure 3.10), however 
there was no significant difference between them. Considering that cells with p4B 11 give a 
maximum activity of 0.025 Jlmoles/minlmg protein, it should not be surprising that a distinct band 
could not be detected. 
1 2 3 4 
A 
B 
Figure 3.9. B. lac/is mRNA from mid-logarithmic cultures grown in different carbon sources probed with (A) the 4.3 
kb HindlII-BamHI fragment from p4B II, and (B) the B. lac/is 16s rDNA probe (prepared in chapter 2). Lane 1: 
mRNA from cells grown in raffmose, Lane 2: mRNA from cells grown in glucose, Lane 3: mRNA from E. coli with 
p4811, Lane 4: mRNA from E. coli with pMTl04. 




















Soya oligosaccharides, of which raffinose is a major component, have been implicated as 
bifidogenic factors (49, 247). Furthermore, we have shown that raffinose was the preferred 
substrate for the growth of B. lactis in comparison to glucose and oligo fructose. Also, a-
galactosidases have transglycosylation activity which could be applied for the development of 
novel prebiotics (310). The characterisation of the metabolism of raffinose by B. lactis, was 
therefore, investigated. 
Several strategies were employed for the isolation of the genes required for the metabolism of 
raffinose. These were (i) screening the B. lactis genebanks on raffmose and the histochemical 
substrate p-nitrophenyl-a-D-galactopyranoside; (ii) amplification of the a-galactosidase from 
B. lactis by peR; (iii) construction and the subsequent screening of a B. lactis genebank prepared 
with DNA which hybridised to the B. longum a-galactosidase gene probe. Three clones 
displaying a-galactosidase activity were isolated as a result. Restriction analysis revealed that 
each of the clones contained inserts ranging from 3.1-0.2 kb in size, and that they were not related 
to each other. This was the first indication that the activity was spuriously being expressed by 
these clones in E. coli. Furthermore, since a-galactosidase genes range from 2.1-2.4 kb in size, it 
was not possible that a functional protein was being expressed from, at least, one of the clones. 
However, E. coli transformed with the vector plasmid, pMTI04, did not display any a-
galactosidase activity, indicating that the cloned B. lactis DNA was somehow involved in the 
activity produced in E. coli. Future attempts to isolate the a-galactosidase from this organism 
should possibly be conducted in the E. coli strain M2508, which has a mutated melA gene (268), 
coding for a-galactosidase. This would possibly reduce the occurrence of false positives as was 
experienced in this investigation. 
Since one of the clones isolated, containing the plasmid p4B 11, had an insert large enough for a 
full length a-galactosidase gene to be present, it was investigated further. Sequence analysis 
revealed 7 putative ORFs, none of which showed identity to other a-galactosidases or related 
proteins. Hybridisation of the insert DNA from p4Bli to RNA from B. lactis cells could only be 
detected when grown in the presence of raffinose and not glucose, thereby suggesting the 
production of a transcript that was regulated by catabolite repression in B. lactis. Furthermore, this 
supported the possibility that the activity detected in E. coli containing p4B 11 was genuine. 











band which could be responsible for the activity. This, however, could be expected since the 
enzyme activity measured from the clone was very low in comparison to that measured in 
B. lactis, even in repressive conditions. 
There are several strategies that could be employed for the isolation of the B. lactis a-
galactosidase gene. The PCR-amplification of the gene could be performed using the High GC 
PCR kit, which facilitates the denaturation of the GC-rich DNA regions, thereby "opening up" the 
DNA to allow the specific hybridisation of the primers and to improve the Taq polymerase 
processivity. Another approach is to purify the B. lactis a-galactosidase using the protocols 
developed for the purification of the B. longum and B. adolescentis proteins (83, 150). The protein 
could be end sequenced, from which PCR primers specific to the B. lactis gene could be designed. 
However, the GalF and GalR primer sequences only differed in 2 bp when the B. adolescentis and 
B. longum sequences were aligned, indicating that the sequences are very conserved, and 
therefore, the B. lactis sequence will probably also not be significantly different. This strategy 
would also identify whether the B. lactis a-galactosidase is homologous to those of B. longum and 
B. adolescentis. Considering that sequence analysis, of the B. longum NCC2705 genome revealed 
the presence of two different a-galactosidase genes, it could be possible that B. lactis gene is 
different to the one that was being amplified. Another consideration is that B. lactis and B. longum 
do not share very high DNA sequence homology (261). Perhaps the a-galactosidase gene could, 
therefore, be amplified from another Bifidobacterium strain that is more closely related to 
B. lactis, such as B. breve, and then used to hybridise to the B. lactis DNA. 
As was mentioned before, raffinose hydrolysis requires the action of two catabolic enzymes. The 
first, a-galactosidase, was investigated in this chapter and could not be isolated from B. lactis. 
The second, a sucrase, was also to be investigated, specially considering that these two genes are 
clustered together in several organisms (12, 233, 238). The following chapter, therefore, reports 
the screening of a B. lactis genebank for sucrose utilisation genes. The isolation, sequence 
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A sucrose utilisation system of B. lactis was cloned in two stages. In the first stage a B. lactis gene 
library was screened for plasmids conferring a sucrose-positive phenotype on E. coli. A plasmid, 
pSuc1, was isolated and contained an insert of 4.6 kb of B. lactis chromosomal DNA. Preliminary 
sequence analysis indicated that the insert contained a truncated sucrose utilisation gene cluster. 
The remainder of the gene cluster was cloned by chromosome walking. 
Nucleotide sequence analysis revealed that this B. lactis sucrose utilisation gene cluster contained 
3 closely linked genes, designated scrP, scrT and scrR, encoding for a sucrose phosphorylase, a 
GaIR-LacI family sucrose regulator and a transporter protein of the sugar transporter family. The 
scrP and scrT genes did not find sequence identity to the equivalent PTS components, namely a 
sucrose-6-phosphate hydrolase and an enzyme II protein respectively, suggesting that sucrose is 
not transported via the PTS in B. lactis. The presence of the scrR gene implied that sucrose 












The carbohydrates inulin, oligofructose and raffmose are some of the major bifidobacterial 
prebiotic compounds, the first two being the most extensively studied (92, 94, 237). The key aim 
of this study was, therefore, to investigate and characterise the utilisation of these carbohydrates 
by B. lactis at the molecular level. 
The approach was two-pronged, involving the isolation of, firstly, the inulinase and secondly, the 
raffinose utilisation genes by complementation of a B. lactis genebank in E. coli. The second 
approach was undertaken and was reported in chapter 3. The isolation of an inulinase was 
considered, however, inulin was not utilised as a sole carbon source by the four bifidobacterial 
strains analysed (chapter 2), and, although B. lactis was able to ferment oligofructose, it supported 
very poor growth. Since it was not clear whether the inability to utilise inulin was due to the 
absence of the catabolic gene or due to transport difficulties, it did not seem feasible to screen on 
inulin. Therefore, another approach was undertaken. 
Inulin is a fructose polymer with an a.(1,2} linked glucose at the terminal end of the molecule, and 
since oligo fructose is an enzymatic hydrolysis of inulin, a proportion of the polymers would also 
have the terminal a.(1,2}-glucose (229, 337). Raffinose also contains the a.(1,2}-glucose-fructose 
bond. Since the a.( 1 ,2} glycosidic linkage of sucrose is found in all three of the oligosaccharides, it 
was decided to screen for the genes involved in sucrose utilisation. 
The work presented in this chapter describes the steps taken to isolate the B. lactis sucrose 
utilisation (scr) gene cluster by screening the B. lactis Sau3A genebank in E. coli. The subsequent 
sequence analysis of all the genes isolated, and the characterisation of the sucrase is described. 
4.3. MATERIALS AND METHODS 
4.3.1. Bacterial Strains, Plasmids and Culture Conditions 
Bifidobacterium lactis was propagated in BYG medium as described in 2.3.1. Where applicable, 











E. coli JM109 (336) was used for all cloning purposes and was cultured as described in 2.3.1. 
MacConkey base medium (Difco Laboratories) and M9 minimal medium (176) supplemented 
with ampicillin (Ap) and 1 % (w/v) sucrose, was used to assess fermentation of sucrose as a sole 
carbohydrate source. 
The following plasmids were used for subcloning and sequencing: M13·derived Bluescript SK 
plasmid (PSK) (Stratagene, La Jolla, California, USA), pEcoR251 (343), and pMT104 (327). 
Further strain and plasmid details are given in Appendices A and B. 
4.3.2. General DNA Manipulations 
Extraction of plasmid DNA, preparation of E. coli JM109 cells, DNA ligations, gel 
electrophoresis and other general manipulations are described in section 2.3.3. 
4.3.3. Screening of the B. lactis Genomic Library 
The B. lactis Sau3A genebank (3.3.4) was transformed into E. coli JM109. Transformants were 
screened for sucrose-positive phenotypes on M9 minimal medium containing sucrose and Ap and 
were confirmed to be sucrose-positive on MacConkey agar, containing sucrose and Ap. 
4.3.4. Southern Blot and Colony Hybridisation 
Southern blot and colony hybridisation procedures were conducted as described in section 3.3.7. 
The 1.4 kb scrP-specific BamHI-HindlII and 0.45 kb scrT-specific PvuI-SalI fragments from 
pSuc 1 were used as probes and were prepared as described in section 3.3.7. 
4.3.5. Sucrase Assays 
E. coli cell free extracts (CFEs) were prepared as described in section 2.3.8. For the temperature 
optimisation preparations, the cells were washed and resuspended in TA buffer (100 mM Tris, 
100 mM acetate, pH 7), whereas for the pH optimisation assays, TAP buffer (100 mM Tris, 100 
mM acetate, 64.2 mM Na2HP04. pH 4-pH 9) was used. Sucrase activity was assayed in the CFEs 
as described in section 2.3.9.1. For the temperature optimisation assays, the reactions were 
incubated at temperatures between 22°C and 100°C. For the substrate specificity assays the 
substrates (sucrose, raffinose, melezitose, oligofructose, and inulin) were supplied at a 
concentration of 1 % (w/v). 
4.3.6. Protein Assays 











4.3.7. Nucleotide Sequence and Analysis 
DNA sequencing was perfonned and analysed as described in section 2.3.4. 
4.4. RESULTS 
4.4.1. Isolation and Preliminary Sequence Analysis of the Truncated scr Gene Cluster 
The Sau3A gene library of B. lactis established in E. coli' JMI09 was screened on minimal 
medium containing sucrose. From approximately 3500 colonies that were screened, six were able 
to utilise sucrose as the sole carbon source. Plasmid restriction analysis of these clones indicated 
that they all had a 1.9 kb BamHI-PstI fragment in common. The plasmid containing the largest 
insert was designated pSuc 1 and its analysis revealed an insert of 4.6 kb (Figure 4.1). In order to 
localise the sucrase activity to a smaller fragment and to facilitate sequence analysis, the insert in 
pSuc1 was digested into several fragments and sub cloned into pSK. The plasmid pHindl (Figure 
4.1) containing a 2.9 kb HindIlI insert fragment was found to confer a sucrose-positive phenotype 
on E. coli'. However, when sucrase assays were perfonned on E. coli cells containing pHindl, the 
activity was reduced 200-fold relative to cells with pSucl, suggesting that sequence downstream 
of the HindIII site was critical for activity. 
The insert of pSucl was sequenced so that the gene expressing sucrase activity could be 
characterised, and to detennine if other related genes were present. This revealed the presence of 
two open reading frames (ORFs) reading divergently (ORFs 1 and 2), and a third truncated ORF 
(Figure 4.1). ORFI showed sequence identity to regulator proteins of the GaiR-LacI family (full 
details are supplied in section 4.4.4.2 and in Table 4.2) and was designated scrR. ORF2, reading 
divergently from scrR, showed sequence identity to sucrose phosphorylases (full details are 
supplied in section 4.4.4.1 and in Table 4.1) and was designated scrP. The truncated ORF3, 
upstream from and reading in the same direction as scrP, found weak sequence identity to 
transporters of the sugar transporter family of pro- and eukaryotes (details are supplied in section 
4.4.4.3 and Table 4.3), and was designated scrT. It appeared, therefore, that a truncated sucrose 
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Figure 4.1. Genetic organisation of the scr genes of the B. lactis sucrose utilisation system. Transcriptional polarities 
are indicated by arrows. Thick and thin lines represent insert and vector respectively. Plasmids pSuc 1 and pSuc2 
originate from the Sau3A genebank constructed in the BgnI site of the vector pEcoR251. Plasmid pSuc3 was 
constructed from pSucl and pSuc2 (see text for details). Plasmid pHindI contains a 2.9 kb HindllI fragment from 
pSucl subcloned in pSK. Sizes are indicated in kb. S, BamHI; Sg/S, BgIIIlSau3A; H, HindIII; P, Pstl; Pvl, PvuI; Sa, 
Sail; Sm, Sma!; St, Stu!. 
4.4.2. Southern Blot Analysis of the Sucrose Cluster 
Before continuing with further analyses, a Southern hybridisation was perfonned to confinn that 
the cloned insert DNA from pSucl originated from B. lac/is. The 1.4 kb BamHI-HindIII was DIG-
labelled and hybridised to B. lactis chromosomal DNA digested with BamHI, HindIII, and 
BamHI-HindIII (Figure 4.2). The probe hybridised to an approximately 7.8 kb BamHI fragment, 
14 kb HindIII fragment, and a 1.4 kb BamHI-HindIII fragment, confIrming that B. lac/is 
chromosomal DNA had been cloned. 
4.4.3. Isolation of the Complete scr Gene Cluster 
The plasmid pSuc1 isolated from the genebank contained a sucrose cluster which was truncated at 
the scrT gene. To isolate the remainder of the gene, colony hybridisation of the B. lactis genebank 











colonies gave a positiv~ signal. two of which appeared to have the same construct from restriction 
analysis of their plasmids. A Southern hybridisation of the digested plasmids was performed with 
the same probe (not shown). and together with the comparison of their restriction patterns to that 
of pSuc1. one clone was selected which was thought to contain the full scrT gene. This was 
designated pSuc2 (Figure 4.1). Sequence analysis of the insert in pSuc2 indicated that the 
complete scrT gene had been isolated. This clone was unable to confer a sucrose-positive 
phenotype on E. coli. Sequence analysis revealed that the scrP ATG start codon was not present. 
1 2 3 
14 kb --... . 
7.8kb--.... ~ 
1.4 kb---+ .. 
Figure 4.2. Southern hybridisation of the scrP gene. The 1.4 kb Bamill-HindIII fragment was used as DIG-labelled 
probe and was hybridised to B.lactis chromosomal DNA. Lane I: B. lactis chromosomal DNA digested with Bamill, 
Lane 2: B. lactis chromosomal DNA digested with HindIII, Lane 3: B. lactis chromosomal DNA digested with 
BamHI-HindIII. No hybridisation was detected with plasmid DNA from pSK (not shown). 
Since the three genes were present on two different clones, a cloning strategy was devised to 
ligate the inserts from pSucl and pSuc2 so that the genes would be assembled on one construct. 
The 2.8 kb HindIII-BamHI fragment from pSuc2 was cloned into pSucl replacing the 1.5 kb 
HindIII-BamHI. and the resultant clone was designated pSuc3 (Figure 4.1). Analysis of the 
sequence across the BamHI site in the insert of pSuc3 confirmed, together with restriction digests. 
that the subclone was successful. Fermentation on MacConkey agar containing sucrose indicated 
that this clone was able to confer sucrase activity on E. coli. 
4.4.4. Sequence Analysis of the B. lactis scr Genes and their Translation Products 
A detailed analysis of the DNA and amino acid sequences of the three B. lactis scr genes was 











4.4.4.1. B. [actis scrP 
The scrP gene consists of 1518 bp encoding 506 amino acids with a calculated molecular mass of 
55,660 Da, and specifies sequence identity to sucrose phosphorylases of various bacteria (Table 
4.1). A multiple sequence alignment of these proteins illustrates several very conserved regions 
(Figure 4.4), however, these domains have not yet been identified or assigned catalytic function. 
A canonical gram-positive Shine-Dalgarno (SD) sequence AGGAGG (315) was located 4 bp 
away from the proposed ATG start codon (Figure 4.3). A detailed analysis of the promoter region 
will be presented in chapter 5. 
Sucrose phosphorylases reversibly catalyse the reaction sucrose + phosphate ~ a-D-glucose-l-
phosphate + D-fructose. This is catalysed in a double replacement reaction, where a glucose-
enzyme complex intermediate is formed (238, 317). Interestingly, sucrose phosphorylases also 
catalyse transglucosylation in addition to phosphorolysis (133) and therefore, can be used for the 
synthesis of novel glucooligosaccharides. This could possibly be applied for the synthesis of 
prebiotic substrates specific for the stimulation of B. lactis. The sucrose phosphorylase from 
L. mesenteroides was able to synthesise glucosyl-xylitol (133). This oligosaccharide is being 
analysed as a preventative for dental caries because it reduced the synthesis of water-insoluble 
glucan which is produced by S. mutans from sucrose. Therefore, this enzyme has potential for 
biotechnological applications. 
Table 4.1. Percent identity and similarity of the deduced B. lactis ScrP to known protein 
sequences. 
Homologous Protein Accession Number % Identity % Similarity 
Agrobacterium tumefaciens SucP AF0652465 57 71 
Agrobacterium vitis SucP P33910 56 69 
Pseudomonas saccharophila sucrose AF158367 53 67 
phosphorylase 
Streptococcus mutans GtfA PI0249 41 58 
Leuconostoc mesenteroides SucP Q59495 39 56 












4.4.4.2. B. lactis scrR 
The scrR gene consists of 978 bp encoding 326 amino acids with a calculated molecular mass of 
35,860 Da. A possible ATG start codon preceded by a potential Shine-Dalgarno sequence 
(AGGAGG) at positions -6 to -11 relative to the ATG was identified (Figure 4.3). The promoter 
region was analysed and will be presented in chapter 5. Two stem-loop structures were detected 
47 and 73 bp downstream of the stop codon, which might function as rho-independent 
terminators, however, the T -stretch is missing. 
At the protein level, sequence identity was observed to the N-terminal regions of the GalR-LacI 
family of bacterial transcriptional regulators (191). Since this region of the GalR-LacI family has 
been implicated in DNA binding due to a helix-tum-helix motif (Figure 4.5), this identity 
suggested that ScrR might also be involved in such interactions. Further investigations were 
performed and will be presented in chapter 5. Moreover, ScrR also showed identity throughout the 
amino acid sequence to other sucrose regulators belonging to the GalR-LacI family (Table 4.2). 
These conserved regions were, at first, proposed to be involved in sugar-binding (328). However, 
when the inducer binding domains of these proteins were aligned (by comparison to the regions 
identified for the E. coli LacI protein) (Figure 4.5), it could be seen that the B. lactis ScrR lacked 
identity in those regions, suggesting that the B. lactis ScrR perhaps responds to a different ligand. 
In the case of K. pneumoniae and S. typhimurium ScrR proteins, the inducer molecule has been 
demonstrated to be fructose or fructose-I-phosphate (127), but for other ScrR proteins, the 
molecules may be sucrose or one of its metabolites, such as sucrose-6-phosphate (116). The 
metabolites produced when sucrose is metabolised by a sucrose phosphorylase would differ to 
those produced by a sucrose hydrolase. Moreover, in B. lactis sucrose would enter the cell in its 
native form for hydrolysis by ScrP, whereas for organisms transporting sucrose via a PTS, the 
product of transport would be sucrose-6-phosphate. Therefore, the B. lactis ScrR might recognise 
a different ligand molecule, which could explain the lack of identity in the inducer binding 
regions. 
Table 4.2. Percent identity and similarity of the deduced B. lactis ScrR to known protein 
sequences. 
Homologous Protein Accession Number % Identity % Similarity 
Lactococcus lactis SacR Q04939 37 57 
Streptococcus mutans ScrR Q54430 31 49 











It is interesting to note that the B. lactis ScrR shares significant homology to the sucrose 
regulators of L. lactis, S. mutans, and P. pentosaceus. In a phylogenetic analysis of sucrose 
regulators (222), it was reported that within the GaiR-LacI family, proteins involved in the 
regulation of sucrose-catabolic genes had evolved separately at least four times. The B. lactis 
ScrR protein would, therefore, fall within the cluster consisting of the S. mutans and 
P. pentosaceus genes. However, unlike in these organisms, the scrR gene of B. lactis is not 
associated with sucrose PTS and hydrolase genes (see chapter 1 for the genetic arrangement of the 
P. pentosaceus, L. lactis and S. mutans scrR gene). In L. lactis and P. pentosaceus these sucrose 
utilisation genes are located on plasmids or transposons (190, 221), and, therefore, horizontal gene 
transfer from these organisms to B. lactis, or perhaps Bifidobacterium (see 4.4.5), could have 
occurred. 
4.4.4.3. B. lactis scrT 
Several possible in-frame ATG start codons were identified for scrT (Figure 4.3), none of which 
have a typical Shine-Dalgarno sequence preceding it. However, an alignment of the Shine-
Dalgarno regions of 6 bifidobacterial genes revealed that only the AGG of the canonical GGAGG 
sequence was conserved (291). On this basis, the sequence GAGG located 11 bp from one of the 
ATG start codons was identified (Figure 4.3). Although this sequence has also been identified as 
the Shine-Dalgarno for the B. longum ldh gene (291), BLAST searches of the scrT amino acid 
sequence only showed identity from the third ATG (Figure 4.3, Figure 4.6). An intergenic region 
of350 bp separates the scrP stop codon and the first ATG codon of the scrT gene. In the analysis 
of this region, transcription terminator sequences (such as a stem loop) or promoter sequences 
could not be identified, suggesting that these two genes could possibly be co-transcribed as an 
operon. This was investigated and is reported in chapter 5. Two stem-loop structures were 
identified 22 and 73 bp from the scrT stop codon which could function as rho-independent 
terminators, however, the T stretch is missing. 
The scrT sequence specified weak identity (20-28%) to a variety of transporters of the sugar 
transporter family of prokaryotes and eukaryotes, with the highest overall identity to a putative 
membrane protein from Caulobacter crescentus (accession no. AE005901) (Figure 4.6). When 
only the N-terminus (200 bp) sequence was used to search the databases, identity to plant sucrose 
symporters was detected (Table 4.3), which did not extend beyond the N-terminus. This suggests 
that the scrT gene product might be involved in the transport of sucrose. The functionality and 











The hydropathy plot ?f the scrT predicted protein revealed a hydrophilic N-tenninus with a 
number of highly hydrophobic regions, interspersed with regions of hydrophilicity (Figure 4.7). 
This secondary structure is common in proteins belonging to the sugar transport family (140), and 
generally have 11 or 12 discrete hydrophobic domains which are potential transmembrane (l-
helices. Therefore the scrT gene likely codes for a membrane-bound sucrose transporter protein. 
The B. lactis ScrT appears to have 11 domains (Figure 4.7). Typically, the carboxyl tennini of 
sugar transport proteins are hydrophilic and are predicted to be on the cytosolic side of the 
membrane. However, ScrT appears to have a hydrophobic C-tenninus. 
Table 4.3. Plant sucrose symporters to which the B. lactis ScrT N-tenninus finds identity. 
Homologous Protein Accession Number % Identity % Similarity 
Vitis vinifera AF182445 33 48 
Solanum tuberosum AF237780 31 47 
Lycopersicon esculentum AF176950 30 44 






















































-----... * K V 
CCGGCCGTTGCGCTTGCGA~GGCCGGACGCCAGACCTCTCTCCATTCCCTAATGAACTGC 
N R I R MIL A A A A L V I V I A V G F 
AACGCCTACGCGTACTACTCACGCCGGCGCCGCTCGTGTTAGTGCTAGCGCTGCGGCTTG 
V WAY A V APT T S V H M S S K V I S 
TGGGTACGCATCCGCTGCCGCCCGCACCACCTCTGCACGTAGCTCGAGAACTGCTACCTC 
V V L S T MAT G I V T S L T N A L N L 
TGCTGCTCGCTCCAGTAACGGCACGGCTAGTGACACCTTTCGCACAACCGCTCCAACTCT 
I G L 0 K G A E K P N P L V A V N L A Q 
TATGGGTCTAGGAACGGCCGAAGGAAGCCTAAGCCGTCGTGCCGGTGCAACTCGCGGACC 
o I ANY V G Y G L G A V A A FLY M G 
AGCTAGCGCAACATCTGCGGCATTGGCTCCGGCCGCTGCCGCCGCTTGTCTATGTACGGG 
M P S R F F L P M A A G V A F L C SAL 
TAGCCGCTCGCCTTCTTGTCGCCGTAGCGCCGTGGCTGCCGCTTGTCCGTCGAACGCTCG 
A V P L K R R G L ROT I P GAT V A A 
CGGTGGCCGTCGAACGCGGACGGCTCTGCCAGCCACTAGCCCGGACGGCACTGCCGCCGC 
I L S V V L T I V GMT A I I T A A K 0 
TAGTCGCTCTGCTGCTCGCACTAGTGCGGGTACCACCGCTACTAGCATCGGCGGAACAGG 
K A N P 0 GAY I Y 0 Q A I Y L Q Y T T 
AAGCGTAAGCCTAGCGGCCGCATCTACATCAGGACGCGTTACATGTCGACCATCCAGCAC 
I M W Y G G M M L T R G V LAY Y FOP 
TAGTAGGTCATCGGCGGGTAGTACTCGCACGCCGGCTGCTCGCGCATCATCTTCAGCCCC 
A H R P P R F N L L V S K V T V H E S Q 
CGCACCGCGCCGCCGGCCTTCAAGTCCTCGTGCCTGAAGTGCCAGTGTACGAGCGAGACG 
E E FRS S K E R P W M A V V FIG T L 
AGGAGCTTCGCCGAGCTGAAGAGTGCGCCGGTGTACCGCTGCTGCTTCTACGGCCACTCT 
S FIG L G M M WAS F L G S Q G Q R L 
GACTTCTACGGGTCTGGGTAGTAGGTACGCCTCTTCTCAGGGCTGACGGGGACTGCGTCC 
F A A G V V S G L T Q G V A I GAG Y F 
TTGCGCCGTGGGTGCTGGCTCGGCTCGCAGACCGGCTGCCGCTACGGCCGCGGCATCTTC 
G SIT G R V K 0 P V R 0 S M V A V Y P 
GGCCTCTAGCATGGCGCGTGGAACAGCCCGTGTGCCAGCCTGTAGTGCCGGTGCATACCG 
5'- G 




N RTF A I A G I A L G T I I G G G V I 
1741 AACGCGCACTTACGCTACCGGGGCTACCGTTCTGGCCACTACTACGGCGGCGGGTGCTAG 












N ALL 'A V I A GIS N V L G L MAE K 
1861 AAGCGGTCGTTACGGTGTTAGCGCGGCTAGCTCAACTGGTTCGGCTCGTACCGAAGGAAC 
S S N D I L E F V R P L I V T S L A V W 
1921 GAGCTCAACAGTTAGTCGAGCTTGTGTGCGCCGTCTTACTGCCACGAGTCGCGGTGGGTG 
3' -GCAGAATGACGGTGCTCAG- 5' 
Primer C2 
P I A C A V A S V T F GIG L R V LEA 
1981 CCTTAGCGCGTCCGCTGACGCCTTTGCCACTTCGGCTACGGGTTCGCGTGCTCAAGCCGG 
5' -CGGAAACGGTGAAGCCGAT- 3' 
Primer St 
•... scrT 
K T P R H G D A S V M P D R M D MFA S 
2041 AACCAGCCCGCCACCGGCAGCCGGCTCTGGTAGCCTAGCGCGTACAGGTACTTACGCCTG 
A E D P V A T D V A A L A A M G S G V A 
2101 CGGAGCAGGCCGTGGCGGCACAGGTGGCGCCGGTCGCGGCGGTACGGCCTCGGCTGCCGG 
SD 
Q S D TAL K T G Q V QED G V S S D A 
2161 ACGCTTAGCCACCGCTCAAACCACGGGACGTGGACGAGCAGCGGGTGTGACGACAGCCGC 
ARK K P M PAT L R SIN E K D E Q S 
2221 CGAGCGAAGAAGCCGTAGCCGCGCCACTCTGCCCTCTACAAGAGGAACAGAAGGACCGAG 
L V K D F D P R D DIG P R I Y G N S G 
2281 TTATGGAACAGCTTCAGCCCCGCCAGCAGCTACGGGCCCGCTTACATCGGCAAGCTCGGG 
T SPA S G G H T D QED V M 
2341 CAGCTGCCGCGCGAGGGAGGCACCCACAGAACAAGCAGTTGGTACTAAAGAGAAAAGGCC 
scrP Stop 
* S A Q M V P 
2401 CTTAGACTTTTATAGACCTTAGAGATAGCCCTTGGCGCGTAGTCGAGCGGACGTACTGCC 
P N A I L DDT R H E G T S D T W V L T 
2461 CGCCCAAGCGTTACTCCAGCAGCCACGCCACGAGCGGTCACCTTAGGCAGGTCTGCTCGC 















A V S Q P N E V G M G K S P T F T L T P 
ACCGCTGCCTGACACCCAAGAGCTGTGGGTACGGGAACCTGCCGCACTTGCACTCGCATC 
F S G F G N W S F A I SED D G V S Y S 
CCTTCCTAGGCTTTGGCAAGG,!'CCTCTTGCGTTAGCTGAGCAGTAGCGGGTGGCTCATCG 
F D G D F A P LEN R F R A LAN L A K 
ACTTCAGCGGCAGCTTGCGGCCGTCGAGCAACGCCTTAGACCGCTCGCGCAAGTCCCGGA 
V V PRE L N K DIE S TTY Y H R N I 
ACTGGTGGCCTGCAAGCTCCAAGAACAGCTAGAGCCTCCAGCACATTATCACCGCCAACT 
D R G V N T R K L L E M D NEG A LAG 
ACAGCGCCGGGTGTAAGCACGCGAACTCGTCGAGGTACAGCAAGAGCGGCCGCTCGCGCG 
V Y Y V Q P V G P L F F Q V A R A A I Y 
GGTGTATCATGTGGACGCCTTGCGGGCCGTCCTTCTTGACGTGCCGCGCACGCCGTTACA 
H Q D N C G LAS Y Y T S N V Q Y L D L 
TTACGACCAGTAACGTCGGCTCGCGGCTTATTATACACCTCAAGTGGACCATCTCCAGCT 
N S A A A G T A A K S E G H T N K A I T 
CCAAGCTTCGCCGCCGCGGCCAACGCCGGAAGCTGAGCGGTACCCACAAGAAGCGCTAGC 
E V M N D V DAD P V L G K L S R D L Q 
AGAGCTGGTACAACAGCTGCAGGCGCAGCCCGTGGTCTGGGAACTCGCTTGCCAGCTCGA 
D S G I D I V GIG D H T D L V T V A N 
CCAGCCTCGGCTACAGCTACTGCGGCTACGGCAGCACGCACAGCTCGTGCCACTGGCGTA 
N P R I E T W HAL A D V K G T F L S H 
ACAAGCCCGCTTAGAGCCAGGTCACGCGCTCGCGCAGGTGGAACGGCCACTTGTCGCTCA 
L L L P P L A F D Y V R D V K A A I E V 
CGTCGTCGTTACCGCCGTCGCGCTTCAGTATCTGCGCTAGGTGGAACCGCCGCTAGAGGT 












E R L R S I L EFT K P T M F CST G A 
3301 GGAGCGCGTCAGCGCTCTACTCAAGCTTCCAGAACCCCCAGTACTTCGTCGACCACGGCC 
E K A G Y G V A D L R I Y K V H S K S M 
3361 GGAGGAACCGCGGCATCGGCTGCCGCAGCTCCGCTTACATGAACTGCACGCTGAACGAGT 
Q D F ISM LYE W G K A S D T DID V 
3421 AGACCAGCTTCTAGCTGTAGTCCATAAGGGTCGGGAACCGCCTCAGCCACAGTTACAGCT 
Q Q P T F T V W V L R T K G A F S Y H T 
3481 GGACGACGCCGCACTTGCACTGGGTGTGGTTCGCCCAGAACGGCCGCTTCGACATCACCC 
F P L G P R PRY I GAL E E ETA G D 
3541 ACTTGCCGTCCGGGCCCGCGCCCGCCATCTACGGCCGCTCGAGGAGGAGCCAGCGCGGCA 
P F V SSM T L F M P Y YES D E G N A 
3601 GCCCCTTGTGCCTCGAGTAGCACTCCTTGTAGCCCATCATGAGCCTTAGGAGCGGCAAGC 
L V D Q F Q K S Q W S M H N V I A DVM 
3661 GCTCGTGTAGGACCTTGACGAACCTGACGGTCGAGTACACCAACTGCTACCGTAGCTGGT 
I D H T K ALE A I D D W D G L R A D V 
3721 ACTACAGTACGCAGAACCGCTCGAGCCGCTACAGTAGGGTCAGTGGCTCCGCCCGCAGCT 
K T H DIP D F GAD A G D F P T F F P 
3781 GGAACCACACCAGCTAGCCCAGCTTCGGACGCAGGCGCGGTAGCTTGCCCCACTTCTTGC 















A LNG D G L R DAY TIL Q V K N K M 
TTCGTTCCAACGGCAGTGGGTTCGCTAGGCGTATCCACTAGTCGACTTGAAACAAGAAGT 








IR1 TS -10 
TCTTCACG- 3' ~~ 
TCTTCACGCGCATGCAAGCGCTCTGCTCTCGGCGTATCAAA TTCGATATTCGACGA 
AGAAGTGCGCGTACGTTCGCGAGACGAGAGCCGCATAGTTTGGCCAAGCTATAAGCTGCT 
-35 -35 -10 
TTCACCGCGCTCTGCCGAAACGCGGTTGCCGGAGGACGAAATCTGCACATACAATCGGAT 
AAGTGGCGCGAGACGGCTTTGCGCCAACGGCCTCCTGCTTTAGACGTGTATGTTAGCCTA 




serR ...• 3 I -GCAGAGCCACTCGTCACAG 
GCGAACATGGTCGGCATGCGCGATGTCGCGAAACGGGCGGGCGTCTCGGTGAGCAGTGTC 
CGCTTG M V G M R D V A K RAG V S V S S V 
AGC- 5' 
TCGCTGGTGATCAACGGCACCGGCTATGTCTCACGCGATATGCGCGAGAAGGTCGAGCAG 
S L V I N G T G Y V S R D M R E K V E Q 
GCCATGCGCGAGCTCGACTATGTGCCCAACGAGCTCGCGCGCAATTTCTACCACGGCAAG 
A M R E L D Y V P N E L A R N F Y H G K 
ACTGACATCATCGGCGTCATCGTGCCCACCATCCAGCACCCGTTCTTCGCCACGCTCACC 
T D I I G V I V P T I Q H P F FAT L T 
GCGCACCTGCAGCACGAGTTCGCGGACCGCGGTCTGCAGACGATGCTGTGCTCCACCGCC 












D SAN' G E A Q Y V D M L R R H S L D A 
4621 CTGGTCGTCGCCGCGCACACCACCCACGACCCGCAGTATTGGCGCGCGATCGACCGCCCG 
L V V A A H T T H D P Q Y W R A I D R P 
4681 GTGGTCGCCTTCGACCGCAATCTGGGGGCGGGGATCACTCAGGTGAGTTCAGACCACGTG 
V V A F D R N L GAG I T Q v S S D H V 
4741 CACGGCGGCGAGCTCATCGCAGAACTCCTCGTGCGCACCGGCGCGCACCATGTGGTCATG 
H G GEL I A ELL V R T G A H H V V M 
4801 GTGGGCGGCCCGCGCGCGCAATTCACCGACCTCGGCGACCACTCCACCTTCCCCACCGTC 
V G G P R A Q F T D L G D H S T F P T V 
4861 CGCTATGTACAGACGTTGGAAGACCGCCTTTCCCAAGCGCGGATTGCGCACACGTACATC 
R Y v Q T LED R L S Q A R I A H T Y I 
4921 GAGTCGGGCGAGGTGTTCGACATCGCCGGCGTGCGGCGTGCGGTTCGCGAGGCATTCGAC 
E S G E V F D I A G V R R A V REA F 0 
4981 ACATACCCGGACATGGATGCGTTCGTGGGGGCAGATCTCGCCGCCGCATTCGCCGTGCAG 
T Y P 0 M 0 A F V GAD L A A A F A V Q 
5041 GAGGCGGTCTCGCGCTCGATCGCGGTGCCCCGTGATGTGCAGATCATCGCCTACGACGGC 
E A V S R S I A V PRO V Q I I A Y 0 G 
5101 ACACTCGCCGCGGATTGCGCCGGCATGCCGCTCACCACGGTCGCCCAGGATTTCAGGCAG 
T L A A 0 C A G M P L T T V A Q 0 F R Q 
5161 ATCGCGCACACCATCGCCGCGTGCGTGGAACACGGGATCGAGTCTTCGCCGCAACGCCCG 
I A H T I A A C V E H G I E SSP Q R P 
5221 GATGCCACGGACGCGATGCCAACATGACGATCATCCCGGTGACGCTGCACGAGCGCGCCA 

























Figure 4.3. Nucleotide and deduced amino acid sequence of the B. lac/is scr gene cluster. Deduced amino acid 
sequences are shown in single-letter code with the coding sequences. Putative initiation and termination codons for 
the scrR. scrP and scrT genes are shown in bold type. Putative promoters (-35 and -10 regions) and ribosome-binding 
sites (SO) are in bold type and underlined. Putative transcription start sites (TS) for the scrP and the scrR genes are 
indicated in bold type. Three indirect repeats (IRI-3) indicated by facing arrows may act as operator sites for GalR-
LacI family regulator proteins. A more detailed illustration of the scrP-scrR promoter region is given in Figure 5. 7. 
Inverted repeat sequences representing potential transcriptional terminators are indicated by facing arrows after the 
scrR and scrT transcription stop codons. The positions and sequences of primers Sp, Sr and St used for the primer 
extension experiments are indicated in bold type with the corresponding nucleotide sequence. The positions and 
sequences of primers A, Band C2 used for the reverse transcription experiments are similarly indicated. The position 
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Figure 4.4. Multiple sequence alignment of bacterial ScrP proteins. Sequences included are: A. vilis SucP (A vit), P. 
saccharophila sucrose phosphorylase (Psac), S. mulans GtfA (Smut), L. mesenleroides SucP (Lmes), B. longum Spl 
(Blon) and B. laclis ScrP (Blac). Sequence accession nwnbers are supplied in Table 4.1. Identical amino acids are 
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Figure 4.5. Multiple sequence alignment of bacterial ScrR proteins. Sequences included are: E. coli Lacl (Ecol), 
L. lactis ScrR (LJac), S. mutans ScrR (Smut), P. pentosaceus ScrR (ppen), B. longum ScrR (Blon) and B. lactis ScrR 
(Blac). Sequence accession numbers are supplied in Table 4.2. E. coli Lacl was included to orientate the helix-turn-
helix DNA-binding domain; inducer binding (I, cross-hatched); dimerisation (0, dark filled box) and tetramerisation 





























































Figure 4.6. Multiple sequence alignment of the deduced B. lac/is ScrT protein (Blac) with putative membrane 
proteins from C. crescen/us (Ccre) (accession no. AE005901) and B. longum (Blon) (accession no. NC004307, ORF 
no. BL0534). Identical and similar amino acids are shaded in dark blue and light blue respectively . 
. 3~ ________ ~~ ________ ~ __________ ~ __________ ~ 
110 220 330 439 
Amino acid nunber 
Figure 4.7. Hydropathy plot of the deduced B. lac/is ScrT protein. The calculation was performed according to Kyte 












4.4.5. Analysis of the B. longum Sequenced Genome for Sucrose-Utilising Genes 
The B. longum sequenced genome (accession no. NC004307) was explored for the presence of 
sucrase genes. Two clusters were identified. The first cluster (Figure 4.8) consists of 3 genes 
namely, cscA (BL0105), encoding a ~-fructofuranosidase/inulinase; cscB (BL0106), encoding a 
sucrose transport protein; and the third gene (BL0107) encodes for a LacI-type transcriptional 
regulator. The second cluster, 540 kb from the first, has genes similar to the B. lactis scr genes 
(Figure 4.8). It consists of the spl gene (BL0536), encoding a sucrose phosphorylase; scrR 
(BL0533) encoding a LacI-type transcriptional regulator; and the third gene (BL0534), which will 
hereafter be referred to as scrT, encodes a putative transmembrane protein (Figure 4.8). 
B.longum 
Sucrase cluster 1 
- < I<--~ cscA cscB Lad-type transcriptional 
jl-fructofuranosidase sucrose permease regulator 
519 aa 501 aa 347 aa 
B. longum < ___ -----'1 <S ...... '. '.' ........... ' .' .. J 
Sucrase cluster 2 scrR 
348aa 
B.lactis '<:}:-:-:-:-:-:-:-:':-:-:-:-I 













Figure 4.8. Comparison of the genetic organisation of the B. lactis and B. longum sucrase gene clusters. The 
B. longum cluster 1 is found at positions 126784 to 130943 bp and cluster 2 at 671691 to 676166 bp on the genome 
map (accession no. NC 004307). The deduced amino acid (aa) sizes for each gene is indicated. For the B. lactis ScrT 
and the B. longum putative membrane protein, the number of amino acids was calculated from the ATG start codon at 
which homology to the C. crescentus protein begins (Figure 4.6). 
The B. longum spl deduced amino acid sequence shows 83.7% identity to the B. lactis ScrP 
(Figure 4.4). The scrT follows the spl by 465 bp, reading in the same direction, and shows 27.9% 
amino acid identity to the B. lactis ScrT (Figure 4.6). The scrR follows from the scrT by 64 bp 
and shows 53.1 % amino acid identity to the B. lactis ScrR (Figure 4.5). 
The genetic organisation of the B. longum scr gene cluster, therefore, differs from the B. lactis one 











suggested (section 4.4.4.-2) that the unusual organisation of the B. lactis scrR with the scrP and 
scrT genes, instead of with sucrose PTS genes, was the result of horizontal gene transfer events 
from another organism to B. lactis. The fact that in B. longum the scrR gene is organised with 
similar genes and in a different orientation to that in B. lactis, suggests that the horizontal gene 
transfer occurred at the genus, and not species level. 
The cscA gene present in the first gene cluster in B. longum (Figure 4.8) has also been identified 
in B. lactis and has been preliminarily characterised (71). The deduced protein sequence of the 
B. longum cscA gene also finds homology to sucrose-6-phosphate hydro lases from other bacteria. 
However, the cscB gene, encoding the sucrose permease, does not find any identity to sucrose 
PTS transporters. Furthermore, other sucrose PTS type genes were not identified upon searching 
the B. longum sequenced genome. It therefore, appears that in B. longum the PTS system is not 
the mechanism by which sucrose is assimilated, and this possibly extends to all species belonging 
to Bifidobacterium (see conclusions). 
4.4.6. Characterisation of the Recombinant Sucrose Phosphorylase Enzyme Activity 
The aim of this study was to determine the optimum conditions under which the cloned sucrose 
phosphorylase activity could be assayed. The reaction catalysed by sucrose phosphorylase is a 
double replacement reaction (316, 317). In the initial phase the reaction involves the formation of 
a glucose-enzyme complex by interaction with sucrose with the release of D-fructose. In the 
second phase the glucose is transferred to an acceptor, such as Pi, which would result in the 
formation of glucose-I-phosphate. Sucrose phosphorylase activity is measured by the rate at 
which sucrose is converted to glucose-I-phosphate, which in tum is assayed enzymatically with 
the enzymes glucose-6-phosphate dehydrogenase and phosphoglucomutase (308, 316). 
Alternatively, the sucrose catabolism activity of sucrose phosphorylase can be measured by the 
rate at which reducing sugar is formed, using dinitrosalicylic acid as a colourimetric indicator 
(175), and this was the method used. However, this method would not distinguish between 
sucrose phosphorylase and hydrolase activity. 
Analysis of enzyme activities in cell-free extracts prepared from E. coli JMI09 cells carrying 
pSucl confirmed the presence of constitutive sucrose phosphorylase activity, and was absent in 
cells carrying the negative control plasmid pMTI04. The pH and temperature optimum for the 
recombinant enzyme were determined. The activity was highest at pH 6 and at 60°C (Figure 4.9). 
A previous analysis of three bacterial sucrose phosphorylases from P. saccharophila, 












ScrP, therefore, is active under more acidic conditions. The temperature optimum of 60°C is 
interesting for two reasons. Firstly, B. laetis has a growth optimum of 3'fC, and secondly, the 
sucrose phosphorylase from L. mesenteroides has been shown to be destroyed by heating to 60°C 
for 1 minute (330). It was found that if the phosphate component of the buffer was eliminated (T A 
buffer), the enzyme activity decreased by 30-fold (from 41.3 to 1.3 j.tmollminlmg protein), 
suggesting that the phosphates in the TAP buffer playa role in the activity of this enzyme. This is 
a biochemical property of these proteins, as without acceptor, in this case Pi, the glucose 
complexed with enzyme cannot be released (316, 238, 317). A similar result was obtained for the 
gtfA of S. mutans (239). This result supports the sequence homology results which indicated that 
the serP gene encodes a sucrose phosphorylase. This could be confirmed by measuring the 
formation of glucose-I-phosphate using the method discussed above. The investigation of the 
substrate specificity indicated that ScrP could catalyse the hydrolysis of sucrose but not raffinose, 
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Figure 4.9. Temperature (A) and pH (B) optima of sucrase activity conferred on E. coli JMI09 by pSucl. Results are 
an average of three experiments with the error bars indicating the standard deviation from the mean. 
4.5. CONCLUSIONS 
Screening for genes involved in the utilisation of sucrose resulted in the isolation of a cluster of 3 
genes. Nucleotide sequence analysis indicated that a sucrose phosphorylase (serP) , a putative 
sucrose regulator (scrR), and a possible sucrose transporter (scrT) had been isolated. Analysis of 
the B. longum sequenced genome revealed the presence of a cluster of genes similar to these 
isolated from B. laetis, as well as a second cluster of genes which are likely to also be involved in 











possibly functions as an Inulinase, or a sucrase. There is evidence that this gene is also present in 
B. lactis (71), and it is therefore, surprising that it was not isolated when the B. lactis genebank: in 
E. coli was screened on sucrose, particularly since the B. lactis cscA gene has been shown to be 
expressed in E. coli (71). Perhaps the combined expression of the three genes present in this 
cluster which is required for a sucrose-positive phenotype to be conferred on E. coli did not occur, 
either due to the nature of the heterologous system, or due to a different organisation of these. 
genes in B. lactis. It is also possible that these genes are not present on a single clone in the 
B. lactis Sau3A genebank. 
As was reviewed in chapter I, the predominant mechanism facilitating sucrose uptake in Gram-
positive bacteria is the phosphoenolpyruvate-dependent phosphotransferase system (PTS), which 
results in the intracellular accumulation of sucrose-6-phosphate. Transport and phosphorylation of 
the carbohydrate is mediated by the sucrose-specific Enzyme II (EIlSer). The sucrose-6-P is further 
metabolised by sucrose-6-P hydro lases, yielding glucose-6-P and fructose. 
The catabolism of sucrose by sucrose phosphorylases results in the products a.-D-glucose-I-P and 
D-fructose, and not glucose-6-P as with the PTS system. Since the deduced amino acid sequence 
of the B. lactis scrP gene demonstrates sequence identity to sucrose phosphorylases, it is likely 
that glucose-l-P is generated by this enzyme. Furthermore, although scrT of B. lactis does not 
show a high degree of sequence identity to any protein in the databases, it does not show any 
identity to PTS permeases. Taken together, these findings suggest that the cloned sucrose cluster 
of B. lactis is not a PTS system. The glucose-I-phosphate generated by the B. lactis scrP could be 
converted by glucose-6-phosphate isomerase for its utilisation by the bifidus pathway of glucose 
fermentation (18). 
It is generally believed that heterofermentative lactic acid bacteria do not possess active 
phosphotransferase systems (232). Sucrose hydrolysis could imply either an invertase or a sucrose 
phosphorylase (63). In L. mesenteroides, for example, it is postulated that sucrose is taken up by a 
permease and is then concomitantly phosphorylated and hydrolysed to yield glucose-l-P and 
fructose intracellularly. Glucose-l-P is then converted by phosphoglucomutase to glucose-6-P, 
which then enters the phosphoketolase pathway (63). This reaction by sucrose phosphorylase 
employs Pi and not a high-energy phosphate bond, and, therefore, offers a significant energy gain 
for the cell. B. longum and B. lactis seem to have both an invertase (cscA) and a sucrose 












the B. longum genome, the idea that PTS systems do not exist in heterofennentative lactic acid 
bacteria is supported, and may apply to Bifidobacterium in general. 
The genetic organisation of the sucrose phosphorylases that have been identified is not clearly 
understood and has only been analysed in Agrobacterium vitis and S. mutans. In S. mutans, the 
sucrose phosphorylase (gtfA) is located in a cluster of multiple sugar metabolism genes and is 
thought to be involved in the utilisation of raffinose (238). The gtfA is regulated by the product of 
the msmR gene, which is thought to be a DNA-binding protein that functions as a positive 
effector. In A. vitis, the sucrose phosphorylase gene is situated on the Ti (tumour-inducing) 
plasmid upstream of a traR-like sequence (79). TraR functions as a transcriptional activator of the 
tra genes, and is thought to be part of the same operon as the sucrose-phosphorylase. However, it 
has not been shown whether the sucrose phosphorylase is regulated by TraR. The sucrose 
phosphorylase is thought to be involved in the utilisation of agrocinopine A, an opine that 
contains a phosphorylated sugar moiety. Analysis of the B. longum genome revealed that the 
sucrose phosphorylase (spl) was also associated with genes which could encode for a membrane 
transporter protein and regulator as in B. lactis. Furthennore, the deduced protein sequences of 
these genes found identity to the B. lactis ScrP, ScrT and ScrR proteins respectively. The scrP and 
scrT genes, but not the scrR gene, are similarly organised in the two bifidobacteria. This genetic 
organisation of scrP with scrR and scrT is, so far, unique to these bifidobacteria. Furthennore, 
Bifidobacterium is the first genus where the scrR is not associated with PTS genes. 
The molecular analysis of the B. lactis scr gene cluster and the physiological analysis of B. lactis 
sucrase activity perfonned in chapter 2, have given insight into how sucrose is metabolised and 
how this metabolism may be regulated. This primary characterisation provided the background 
from which an analysis of the genetic regulation of sucrose metabolism could be conducted. The 
transcriptional regulation of the B. lactis scr gene cluster and the role of the ScrR in the regulation 
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5.1. SUMMARY 
RNA analysis indicated that the scrP, scrR and scrT genes were regulated at the transcriptional 
level, and that their expression was induced by the presence of sucrose and raffinose, and was 
repressed by glucose. scrR-deletion constructs in E. coli revealed that ScrP activity was only 
produced if the scrR gene was present. Deletion of the scrR gene abolished ScrP activity, 
suggesting that the ScrR protein functions as a positive regulator. Analysis of the divergent scrP-
scrR promoter region revealed the presence of three inverted repeats which showed sequence 
identity to operator sequences of the GaiR-LacI family proteins, and could, therefore, function as 
ScrR binding sites. Furthermore these inverted repeat sequences also showed identity to the 
CcpA-CRE consensus sequence suggesting that the scrP and scrR genes might also be regulated 
by the catabolite control protein CcpA. The scrP and scrR transcriptional start sites were 
identified by primer extension analyses and were found to be adjacent to two of the palindromic 
sequences identified. These two sequences could, therefore, be binding sites for a transcriptional 
repressor, such as CcpA. The third palindromic sequence was found adjacent to the scrP -35 
region, and could, therefore, function as a binding site for a positive regulator protein, such as 
ScrP. Gel shift assays were performed to determine the role of the ScrR protein in DNA-binding. 
Purification of ScrR-His fusion protein did not yield a soluble product, therefore, the gel shifts 
were performed using B. lactis crude extract from sucrose- or glucose-grown cells, and the scrP-
scr R promoter DNA fragment. A shift was observed with both extracts, which was inhibited when 
unlabelled promoter DNA was added as competition. This could suggest that ScrR was bound to 
the promoter fragment when extract from sucrose-grown cells was used, and that another 













The expression of sucrose catabolic genes has in most cases been shown to be regulated at the 
transcriptional level. Transcription is generally negatively controlled by a sucrose regulator. This 
has been demonstrated for Salmonella typhimurium (127), Klebsiella pneumoniae (127), Vibrio 
alginolyticus (22), Staphylococcus xylosus (89), Lactococcus lactis (159), and Clostridium 
beijerinckii (222). Furthermore, the sucrase genes of these systems are all under glucose 
regulation as well. 
In the systems mentioned above, the sucrose regulator belongs to the GalR-LacI family of 
regulators, and contains a DNA binding helix-tum-helix domain on the N-terminus. These 
proteins bind to palindromic operator sequences, thereby blocking transcription (328). In the 
presence of inducer, usually sucrose or sucrose derivatives, the regulator is no longer able to bind, 
and transcription continues. The B. lactis scrR was shown to have sequence identity to GalR-LacI-
like sucrose regulatory proteins (chapter 4). Furthermore, as with L. lactis (221), S. mutans (256), 
Lactobacillus plantarum (190) and Pediococcus p'entosaceus (151), the B. lactis scrR gene is 
clustered with sucrose catabolic genes, suggesting an involvement in their regulation. 
Evidence has already been presented in preceding chapters indicating that sucrase activity in 
B. lactis is induced by sucrose and repressed by glucose. The main objective of the work 
described here was, therefore, to determine how this regulation was facilitated. For this, it was 
necessary firstly, to identify whether the scrP, scrR and scrT genes were transcriptionally 
regulated, and secondly, to establish whether the scrP and saT genes were transcriptionally 
coupled. These aspects were investigated by northern blot analysis. Thirdly, it was necessary to 
determine the regulatory role of the scrR gene product, and this was analysed in E. coli with scrR 
deletion constructs. ScrR was also investigated for its ability to bind to the scrP-scrR promoter 











5.3. MATERIALS AND METHODS 
5.3.1. Bacterial Strains, Plasmids and Culture Conditions 
Bifidobacterium lactis was propagated anaerobically in BYG medium as described in section 
2.3.1. Where applicable, 1 % (w/v) of the carbohydrate was substituted for glucose. 
Corynebacterium glutamicum 13032 was propagated aerobically in LM media (appendix B.2.) 
containing 50 Jlg/ml nalidixic acid at 30°C with vigorous shaking. Where indicated, 5 Jlg/ml 
chloramphenicol, or 50 Jlg/ml kanamycin was added to media. 
E. coli JM109 was cultured as described in section 2.3.1. Where indicated, M9 minimal medium 
(176) was supplemented with Ap (100 Jlg/ml) and 1% (w/v) sucrose or glucose. Growth curves 
were performed by inoculating from an overnight LB culture of E. coli transformed with the 
relevant plasmid into minimal medium (10.2 dilution) and monitoring growth by measuring A600 at 
various time intervals. E. coli cells transformed with C. glutamicum plasmid DNA were plated 
onto Luria agar (253) containing 5 Jlg/ml chloramphenicol or 50 Jlg/ml kanamycin. 
Plasmids used for subcloning and sequencmg are listed in section 3.3.1. In addition, the 
C. glutamicum plasmids pEKplCm (Figure 5.1), pGS and p~GS2 were also used in this study. 
The construct pGS has the C. glutamicum glutamine synthetase promoter cloned into the 
pEKplCm multiple cloning site, and confers CAT activity on C. glutamicum (272). pLlGS2 was 
constructed by digesting pGS plasmid DNA with XhoI and MluI restriction enzymes (Figure 5.1), 
and the resulting 5.8 kb fragment ends were blunted and re-ligated. 
5.3.2. General DNA Manipulations 
Extraction of plasmid DNA from E. coli, preparation of E. coli JMI09 cells, DNA ligations, gel 
electrophoresis and other general manipulations are described in section 2.3.3. 
5.3.3. Extraction of Plasmid DNA from C. glutamicum 
pGS and p~GS2 plasmid DNA was extracted from C. glutamicum as follows. Single colonies 
were inoculated into 10 ml LM medium containing 0.5% glycine and incubated OIN. Cells were 
harvested, resuspended in 200 Jll ice-cold solution 1 (50 mM glucose, 10 mM EDTA, 25 mM 
Tris-HCI pH 8, 15 mg/mllysozyme) and incubated for 1 hour at 37°C. Freshly prepared solution 











incubated on ice for no longer than 5 minutes. Ice-cold potassium acetate solution (300 J1l) was 
added to the cell suspension and incubated for 5 min on ice. Potassium acetate solution was 
prepared as follows: 11.5 ml glacial acetic acid and 28.5 ml H20 was added to 60 ml 5 M K-
acetate. The cell suspension was microfuged, and 0.9 ml of the supernatant was transferred to a 
fresh tube. DNA was extracted with an equal volume of ph en oIl chloroform (1:1), followed by an 
extraction with chloroform/isoamyl alcohol (24:1). Plasmid DNA was precipitated according to 
standard procedures (253), and was resuspended in 20 J.lI buffer (10 mM Tris-Hel pH 7.6, 1 mM 
EDTA, 1 mglml RNAse A). For plasmid digestions, 5-10 J1l DNA was used. 
Mes 
B S P H 
MluI 
Figure 5.1. Partial restriction enzyme map of the Corynebacterium g/utamicum promoter probe plasmid vector 
pEKplCm. For full pEKplCm details please see reference 72. Abbreviations: MCS, multiple cloning site; B, Bamlll; 
If, HindIII; P, PstI; S, Sail. Not drawn to scale. (Adapted from reference 72). 
5.3.4. Extraction of Total RNA 
Total RNA was isolated from mid-logarithmic phase cultures of B. laetis and E. eoli as described 
in section 3.3.11. 
5.3.5. Northern and RNA Slot Blot Analysis 
Northern hybridisation and RNA slot blot analysis were performed as described in section 3.3.12. 
As internal controls, a 16S rDNA probe and a ~-lactamase probe were used for the B. laetis and 
E. eoli studies respectively. The gene specific fragments used as probes were: 1.4 kb HindIII-
BamHI (scrP), 0.45 kb PvuI-PvuI (serR), 0.85 kb PvuI-PvuI (serI), and were prepared from 
pSucl plasmid DNA. The 0.45 kb XmnI-BglI (~-lactamase) fragment was prepared from 











2.3.2. Signal intensities were measured using a MacBeth® Transmission densitometer TD 109. 
Results were expressed as a ratio of the gene specific signal to the internal control signal. 
5.3.6. Primer Extension Analyses 
Primer extension was carried out as described (206) with some modifications. RNA (100-120 Jlg) 
was precipitated and the pellet dissolved in 100 JlI HP buffer (40 mM PIPES pH 6.4, 1 mM 
EDTA pH 8.0, 400 mM NaCl, 80% deionised fonnamide). Fluorescently labelled Cy5 primer 
(4 pmol) was added and incubated for 10 min at 95°C to denature, and then hybridised overnight 
at the required temperature for each gene primer. RNA hybridised to primer was precipitated with 
300 JlI of ice-cold water and 800 JlI ethanol, incubated at -20°C for 30 min and then centrifuged 
(14000 g, 12 min, 4°C). The pellet was dried, dissolved in 20 JlI RTB buffer (4 JlI AMY reverse 
transcriptase buffer, 1 JlI 10 mM dNTP mix, 1 JlI 40 U RNasin, 2 JlI 1 mg/ml actinomycin D, 
16 JlI water), and incubated for 2 min at 42°C. Two microliters (20 U) of AMY reverse 
transcriptase (Promega) was added and the reaction was incubated for 2 hours at 42°C. The 
reaction was stopped with 1 JlI of 0.5 M EDT A (PH 8.0). RNA was digested by incubation for 
30 min at 37°C with 1 JlI RNAse (10 mg/mI). Aft~r digestion, 150 JlI TES buffer (10 mM Tris-
HCI pH 7.6, ImM EDTA, 100 mM NaCI) and 500 Jll of cold ethanol was added, and the cDNA 
was precipitated. The pellet was dissolved in 5 JlI TE (10 mM Tris, 1 mM EDTA, pH 7.6). Five 
microliters of STOP buffer was added and the solution heated for 5 min at 95°C, and was then 
sequenced. The gene-specific primers used were: Primer Sp (scrP) 5'-GCA GAA TGT CGG TCA 
TCG AAG C- 3'), Primer Sr (scrR) 5'-CGA GAC ACT GCT CAC CGA GAC G- 3'), and Primer 
St (scrT) 5' -CGG AAA CGG TGA AGC CGA T- 3'). 
5.3.7. peR Amplification of the scrP-scrT Intergenic Region 
The PCR reaction was as follows (50 JlI): 5 JlI buffer (supplied with the enzyme); 2.5 mM 
MgCb; 0.5 JlM of each primer; 200 JlM of each dNTP; 50 ng DNA; and 1 U of Taq DNA 
polymerase (Superthenn). The amplification program consisted of one cycle of 96°C for 5 min, 
then 25 cycles of 96°C for 1 min, 60.5°C for 45 s, and 72°C for 1 min, and finally one cycle of 
72°C for 5 min. The reaction was cooled down to 4°C. Primers A (5' -CTGCTGGAGTAACGCT 
Too- 3') and B (5' -GCGCTCGTAGTACAACATCG- 3') were used (Figure 4.3.). 
5.3.8. Antimicrobial Susceptibility Tests 
Minimum inhibitory concentrations (MIC) were detennined by a two-fold macro dilution broth 











dilution series of BYG medium containing the relevant antibiotics. This was incubated at 37°C 
and visually examined for turbidity after 48 hours. The lowest concentration of antimicrobial 
agent that resulted in complete inhibition of visible growth represented the MIC. The following 
antibiotic concentration ranges were tested: ampicillin 0.8-50 J.lg/ml, erythromycin 0.15-5 Ilg/ml, 
chloramphenicol 0.25-15 J.lg/ml. 
5.3.9. C. glutamicum Electroporation 
Electrocompetent C. glutamicum 13032 cells were prepared as follows. A 10 ml LM overnight 
culture was added to 400 ml LM contaIning 0.5% glycine and nalidixic acid and incubated until 
an OD578 0.4 was reached. Cells were chilled on ice for 10 min, and then harvested (10 000 g, 10 
min, 4°C). Cells were resuspended in 100 ml ice-cold buffer (10% (w/v) glycerol, 8 mM Tris-
HCI, pH 7.4) and were harvested as before. The washing was repeated twice more, and cells were 
resuspended in 0.4 ml ice-cold 10% (w/v) glycerol. Cells were ali quoted (100 J.ll) into pre-cooled 
Eppendorf tubes and stored at -70°C. C. glutamicum cells were electroporated as follows. Cells 
were thawed on ice, washed twice with 20 volumes of ice-cold 10% (w/v) glycerol, and 
resuspended in 98 J.ll 10% glycerol. Plasmid DN~ (500 ng in 2 J.ll dH20) was added to cells, 
mixed and dispensed into cold electroporation cuvettes (Bio-Rad, 2 mm electrode gap). A high 
voltage electric pulse was delivered with a Gene Pulser apparatus (Bio-Rad) by using the 25 J.lF 
capacitor, applying a voltage of2.5 kV at a resistance of 400 n. One ml ofBHIS medium (37 gIL 
BHI (Difco), 0.5 M sucrose) was added to cells and incubated at 30°C for 1-2 hours. Cells were 
plated onto LM medium containing 0.5 M sucrose, nalidixic acid, and chloramphenicol. 
5.3.10. Overexpression of ScrR in E. coli 
The B. lactis scrR gene was amplified using the ScrRF (5'-GGA TCC ACA TGG TCG GCA 
TGC GCG ATG TCG- 3') and ScrRR (5'-AAG CTT TCG TCA TGT TGG CAT CGC GTC C-
3') primers, introducing the BamHI and HindIII restriction sites (underlined) respectively, in the 
following PCR reaction (50 J.lI): 5 J.lI buffer (supplied with the enzyme); 2.5 mM MgClz; 0.5 J.lM 
of each primer; 200 J.lM of each dNTP; 50 ng chromosomal DNA; and 1 U of High Fidelity Taq 
DNA polymerase (Roche). The amplification program consisted of one cycle of 96°C for 5 min, 
then 25 cycles of 96°C for 1 min, 60°C for 45 s, and 72°C for 1 min, and finally one cycle of 72°C 
for 5 min. The reaction was cooled down to 4°C. The 0.9 kb DNA fragment ends were blunted 
using T4 DNA Polymerase, were purified using the PCR Product Purification Kit (Roche), and 
were ligated into pEcoR251 plasmid vector and used to transform E. coli JMI09 cells. Plasmid 
DNA was isolated from all transformants and was digested with BamHI and HindIII restriction 












and HindIII restriction sites of the expression vector pProEx HTc (Life Technologies) (see Figure 
A.4. in appendix for plasmid map), downstream of, and in frame with, the 6 histidine residues and 
the ATG translational start. A small scale induction of E. coli JM109 cells transformed with the 
resulting plasmids was performed and the proteins were analysed by SDS-P AGE as described by 
the supplier (Life technologies). One clone, pExScrR4, was sequenced to confirm the presence of 
the scrR gene and was selected for the purification of ScrR-His fusion protein. 
For the production and purification of ScrR-His fusion protein E. coli (pExScrR4) was cultured in 
LB medium to an OD600 0.5. Expression of the His6-scrR fusion was induced by the addition of 
IPTG to a final concentration of 0.6 mM. After 2 hours, cells were harvested by centrifugation 
(6 000 g, 5 min, 4°C), resuspended in 2 ml buffer (100 mM NaH2P04, 10 mM Tris-HCI, 10 mg/ml 
lysozyme, pH 8.0) and incubated for 30 min, 4°C. The suspension was sonicated (4°C) at 95 W 
for 3 min with 30 s cooling intervals (Virsonic Digital 475 Cell Disruptor), and then 10 ml of 
buffer (100 mM NaH2P04, 10 mM Tris-HCl, 8 M urea, pH 8.0) was added. After a 1 h incubation 
at room temperature (RT) the suspension was centrifuged (10 000 g, 25 min, RT) to pellet the 
cellular debris, and the lysate was bound to the Ni-NTA resin. Purification steps were carried out 
as recommended by the supplier (Qiagen Inc.). The eluted protein was dialysed in a stepwise 
manner in ScrR buffer (20 mM Tris-HCI pH 7.5, 0.4 M NaCl, 0.1 mM EDTA) containing 10% 
(w/v) glycerol and decreasing concentrations of urea (2 M - 0 M), until all the urea had been 
dialysed out. Precipitation of the protein resulted if the urea was not dialysed gradually. Protein 
fractions were analysed by SDS-PAGE (145). 
For the isolation of inclusion bodies, bacterial cells were resuspended in lysis buffer 2 (50 mM 
Tris-HCI pH 8, 5 mM j3-mercaptoethanol, 10 mM EDTA, 0.5 % triton) and were incubated for 5 
min at room temperature. Protein was centrifuged (14 000 g, 15 min, 4°C) and was resuspended in 
ScrR buffer. 
5.3.11. Western Hybridisation 
Proteins from SDS-PAGE gels were transferred onto nylon membrane as described previously 
(303). Hybridisation and detection of mouse Penta·His antibody (Qiagen) was perfonned 
according to the manufacturer's instructions. 
5.3.12. MALDI-TOF Mass-Spectrometry 
Purified ScrR-His protein was digested with trypsin as described previously (70). Molecular 











Biosystems Voyager-DE™ PRO Biospectrometry MALDI mass spectrometer using CHCA (a.-
cyano-4-hydroxycinnamic acid) matrix. Bovine carbonic anhydrase II was used as a standard 
control. Using the MS-Fit fingerprinting tool (16) the peptide digest sizes were used to perform 
homology searches against the NCBI database. 
5.3.13. Processing of B. lactis Cells for Gel Shift Assays 
B. lactis cells grown to mid-logarithmic stage in BY medium containing 1% (w/v) glucose or 
sucrose were harvested (6 000 g, 10 min, 4°C), and the cell pellet was washed and resuspended in 
buffer (20 mM Tris-HCI pH 7.5, 0.4 M NaC!, 0.1 mM EDTA). Cells were disrupted by sonication 
(95 W for 3 min with 30 s cooling intervals, 4°C), and the cell debris was removed by 
centrifugation (14000 g, 25 min, 4°C). The supernatant containing protein was stored at -20°C. 
5.3.14. Amplification of Promoter Fragments for Gel Shift Assays 
Four scrP-scrR promoter fragments were constructed as described below and are referred to by 
their sizes, and were prepared as follows. The 450 bp fragment was amplified by PCR 
(amplification details are described below) using pIjmers Sp2 and Sr2 (Figure 5.7 C). Primers Sp 
and Sp2 are the same except that the latter primer has the BamHI restriction site incorporated into 
the sequence. Similarly for primers Sr and Sr2, except that the restriction site is HindIII. After 
amplification, the 450 bp promoter fragment was purified and then digested with HindIII 
restriction enzyme to yield the 300 bp and 120 bp fragments. The 270 bp fragment was amplified 
using the primers Sr2 and DIR (Figure 5.7 C). Purified fragments were non-radioactively 3'end-
labelled with DIG-ll-ddUTP using terminal transferase as per manufacturer's instructions 
(Roche). The PCR reactions were as follows (50 Ill): 5 III buffer (supplied with the enzyme); 
2.5 mM MgCh; 0.5 IlM of each primer; 200 IlM of each dNTP; 50 ng chromosomal DNA; and 1 
U of Taq DNA polymerase (Supertherm). The amplification program consisted of one cycle of 
96°C for 5 min, then 25 cycles of 96°C for 1 min, 54°C for 45 s, and 72°C for 1 min, and finally 
one cycle of 72°C for 5 min. The reaction was cooled down to 4°C. Primers are shown in Figure 
5.7 C. Primers: Sp2 5'-CGC GGA TCC GCA GAA TGT CGG TCA TCG AAG C-3', Sr2 5'-
CCC AAG CTT CGA GAC ACT GCT CAC CGA GAC G- 3', DIR 5' -CCC AA GCT TGT 
TTT ACC TCA TTC TTCA CG- 3'. Underlined sequences indicate the BamHI and HindIII 
restriction enzyme sequences incorporated to facilitate cloning of the PCR fragments. 
5.3.15. Gel Shift Assays 
Besides the protein and target DNA fragments, all assay components were supplied in the 











Tris-HCI, pH 7.5, 50 ~ NaCI, 0.5 mM DDT, 5 mM MgCh, I mM EDTA, 10% glycerol, 0.05% 
NP-40, 1 J.1g poly (d(I-C», 7.5 ng labelled DNA probe, 230 ng unlabelled DNA probe (cold 
target), 7 J.1g purified ScrR-His or 75 J.1g of B. lactis crude extract. Sucrose or glucose (final 
concentration of 1 mM) was added when indicated. After 20 min incubation at room temperature, 
samples were loaded onto an agarose gel (2%), prepared with low-ionic-strength buffer (7 mM 
Tris-HCI, pH 7.5, 3 mM NaAc, 1 mM EDTA), and were electrophoresed at room temperature in 
the same buffer with constant circulation. After electrophoresis, the DNA was transferred 
overnight to Hybond W nylon membrane via the capillary transfer procedure (253) using the 
electrophoresis buffer for transfer. Detection of the DIG-labelled DNA was performed as 
described by the manufacturer (Roche). 
5.4. RESULTS 
5.4.1. Regulation of Expression of the saP, scrR and scrT genes in B. lactis 
The presence of scrR, specifying a GaIR-LacI-type regulatory protein, suggested that the scr gene 
expression might be regulated at the transcriptional level. RNA slot blot analysis was, therefore, 
performed to investigate the transcriptional regulation of the scrP, scrR and scrT genes by growth 
in various carbohydrates. B. lactis RNA extracted from cells grown on glucose, sucrose, glucose 
and sucrose, raffinose, or oligo fructose was hybridised to probes specific for the scrP, scrR and 
scrT transcripts (Figure 5.2). RNA from E. coli cells with pSuc1 (positive control) and pMTI04 
(negative control) was included in the analysis. In comparison to glucose-grown cultures, the scrP 
mRNA levels were increased approximately 6-fold in the presence of sucrose or raffinose, and 
1.25-fold in the presence of oligofructose. In the presence of glucose and sucrose, scrP expression 
was only increased approximately 4-fold. For scrR and scrT, mRNA signals were only present 
under inducing conditions, in the presence of sucrose or raffinose. Therefore, all three of the scr 











A. 16s rRNA scrP scrT 
scrR 
R OF S G GS R OF S G GS R OF S G 
B. saP saT 
scrR 
GS 0.55 (0.16) ND 
ND 
R 0.83 (0.09) 0.14 (0.03) 
0.16 (0.09) 
OF 0.16 (0.08) ND 
ND 
S 0.78 (0.02) 0.27 (0.007) 
0.16(0.04) 
G 0.13 (0.07) ND 
ND 
Figure 5.2. RNA slot blot analysis of the serP, serR and scrT mRNA from mid-logarithmic phase cells of B. lac/is 
grown in different carbon sources. (A) Gene-specific rnRNA and l6s rRNA signals detected on slot blot analysis. (B) 
rnRNA levels expressed as a ratio of the gene specific hybridisation signal to the J6s rRNA hybridisation signal. 
Experiments were performed in duplicate and standard deviations are shown in parentheses. GS, glucose plus 
sucrose; R, raffinose; OF, oligofructose; S, sucrose; G, glucose; ND, no gene specific signal detected. 
These fmdings also correlate with the observations made at the physiological level, where sucrase 
activity was induced by sucrose and raffinose, and repressed by glucose (chapter 2). However, 
sucrase activity was repressed 2-fold by glucose, whereas serP mRNA production was repressed 
6-fold. Furthermore, sucrase activity was the same for cells grown in glucose or in glucose plus 
sucrose, whereas scrP mRNA was significantly induced when grown in the presence of the two 
sugars. Since the sucrase assays were performed on total protein, other enzymes such as 
invertases, fructosyltransferases, and fructanases could have contributed to the activity. Assuming 
that this was the case, it could be possible that more than one sucrose catabolite system exists in 
B. lactis: (i) constitutively expressed systems which are responsible for the basal sucrase activity 
seen in the presence of glucose, and (ii) systems which are induced by sucrose and raffinose and 
repressed by glucose, as seen with scrP. As was discussed in chapter 4, analysis of the B. longum 
genome revealed the presence of a f3-fructofuranosidase (cscA), suggesting sucrase or invertase 
activity. Furthermore, this gene has been cloned from B. lactis (71). However, the genetic 
organisation of the B. longum cscA gene with a GaIR-LacI-type regulator, suggests that its activity 
would be regulated, and therefore, would not contribute to the constitutive activity in the presence 











mRNA transcripts were detected for all three genes in E. coli cells harbouring the plasmid pSuc1, 
but were absent from cells with pMT104. The serP and serT genes are inversely orientated to the 
A promoter on the plasmid pEcoR251 (Figure 5.4). It would follow therefore, that they are 
expressed from a B. laetis sequence recognised in E. coli. The serR gene could however, be 
expressed from a B. laetis promoter or the A promoter. 
5.4.2. Investigation of serP-scrT Co-transcription 
The possibility that the serP and the scrT genes were transcribed as an operon was suggested by 
the fact that the serT gene was clustered with, and present in, the same orientation as the serP 
gene, and that the two genes were similarly regulated at the transcriptional level (Figure 5.2). 
Furthermore, serT promoter sequences could not be identified in the intergenic region between the 
two genes. Three strategies were employed to determine whether these genes were 
transcriptionally coupled. These were northern hybridisation, serT primer extension analysis, and 
reverse transcriptase PCR. 
5.4.2.1. Northern Blot Analysis 
B. laetis RNA extracted from cells grown on sucrose or glucose plus sucrose was hybridised to 
probes specific for thescrP and serT genes (Figure 5.3 B). If these two genes were 
transcriptionally coupled, a transcript size of 3290 bp (from the transcription start and termination 
codon of the serP and serT genes respectively) would be expected. A distinct band could not be 
identified from B. laetis RNA with either of the gene probes. Rather, a smear starting at 3.3 kb 
was detected, probably representing serP or serTmRNA co-migrating with high concentrations of 
ribosomal and degraded RNA. Two regions where signal was not detected presumably represent 
23S and 16S ribosomal RNA shielding due to high concentrations. Although it cannot be 
excluded that the smears represent non-specific hybridisation, the difference in signal intensities 
obtained between sucrose- versus glucose plus sucrose-grown samples suggests that hybridisation 
was gene-specific. Relatively good quality RNA was achieved (Figure 5.3 A) and therefore, the 
inability to obtain a distinct mRNA signal cannot be accounted for. Variations in RNA and probe 
concentrations, and RNA transfer times did not improve the hybridisation signals. 
Hybridisation of RNA from E. coli cells with pSuc3 to the scrT probe resulted in several distinct 
bands with sizes of 3.3 kb, 1.8 kb, 1.4 kb, and 0.9 kb (Figure 5.3 C). This suggested that, at least 
in E. coli, the serP and serT genes were co-transcribed as an operon. The other bands detected for 
serT could represent processed derivatives of the serP-scrT transcript, or could represent other 











transcribed from its own or another promoter-like sequence, since the first putative scrT irutiation 
codon is separated by 1318 bp from the tennination codon (Figure 4.3.). Although promoter 
sequences were not identified for scrT, there may be spurious sequences which are recognised and 











Figure 5.3. RNA analysis of the scrP and scrT genes. A: RNA extracted from B. lac/is cells grown on glucose plus 
sucrose (lane 1) and sucrose (lane 2), electrophoresed on a formaldehyde gel (253). 8: Northern blot conducted with 
the scrP specific probe hybridised to B. lac/is RNA from cells grown on glucose plus sucrose (lane I) and sucrose 
(lane 2). C: Northern blot conducted with the scrT specific probe hybridised to RNA from E. coli cells with the 
construct pSuc3. D: RNA slot blot conducted with the scrT specific probe hybridised to RNA from E. coli cells with 
the constructs pSucl (lane J), pAReg2 (lane 2), or pSuc2 (lane 3). 
The construct pSuc2 does not confer sucrase activity on E. coli cells since the serP promoter and 
A TO codon is truncated. Therefore, if scrT transcripts could be detected from this clone, it would 
conftnn the serP-independent transcription of scrT that was suggested from the Northern blot 
results. RNA slot blots were perfonned with RNA from E. coli cells with pSuc 1, pL\Reg2 and 











detected from cells with pSuc2, but the reduced level compared to that obtained from cells with 
pSuc 1 and pLlli.eg2, suggest that it is not the major scrT transcript produced in E. coli, further 
supporting the co-transcription of scrT with scrP. 
5.4.2.2. Primer Extension Analysis ofscrT 
Primer extension analyses were undertaken to investigate whether transcription from a scrT 
promoter occurred in B. lactis as was seen in E. coli. No transcription start signals could be 
detected. This is further evidence to support the co-transcription of the scrP and scrT genes, and 
that the scrT transcript identified in E. coli must be due to the recognition of spurious promoter 
sequences in the intergenic region between the two genes. 
5.4.2.3. Reverse Transcriptase PCR (RT-PCR) 
Since co-transcription of the scrP and scrT genes could not be shown in B. lactis by Northern 
hybridisation, analysis by RT-PCR was attempted. Primers A and B (Figure 4.3) designed to 
sequence within the scrP and scrT genes respectively, would only give a RT-PCR product of 782 
bp if the two genes were co-transcribed. As a positive control, primers B and C2 (Figure 4.3) 
specific for scrT were designed which would yield a 290 bp product. PCR performed with primers 
A and B and pSucl plasmid DNA resulted in a 680 bp fragment. Since this was smaller than 
expected, the fragment was cloned and sequence-analysed. The sequence indicated that a different 
region of the pSucl insert had been amplified. The PCR conditions were varied but did not result 
in the amplification of the correct DNA fragment, therefore due to the non-specificity of the 
primers, the RT-PCR could not be performed. 
5.4.3. Regulation of scrP by scrR in E. coli 
The majority of GalR-LacI proteins function as negative regulators (328). Certainly, all the ScrR 
proteins to which the B. lactis ScrR found sequence identity to are reported to function in this way 
(Table 4.2). Transcriptional analyses of scrR showed that mRNA production was induced in the 
presence of sucrose and raffinose, and could not be detected in the presence of glucose (5.4.1). 
This would be typical of a positive regulator. However, the possibility of it being a negative 
regulator could not be excluded. 
Targeted disruption of the scrR gene in B. lactis would be the ideal route to investigate the role of 
ScrR in transcriptional regulation. However, due to the limited molecular genetic tools available 
for Bifidobacterium, the development of cloning vectors and transformation techniques has not 











therefore, conducted using deletion constructs in E. coli JM 109 by measuring sucrase activity 
produced by the cells transformed with each of the constructs. The constructs designed are 
illustrated in Figure 5.4 and are described in the legend. They are as follows: pSuc3, containing 
the scrP, scrR, and scrT genes; pSucl, which has 195 of 438 amino acids of the scrT gene 
truncated; pLlST8, which has the scrT gene deleted; pLlReg2, which has 245 of 326 amino acids of 
the scrR gene truncated; and pLlSTR1, which has the scrR gene truncated and the scrT gene 
deleted. 
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I"- Q 
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Figure 5.4. Analysis of sucrase activity produced in E. coli JM 109 cells containing scr deletion constructs grown in 
LB. The plasmids pSucl and pSuc2 originate from the B. lactis gene bank, and were used to construct plasmid pSuc3 
(see chapter 4 for details). From pSuc3, the 3.4 kb SmaI-StuI and 3.9 kb PstI fragments were cloned into the BgnI site 
of pEcoR251 resulting in plasmids pAST8 and pAReg2 respectively, which have the scrT gene and 245 amino acids 
of the scrR gene deleted respectively. The 2.2 kb SmaI-PstI fragment from pSuc3 was cloned into pEcoR251 
reSUlting in plasmid pASTRl, which has the scrT gene deleted and the scrR gene truncated. Sucrase activity conferred 
on E. coli by the constructs was measured in cell extracts and expressed as Ilmol reducing sugar/min/mg protein. 
Assays were performed in duplicate and standard deviations are shown in parentheses. Cells used for the assays were 
also analysed for the presence of plasmid (Table 5.1). The filled in box and arrow on pSuc3 indicate the position and 
direction of the A. promoter (PA) present on the pEcoR251 vector. Sizes are indicated in kb. B, BamHI; BglS, 











The analyses were initially performed in minimal mediwn containing glucose or sucrose. Growth 
curves were performed so that suitable sampling time points could be determined (Figure 5.5). 
RNA extracted from mid-logarithmic (OD6oo 0.7) E. coli cells harbouring the various deletion 
constructs, was hybridised to probes specific for the scrR, scrP, scrT and ~-lactamase genes. 
Probing for the ~-lactamase gene served as an indication of the presence of the plasmid in each 
strain. It became apparent that, although cells were cultured in ampicillin and reached OD6oo 
values of 1.4, transcription of the ~-lactamase gene could not be detected for some of the samples 
(Figure 5.6), suggesting that the cells did not contain plasmid. To confirm this, plasmid-
containing cells were cultured in glucose and sucrose minimal mediwn broth until mid-
logarithmic growth was attained, and were then plated on Luria agar with and without ampicillin 
so that the percentage cells containing plasmid could be nwnerically determined (Table 5.1). It 
was found that after the growth in minimal media, cells which should have contained the 
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Figure 5.5. Growth curves of E. coli with the scr deletion constructs grown in minimal mediwn containing (A) 
glucose or (B) sucrose. Growth was monitored by measuring absorbance at 600 run (OD600) at the times indicated. 
Symbols: (0) pSuc3; (_) pSucl; (A) p~ST8; (x) pdReg2; (e) p~STRl; (0) pMT104. 
Growth periods of 15-25 hours were required for the cells to reach mid-logarithmic growth in 
minimal mediwn (Figure 5.5). In order to reduce the growth period and thereby reduce plasmid 
loss/cell death, cells with the various constructs were cultured in LB until an OD600 0.5 was 
reached. The percentage of cells containing plasmid was determined as before (Table 5.1). The 
different constructs were found to be more stable in LB, with the majority of strains containing 
plasmid, however, this percentage varied each time it was performed, and is reflected by the 
standard deviations calculated for the two experiments (Table 5.1). It is interesting that growth in 
minimal mediwn containing sucrose reached OD600 levels as high as 1.4 in the absence of the 











minimal medium containing glucose, and that the percentage of cells which did contain plasmid 
varied considerably in LB, suggests that the system is not a stable one, and that, therefore, the 
results in minimal medium should be treated with reserve. 
Table 5.1. Analysis of plasmid levels and sucrase activity in E. coli 1Ml 09 cells with the scr 
deletion constructs. 
Construct Medium %. Cells Sucrase AlB 
containing Activity (A) 
plasmid (B) 
• 
I pSuc3 MM+G 0.0077 
• MM+S 0.000l 
LB 100 (0) 161.15 (1.9) 1.61 
pSuc1 MM+G 92 
MM+S 100 
LB 74.6 (14.8) 37.25 (0.07) 0.50 
pAST8 MM+G 74 
MM+S 1.5 
LB 54.9 (22.9) 18.15 (9.5) 0.33 
pL\Reg2 MM+G 100 
MM+S 100 
LB 97.35 (3.75) 0.14 (0.01) 0.0014 
pASTRl MM+G 0.00074 
IMM+S 0.0056 
LB 81.6 (26.0) 22.5 (11.3) 0.28 
pMT104 MM+G 100 
Experiments in LB were conducted in duplicate and the standard deviation is shown in parentheses. 
(A): Sucrase assays were performed on the same cells that were used to analyse plasmid (B) (Figure 5.4). 
(AlB): Ratio of sucrase activity (A) VS. % of cells containing plasmid (B). 
Sucrase assays were performed, and due to the plasmid variability, the same cell samples that 
were analysed for plasmid described above were used for the assays. Sucrase activity was highest 
with pSuc3 (Figure 5.4), Table 5.1), where all three genes are present. Activity was reduced 1000-











(scrT truncated), p~ST8 (scrT deleted) and p~STR1 (scrT deleted and scrR truncated) 
respectively. In Table 5.1 the sucrase activity obtained was nonnalised to the % number of cells 
containing plasmid. This calculation was to detennine if the reduced activity obtained by cells 
with pSuc1, p~ST8 and p~STR1 was only due to the fact that fewer cells contained plasmid. This 
ratio reflected the same trend as the sucrase assay results did. Comparing the activity between 
cells with pSuc3 and p&eg2, it appears that ScrR functions as a positive regulator, even in the 
absence of sucrose. The reduced activity in cells with pSuc1 and p~ST8, where the scrR gene is 
present, suggests that the scrT gene product contributes to the expression of scrP, also in the 
absence of sucrose. Cells with p~STR1 and p~ST8 gave similar activity regardless of whether 
scrR was present or not, confinning the requirement of scrT for activity. Furthennore, cells with 
pSuc1, where part of the scrT gene is present, displayed a 2-fold increase in sucrase activity 
compared to cells with p~ST8 or p~STR 1 which have the scrT gene completely deleted. This 
could suggest that the truncated scrT produces a partially functional protein which is able to 
contribute slightly to the activity. 
A 
B 
Figure 5.6. RNA slot blot analysis of ~-Iactamase transcription in E. coli cells containing the scr deletion constructs 
grown in minimal medium containing (A) sucrose or (B) glucose. Lane I: pSuc3, Lane 2: pSucI, Lane 3: pdST8, 
Lane 4: pdReg2, Lane 5: pdSTRI, Lane 6: pMTI04. 
Some proteins have been shown to engage in multiple functions. In particular, certain transporter 
proteins possess regulatory components. In Saccharomyces cerevisiae the SNF3 gene, required for 
hlgh-affinity glucose transport, belongs to the family of sugar transporters to which the B. lac/is 
scrT gene product found identity (20, 140). A number of observations, however, suggest that 
SNF3 might not be a functional transporter, but rather acts by regulating the expression or activity 
of other hexose transporter proteins. The E. coli MalK maltose transporter has been shown to 
interact with the positive regulator MalT, thereby abolishing MalT-dependent transcription (25, 











regulator of the bgl operon involved in the catabolism of aromatic ~-glucosides (164). Studies on 
the put operon of S. typhimurium involved in the catabolism of proline have indicated that the 
putA gene product is both a negative regulator of the put operon expression, and a membrane-
bound bifunctional oxidase-dehydrogenase (165). The ginA gene product of B. subtilis, which 
codes for the enzyme glutamine synthetase, has been implicated in the autoregulation of the ginA 
gene (270). Hence, the presence of proteins with dual functions may be a more common feature 
among prokaryotes than is currently understood. It is, therefore, possible that the B. lactis scrT 
gene product might similarly have a regulatory component in addition to its transport function. 
Alternatively, the perceived regulatory role of scrT could be a result of counter-transcription from 
the lambda promoter (PJ present on the pEcoR251 vector (Figure 5.4). Two possible terminators 
were identified 22 and 73 bp from the scrT stop codon (see section 4.4.4.3). With construct 
pSuc1, the absence of these terminators could possibly allow counter-transcription to run into 
scrP, thereby reducing its transcription. Similarly with constructs pLlST8 and pLlSTRI, by moving 
scrP closer to PI" the negative effect is enhanced. 
Interestingly, cells with pSuc3 were unable to grow in LB containing sucrose. Initially, this 
together with the cell death/loss of plasmid discussed above, gave the impression that the 
overexpression of scrP might be lethal, as has been seen with the levansucrase (sacB) gene from 
Bacillus subtiUs (88). However, the plasmid pLlSTRI had more of an effect than pSuc3, even 
though sucrase activity was reduced 7-fold in cells with pLlSTRl. Alternatively, if sucrose was not 
hydrolysed efficiently by cells with pSuc3, the accumulation of sucrose in the cells could have 
caused cell lysis. This has also been reported for E. coli rqfD mutants (see section 1.7.1.) (12). 
Nevertheless, it is possible to conclude that sucrose has a detrimental effect only when the full 
scrT gene is present, since cells containing pSuc1, where the scrT gene is truncated (Figure 5.4), 
were culturable in LB containing sucrose, and they displayed the same activity in the presence or 
absence of sucrose. This could possibly indicate that the scrT gene product is involved in the 
transport of sucrose in E. coli. Furthermore, cells with pdReg2 displayed an 8-fold increase in 
sucrase activity when cultured in minimal medium containing sucrose (1.37 JIDlollminlmg 
protein) compared to in glucose (0.17 JIDlollminlmg protein), clearly indicating that scr P is 
induced by sucrose, but that the major induction occurs in the presence of scrR .. Due to the 
heterologous nature of this study and the numerous interactions possible, it is difficult to analyse 
exactly how these genes function and interact, and it is, therefore, impossible to understand every 











5.4.4. Analysis of the Divergent scrP-scrR Promoter Region 
An intergenic region of 320 bp between the ATG codons of the divergent serP and serR genes 
(Figure 5.7) was analysed for promoter and regulatory sequences, and primer extension 
experiments were performed to identify the transcriptional start for the two genes. Such an 
analysis could give some insight as to how these genes might be regulated. 
Primer extension analyses were performed on RNA extracted from B. laetis cells grown in 
raff"mose or glucose plus sucrose using serP- and scrR-specific primers (Figure 5.7). For serP, a 
transcription start site was assigned to a T at position 102 bp in front of the ser P ATG start codon. 
The signal intensities (determined by height of the peaks) did not reflect the transcriptional levels 
between raffinose or glucose plus sucrose samples as was expected. If however, the primers were 
not present in excess, such determinations would not be possible. Screening for promoter 
consensus sequences did not reveal any typical E. eoli -10 and -35 sequences. In C. glutamicum, 
a Gram-positive and high GC organism closely related to Bifidobaeterium, an analysis of 33 
promoters revealed the consensus sequences to be (TA.aaT) for the -10 region, and (ttGcca) for 
the -35 region (206). For the B. lactis serP, a GGTAAA sequence 13 bp from the transcription 
start site was identified (Figure 5.7). In the C. glutamicum promoter study, this sequence was 
shown to be a probable -10 sequence (206). A TTGCAT sequence in the -35 region, which was 
also identified in C. glutamieum, was found which might be involved in transcription initiation. 
For the serR gene, several possible transcription starts were identified, but were not consistently 
obtained with repeated primer extension experiments. However, only for one of these, an A 
situated 68 bp in front of the serR ATG, could a potential promoter consensus sequence be 
identified: TACAAT in the -10 region and TTGCCG in the -35 region (Figure 5.7). As for the 
promoter of the ser P gene, these sequences share closer homology to the C. glutamieum than the 
typical E. coli promoter sequences. Neither C. glutamieum nor E. coli type promoter sequences 
could be identified for the other transcription starts identified. Further primer extension 
experiments performed with a different primer might help resolve which of the serR transcription 
starts is the correct one. However, in three of the four primer extension experiments perfo;rmed, 
the transcripts terminated in a GC-rich region (Figure 5.7 C). This was probably more the case of 
the reverse transcriptase enzyme prematurely falling off due to a GC-compression, rather than 
genuine mRNA termination. Since this region is -35 bp from the scrR initiation codon, it would be 





















17 CGAAGCAAGGTTGCCGTCACCCAAGCGATCCGCATAGGTGATCAGCTGAACTTTGTTCTT 76 
GCTTCGTTCCAACGGCAGTGGGTTCGCTAGGCGTATCCACTAGTCGACTTGAAACAAGAA 
77 CATGGCTCCTCCTGGATTCGTCTATCACGTCTTCGGGATATCTCCGGGGCGATGCGTCTG 136 
GTACCGAGGAGGACCTAAGCAGATAGTGCAGAAGCCCTATAGAGGCCCCGCTACGCAGAC 
.... sarP SO 
Primer OIR 
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ATTCTTCACGCGCATGCAAGCGCTCTGCTCTCGGCGTATCAAA~GGTTCGATATTCGAC 
TAAGAAGTGCGCGTACGTTCGCGAGAC~GAGCCGCATAGTTTGGCCAAGCTATAAGCTG 




257 GATTCACCGCGCTCTGCCGAAACGCGGTTGCCGGAGGACGAAATCTGCACATACAArCGG 316 
CTAAGTGGCGCGAGACjPCTTTGCGCCAACGGCCTCCTGCTTTAGACGTGTATGTTAGCC 
TS SO 
317 ATAGTGCTCGTCAAACCGGTTCGATAECQCGGGC9ATAGCGCACGGAGCAGAAAATGAGG 376 
TATCACGAGCAGTTTG~~AAGCTATGGCGCCCGCTATCGCGTGCCTCGTCTTTTACTCC 
IR3 4"'======~:--, ~ 
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Figure 5.7. Mapping of the transcription start site of the B. laclis saP and saR genes by primer extension analysis. 
A: Primer extension product obtained for the saP gene using RNA extracted from B. laclis grown in BY medium 
containing sucrose (blue curve) or glucose plus sucrose (black curve). A and T sequencing reactions (green and red 











analysed. The Cy5 -labelled Sp and Sr primers were used for both the primer extension and sequencing reactions of the 
scrP and scrR genes respectively. C: Nucleotide sequence of the promoter regions preceding the scrP and scrR 
genes. Putative promoters (-35 and -10 regions) and ribosome-binding sites (SD) are in bold type and underlined. 
The transcriptional start site (TS) of scrP, as determined by primer extension analysis, is indicated in bold. A possible 
transcription start for scrR is also shown in bold. The compression at which the majority of the scrR transcripts 
terminated are boxed (see text for details). Primers Sp, Sr and DIR shown in bold type were used to generate the 
fragments for gel binding analyses. The coloured arrows indicate directions of the direct and indirect repeat 
sequences. The palindromic sequences, IRl, IR2 and IR3 discussed in the text which may act as operator sites for 
GalR-Lac! family regulatory proteins are shown in black. Other palindromic sequences which might also be involved 
are shown in different colours. 
Table 5.2. Comparison of the inverted repeat sequences identified in the scrP-scrR promoter 
region to the CRE consensus sequence and the GaiR-LacI operator consensus sequence. 
Element Sequence Position in 
Figure 5.7 
GalR-LacI operator consensus M3N2CI/G' IN' 2 T' 3 T' 4 
CRE consensus (T/A)IG2N3A~5(C/G)6C7/G8N9(T/A)\O(T/A)IIN12CI3AI4 
Inverted repeat 1 (IR 1 ) T7C6GsM3C2CI/G'IG'2 T' 3T' 4C' sG'"A' 7 168 bp - 181 bp 
Inverted repeat 2 (IR2) T ~8 T7C"AsM3C2CI/G' IG' 2 T' 3 T' 4C' sG'"A' 7T' 8 A' 9 233 bp - 250 bp 
Inverted repeat 3 (IR3) T7C"AsM3C2CI/G' lG'2T' 3T ' 4C' sG' "A '7 327 bp - 340 bp 
The bases that differ from the CRE consensus described in the text are shown in bold type. 
Numbering: although the CRE consensus is also an inverted repeat homologous to the GalR-Lac! operator consensus 
sequence, it is numbered from left to right, whereas the GalR-LacI sequence is numbered from the centre of the 
palindrome. 
GalR-LacI family regulators typically act at palindromic operator sequences centred around a 
(~3N2CtfG' IN' 2 T' 3 l' 4) consensus (328). Three palindromic repeats (IRl, IR2, IR3), the first 
perfect and the second two imperfect, were identified (Figure 5.7, Table 5.2). These sequences 
could serve as a potential operator sites for the ScrR regulator (328). They also show homology to 
the consensus sequence of catabolite response elements (CREs) (Table 5.2) which control 
catabolite repression in Gram-positive bacteria (120). All three of the palindromic sequences 
differ from the CRE consensus sequence at the 2nd and 13th positions (Table 5.2). It has been 
shown that mutation of the first nucleotide in the B. subtilis amylase CRE has little effect on 
catabolite repression. Notably, mutation of position 13 of the amylase CRE largely alleviated 
catabolite repression, and therefore, identity to CRE sequences might be coincidental. Several 











which could be involv€?d-in promoter activity or could serve as potential protein sites for the ScrR 
and other regulators (Figure 5.7 C) (201). In order to establish the possible role ofthese sequences 
in gene regulation, gel binding analyses between the ScrR and the promoter region were 
perfonned and will be presented in section 5.4.6. 
5.4.5. Development of a Promoter Expression Vector for B. lactis 
Although 'a Bifidobacterium-E. coli shuttle vector (pBK.J50FIR) expressing the chloramphenicol 
resistance gene has been developed (205), expression and promoter probe vectors have yet to be 
constructed for genetic manipulations in Bifidobacterium. However, Corynebacterium vectors 
have been shown to be able to replicate in Bifidobacterium (8), and a family of C. glutamicum-
E. coli shuttle vectors for cloning, controlled gene expression, and promoter probing have been 
constructed (72). We were, therefore, interested in investigating the possibility of using these 
Corynebacterium vectors for genetic analyses in B. lactis. Specifically, we wanted to investigate 
scrP and scrR promoter activities in response to growth in different carbon sources, and to 
detennine firstly, the promoter-active sequences required for gene expression and secondly, the 
elements required for transcriptional regulation. 
The C. glutamicum-E. coli promoter probe vector pEKplCm, carries a promoter-less cat reporter 
gene followed by transcription tennination sequences (Figure 5.1). A multiple cloning site (MCS) 
in front of the cat gene allows for the cloning of promoter fragments. The region between the 
MCS and the reporter gene contains translational stop codons in all three reading frames followed 
by a ribosome-binding site. Promoter activity is detennined by measuring CAT activity (72). The 
kanamycin-resistance-encoding gene is present for the selection of transfonnants. Bifidobacteria 
however, are resistant to this antibiotic (155), and B. lactis was highly resistant to kanamycin 
when it was plated on agar containing a filter disc delivering 1 mg of the antibiotic (C. Price, 
personal communication). Bifidobacteria are, however, susceptible to erythromycin and the p-
lactam antibiotics (155). We, therefore, investigated the possibility of replacing kanamycin 
resistance with ampicillin or erythromycin resistance for the selection of pEKplCm B. lactis 
transfonnants. The minimum inhibitory concentrations (MIC) of these antibiotics, including 
chloramphenicol, were detennined in B. lactis, and the cells were found to be susceptible to ::;;0.8 
~g!ml of ampicillin, 1.25 ~g!ml of erythromycin, and between 1.875-3.75 ~g!ml of 
chloramphenicol. Due to the extreme sensitivity of B. lactis to ampicillin, this antibiotic was 











Analysis of the pEKplCm restriction map revealed the restriction sites XhoI and MluI (Figure 5.1), 
and that digestion with these enzymes would result in the deletion of a 1.6 kb fragment containing 
a large portion of the kanamycin-resistance gene, which could then be replaced with the 
ampicillin-resistance gene. However, a 300 bp fragment flanking the kanamycin-resistance gene 
would also be deleted which could be detrimental to the plasmid's function. The 1.6 kb XhoI-MluI 
fragment was deleted from pGS2, resulting in the construct p.6.GS2 (see 5.3.1 for details). E. coli 
cells transfonned with p.6.GS2 were sensitive to kanamycin, whereas cells with pGS were 
resistant, indicating that the kanamycin-resistance had been successfully deleted. In order to 
detennine whether the 300 bp fragment was required, C. glutamicum cells were transfonned with 
pGS and p.6.GS2 plasmid DNA and were plated onto agar containing chloramphenicol and 
nalidixic acid. Transfonnants were obtained for both plasmids, however, plasmid DNA could only 
be extracted from cells that had been transfonned with pGS DNA. This suggested that the p.6.GS2 
plasmid was unable to survive in C. glutamicum, and that the 300 bp fragment was essential for 
plasmid function. It would, therefore, be impossible to replace kanamycin-resistance with 
ampicillin-resistance as was intended. Although it could have been possible to select for 
transfonnants on chloramphenicol, this would only have been possible if a functional promoter 
was cloned, and this could have been investigated with the B. lactis scrP and scrR promoters. 
However, it would not have been possible to obtain a negative control to detennine the basal CAT 
activity in B. lactis. We were, therefore, unable to perfonn promoter analyses in B. lactis using the 
Corynebacterium promoter vector. 
5.4.6. Binding of ScrR to the scrP-scrR Promoter DNA 
Sequence identity of the B. lactis ScrR to GaIR-LacI-like proteins suggested that it might bind 
DNA at palindromic operator sequences in promoter regions. Three such sites were identified in 
the scrP-scrR promoter region (Figure 5.7). To confinn this function and to detennine the 
sequences to which it binds, gel shift assays were perfonned using different protein preparations. 
Ideally, DNA-protein interactions are perfonned with purified recombinant fusion protein. This 
facilitates the acquisition of large amounts of protein free of nucleases, phosphatases and 
proteases which may be detrimental to the fonnation of the DNA-protein interaction being 
investigated. The B. lactis ScrR was, therefore, N-tenninally fused to a 6 histidine sequence 
(pExScrR4) and was overexpressed in E. coli JM109 (see 5.3.10 for details). Analysis of the 
expression revealed that the protein was associated with the insoluble pellet, fonning inclusion 
bodies in E. coli. Aggregation of proteins is favoured at high temperatures (ISO), and it has been 











However, even at thi~ lower temperature, together with reduced concentrations of IPTG, the 
protein remained insoluble. Therefore, ScrR was purified by affinity chromatography using 
denaturing conditions. SDS-P AGE analysis indicated that a protein of approximately 40 kDa had 
been purified (Figure 5.8). From the DNA sequence, the B. lactis ScrR is predicted to have a 
molecular weight of 37 kDa. The extra 3 kDa are contributed by the additional 27 amino acids of 
vector sequence which are translated before the scrR gene. Attempts to renature the purified. 
protein resulted in precipitation. However, stepwise dialysis in the presence of buffer containing 
10% glycerol greatly assisted in the solubilisation of the protein. Similar difficulties with the 
purification of the Erwinia amylovora and Staphylococcus xylosus ScrR proteins linked to a His-
tag were reportedly experienced, and they could only be purified by fusion to the maltose binding 
protein (24, 89). 
A Western hybridisation of the purified ScrR fusion protein probed with mouse antibodies to the 
histidine tag was performed to confirm that the protein isolated was a histidine fusion protein 
(Figure 5.9). An approximately 37 kDa protein band was detected, as well as a band larger than 
106 kDa for the purified ScrR fusion protein. The larger band presumably represents aggregated 
ScrR protein, indicating that dialysis in the presence of 10% glycerol was not sufficient to prevent 
the protein from aggregating as was initially thought. To confirm that the protein purified was the 
ScrR, MALDI-TOF (matrix-assisted laser desorption ionisation-time of flight) analysis was 
performed. MS-Fit homology searches of the peptide masses identified the B. lactis ScrR 
sequence (Table 5.3). 
Table 5.3. MS-Fit peptide search results of the ScrR-His protein MALDI-TOF mass spectrometry 
data. 
Protein Accession No. MOWSE Masses Matched ProteinMW 
Score (%) (kDa) 
B. lactis ScrR AF441242 5.532e+006 54 35.55 
C. crescentus ATP- NP _419007.1 1. 14ge+006 54 36.13 
binding protein 



















Figure 5.8. Purification of the B. lac/is scrR-histidine fusion protein expressed in E. coli. Lane 1: non-induced cells, 




Figure 5.9. Western hybridisation of mouse histidine antibodies to purified ScrR-His fusion protein. Lane I: Purified 
ScrR-His fusion protein dialysed in buffer containing 10% glycerol, Lane 2: Denatured protein from IPTG-induced E. 
coli ce\1s with pExScrR4, Lane 3: Inclusion bodies from IPTG-induced E. coli cells with pExScrR4, Lane 4: 
Denatured protein from IPTG-induced E. coli cells with the control vector plasmid pProEx HTc. Preparation of Scr-
His fusion protein and inclusion bodies is described in 5.3.10. 
Gel shift assays were perfonned non-radioactively and were optimised using 2% agarose gels. 
DNA-protein complexes are commonly resolved using 4-8% polyacrylamide gels. However, for 
electrophoresis of DNA fragments larger than 300 bp, agarose gels are recommended. Four DNA 
fragments were analysed: 450 bp scrP-scrR promoter fragment (positions 1 to 441 , Figure 5.7 C); 











fragment (positions 187 to 441, Figure 5.7 C) which has one of the palindromic sequences 
deleted; 150 bp fragment (positions 1 to 146, Figure 5.7 C) which does not have any identified 
promoter or protein binding sites. Gel shifts were attempted with the purified ScrR and the 450 bp 
DNA fragment but a shift was not detected. Although sucrose has not been shown to be the ligand 
for the B. lactis ScrR, it was included in the binding reaction, but it did not have an effect on the 
binding. The DNA-binding domain of ScrR is located in the N-terminus, 4 amino acids from the 
ATG start codon (Figure 4.4). The lack of binding could, therefore, be due to the interference of 
the leader amino acids (containing the His-tag) with the binding or proper folding of the protein. It 
is possible to remove the histidine residues from the purified protein by protease cleavage and this 
could be investigated in order to determine whether the binding properties of ScrR would be 
restored. It is also possible to fuse the histidine tag on the C-tenninus of the protein so as to avoid 
possible interference of the His-tag with the binding of the protein, however, this vector was not 
available to us. In light ofthe S. xylosus and E. amylovora studies however, further analyses using 
a His-fusion protein will probably be futile, and therefore, the fusion of ScrR to the maltose-
binding protein will rather be investigated. As was seen in the Western hybridisation, the majority 
of the purified protein was in an aggregated form, even in the presence of SDS (Figure 5.9), a 
common occurrence for DNA-binding proteins when highly expressed in E. coli (89, 116). This 
further suggests that the protein is not folded in its native confonnation and could also, therefore, 
be why the purified ScrR was unable to bind to the scrP-scrR promoter DNA. 
Since binding was not achieved with the purified ScrR, gel binding assays were perfonned using 
crude extract prepared from B. lactis cells cultured in media containing either glucose or sucrose. 
When the 450 bp promoter fragment was used, a shift was achieved with protein from both 
glucose- and sucrose-grown cells, which was inhibited when unlabelled DNA probe was added as 
competition (Figure 5.10). 
In the transcriptional analysis of scrR, transcripts could not be detected from cells which had been 
grown in glucose (section 5.4.1, Figure 5.2). Therefore, sufficient regulator protein would not be 
expected from glucose-grown cells to result in a shift. In Gram-positive organisms, catabolite 
repression is mediated by a transcriptional regulator, the catabolite control protein (CcpA) (243). 
CcpA proteins exhibit similarities to the GalR-LacI transcriptional repressors, and bind to 
palindromic operator sequences called catabolite-responsive elements (CRE) (120, 243). The 
palindromic sequences in the scrP promoter region to which ScrR was thought to bind to, also 
exhibit similarity to the CRE of CcpA proteins (see section 5.4.4). Since it was shown that the 











extract from glucose-grown cells could be due to CcpA binding. Certainly, the binding of a 
protein to the proposed CRE overlapping the serP transcriptional start site would result in 
transcription inhibition, consistent with the CcpA mode of action (41, 120). 
A 12345 B 124 
DNA-Protein - ... 
Unbound DNA - .... 
Figure 5.10. Gel mobility shift assay with B. lac/is crude extract and the scrP-scrR promoter DNA fragments. A: 450 
bp promoter fragment, B: 150 bp promoter fragment. Lanes I: no protein, lanes 2: protein from sucrose-grown cells, 
lane 3: protein from sucrose-grown cells and cold target DNA, lanes 4: protein from glucose-grown cells, lane 5: 
protein from glucose-grown cells and cold target DNA. After a 20 min incubation at room temperature, samples were 
loaded onto a 2% agarose gel. The autoradiographs of the gels are shown. 
The eepA gene has been identified in B. adoleseentis (Accession no. AF 411186, unpublished) in 
close proximity to an alpha-glucosidase (agIB) gene. An alignment of the B. longum genome 
sequence (Accession no. NC004307) with the B. adoleseentis eepA sequence identified a gene, 
which had similarity to GalR-LacI transcriptional regulators, with an alpha-glucosidase gene next 
to it (ORFs BL0528 and BL0529 respectively). As was reviewed in chapter 1, CcpA binding is 
stimulated by the HPr protein of the PTS, phosphorylated at serine-46 (226). Consequently, 
sequence analysis of the B. longum NCC2705 genome revealed the presence of a gene encoding 
HPr (BL0412). These analyses, at first, suggested that catabolite repression in Bifidobaeterium 
could also be mediated by CcpA. However, the putative CcpA proteins of B. adoleseentis and B. 
longum did not show significant identity (only 25% at the protein level) to CcpAs of B. subli/is 
(Accession no. NP _390852), S. xylosus (Accession no. CAA64713), L. laetis (Accession no. 
AAK29739) and S. mulans (Accession no. 007329). The CcpAs of B. laetis, S. xylosus, L. laelis 
and S. mulans, however, showed 60% sequence identity at the protein level. Furthennore, the B. 
longum HPr protein lacks serine at position 46, and the genome lacks HPr kinase which is 











high GC Gram-positive bacteria serine phosphorylated HPr, and CcpA, do not playa role in 
catabolite repression (207). Based on these fmdings, it is possible that glucose repression is also 
mediated via a different mechanism in bifidobacteria. 
The gel shift obtained with protein extract from glucose-grown cells was, therefore, more likely 
due to some other regulatory protein involved in catabolite repression. Catabolite regulation 
mechanisms have not yet been clearly identified in Gram-positive bacteria, much less in 
bifidobacteria. As was discussed in chapter 4, it appears that B. longum has a second sucrose-
utilisation gene cluster, and evidence suggests that it too exists in B. lactis. This cluster also 
contains a GaIR-LacI family regulatory protein. Perhaps this protein functions as a negative 
regulator of sucrose-utilisation genes, binding in the presence of glucose to inhibit transcription. 
The fmding that ScrR functions as a positive regulator suggested that by binding DNA it would 
result in initiation of transcription of, at least, the scrP gene in the presence of sucrose or one of 
its metabolites. Activator sites usually occur in the -40 to -35 promoter region, just upstream from 
the RNA polymerase recognition site (134, 217). Consistent with this, an imperfect palindrome 
(IR2) site was identified 18 bp upstream of the proposed scrP -35 promoter region (Figure 5.7). 
Taken together with the fact that both scrP and scrR transcription was induced by sucrose, it is 
possible that the shift obtained with protein from sucrose-grown cells could be as a result of ScrR 
binding to the scrP, and possibly even the scrR, promoter. 
Although it has been postulated that the gel shifts obtained were as a result of ScrP binding, it is 
entirely possible that another protein, such as RNA polymerase, or a complex of proteins, caused 
the shifts observed. A shift was not seen when the 150 bp DNA fragment was used as a target 
(Figure 5.10 B), suggesting that the 450 bp fragment shifts with B. lactis protein extract was due 
to sequence-specific binding. Gel shifts performed with the 300 and 270 bp fragments were 
inconclusive as smears were obtained which could not be resolved. We were, therefore, unable to 
determine the role of the palindromic sequences in binding. However, this may indicate that 
either, binding occurs at several sites other than the three palindromic sequences that have been 
discussed, or, that the regulatory proteins simultaneously bind to a number of sites, as with the 
AraC and MalT positive regulators in E. coli (264). Several direct repeat sequences were 
identified which could be involved in protein binding (Figure 5.7C) (201), as has been shown for 
the AraC protein (264). Other invert repeat sequences, spaced distantly from each other were also 
identified which could be involved in DNA-looping to facilitate protein-protein interactions, as 











Further investigations using purified ScrR protein will be required to conflIm the mechanism by 
which ScrR specifically acts. 
5.5. CONCLUSIONS 
RNA slot blot analysis demonstrated that the scrP, scrR and scrT genes were similarly regulated 
at the transcriptional level, and were induced by growth in sucrose and raffmose, but were 
repressed in glucose. Identity of the scrR gene product to members of the GaIR-LacI family of 
transcriptional regulators suggested that it was involved in the regulation of the scr genes. The 
role of the scrR gene product was investigated in E. coli with plasmid deletion constructs. Even 
under non-inducing conditions, it was found that when the scrR gene was truncated, sucrase 
activity was reduced tOOO-fold. This suggested that the scrR gene product played a role in 
regulation, of at least the scrP gene, by a positive regulatory mechanism. Analogy with other 
GaIR-LacI-like regulatory proteins suggests that the B. lac tis ScrR binds to an imperfect 
palindromic operator site in the vicinity of the scr P promoter. Such a site was identified 
(T9AgT7C6A5~A3C2Cl/G'lG'2T'3T'4C'5 G'6A'7T'gA'9) (Table 5.2) 18 bp upstream of the scrP-
35 promoter region (Figure 5.7C), a likely position for the binding of an activator protein (134, 
217). The possible ScrR mode of action is discussed in the fmal chapter. Although the majority of 
GalR-LacI members function as negative regulators, including the ScrR of S. typhimurium (127), 
K pneumoniae (127), V. alginolyticus (22), S. xylosus (89), c. beijerinckii (222), and the SacR of 
L. lactis (159), some positive regulators also belong to this family, while some perform both 
functions (160, 214, 218, 243, 309, 313). Certainly, this is the flIst sucrose-regulator identified 
that positively regulates the transcription of sucrose-catabolic genes. 
In order to determine whether ScrR did in fact bind to the proposed imperfect palindromic 
sequence, gel binding assays were performed. A shift of the scrP-scrR promoter fragment was 
obtained with crude protein from B. lactis cells grown in sucrose-containing medium and, binding 
was found to be sequence specific. However, it is not possible to conclude, however likely, that 
the shift was as a result of ScrR binding. 
Analysis of sucrase activity in E. coli with the deletion constructs indicated that ScrR could only 
positively regulate ScrP activity in the presence of a full length scrT gene. Although very weak 











was no evidence to suggest that it could be involved in the regulation or stabilisation of sucrase 
activity. Since sucrose was not present in the media for these experiments, the positive effect 
cannot be attributed to the transport of sucrose into the cell, which would result in the induction of 
sucrase activity. Perhaps the scrT gene product has a dual function, having both transport and 
regulatory functions as for the bglS, gInA, putA, malK, and SNF3 gene products discussed in 
section 5.4.3. Alternatively, the deletion of a possible terminator upstream of the scrTstop codon, 
allowing counter-transcription of scrP from PA" could have resulted in the reduced ScrP activity 
observed. 
In low-GC Gram-positive bacteria catabolite repression is mediated by the binding of the CcpA 
protein (belonging to the GaIR-LacI family of transcriptional regulators) to the cis-acting CRE, 
present near the promoter of genes affected by catabolite repression (328). In high-GC Gram-
positive organisms, this is thought to be mediated via a different mechanism (207). Several 
observations indicated that the B. lactis scr genes are also controlled by catabolite repression. 
Firstly, sucrase activity in B. lactis was reduced in glucose-grown cells (chapter 2). Secondly, 
RNA slot blot analyses indicated that the scrP, scrR and scrT genes were repressed by glucose at 
the transcriptional level (Figure 5.2). Thirdly, the 450 bp scrP-scrR DNA promoter fragment was 
shifted when incubated with protein from glucose-grown cells. Although there was some evidence 
to suggest that catabolite repression is also mediated by CcpA in B. lactis, two important fmdings 
suggest that this is unlikely, at least in B. longum, and possibly also in bifidobacteria in general: 
(i) the B. longum HPr protein lacks a serine at position 46, (ii) B. longum lacks HPr kinase. The 
mechanisms involved in glucose-mediated repression, therefore, remain to be discovered. 
Collectively, the experimental data presented in this chapter suggest that, at least in E. coli, the 
B. lactis scr gene cluster is regulated by several mechanisms: positively by ScrR, sucrose, and the 
scrT gene product; and negatively by glucose and an as yet unidentified regulatory protein. While 
the precise details of the regulatory mechanisms remain unclear, particularly the involvement of 
the scrT gene product, a preliminary model can be hypothesised. This model will be discussed in 













The probiotic organism, Bifidobacterium lactis, was isolated from a yoghurt starter culture with 
the aim of analysing its utilisation of carbohydrates for the identification of prebiotics. The 
development of prebiotic substrates for bifidobacteria to be included in food products and for 
synbiotic applications is advancing rapidly. Despite this, relatively little research has been 
conducted to show which bifidobacterial strains actually metabolise the prebiotic substrates that 
have been identified. More importantly, the genetic mechanisms by which prebiotics are 
metabolised by the bifidobacteria have not been identified. The prebiotic oligosaccharides 
raffinose and oligo fructose, have been identified as bifidogenic, however, B. lactis growth was 
stimulated most in the presence of the former substrate. In order to establish the mechanisms 
required for bifidobacteria to utilise these substrates, the physiological and genetic utilisation of 
raffmose and sucrose was analysed. These analyses were performed in the industrial B. lactis 
strain, since it already is an established biotechnologically valuable organism and is currently 
included for the fermentation of food products and in pharmaceutical supplements. 
The isolation of the raffinose utilisation genes, in particular the a-galactosidase was attempted by 
several strategies. These included amplification by peR, hybridisation using a B. longum a-
galactosidase DNA fragment, and the screening of two genebanks on raffinose, sucrose, and the 
histochemical substrate p-nitrophenyl-a-D-galactopyranoside. A construct conferring very weak 
a-galactosidase activity on E. coli, p4B 11, was isolated. Sequence analysis of the p4B 11 insert 
identified several ORFs, none of which showed identity to an a-galactosidase or related protein, 
and activity could not be assigned to any of them. At the physiological level, a-galactosidase 
activity was repressed in the presence of glucose, and induced in raffinose in B. lactis cells. RNA 
slot blot analyses using the cloned insert fragment from p4B 11 as a probe revealed similarly that 
B. lactis mRNA was induced by growth in raffinose, and could not be detected in glucose. This 
suggested that the activity was not spuriously produced in E. coli. However, the identity of the 
transcript which hybridised to the probe could not be determined. It was also not possible to 
identify a protein which could be responsible for the activity by SDS-P AGE analysis. 
In order to identify the genetic element responsible for the activity produced by the clone, the 











transcription/translatio~ system. However, when the insert was subcloned, the activity was lost, 
and could not be attributed to the truncation of any of the ORFs identified nor due to their 
direction relative to the vector A promoter. It is possible that due to sequencing errors, the correct 
open reading frame was not identified, and that it was truncated in the preparation of the 
subclones. Analysis using the transcription/translation system, and re-sequencing of the insert, 
would facilitate in determining if this was the case. 
Further attempts to isolate the B. lactis a-galactosidase gene will be considered. The B. factis 
genebanks could be re-screened, possibly using the E. coli M2508 mutant in the me/A gene. A 
different histochemical substrate, 5-bromo-4-chloro-3-indolyl-a-D-galactopyranoside (similar to 
X-Gal, but with the a- instead of the ~-link) could be used, which has been shown to be effective 
in the isolation of three a-galactosidases from Trichoderma reesei by complementation and by 
plating the transformants on agar plates containing the substrate (166). The PCR using the 
bifidobacterial a-galactosidase gene primers could be repeated using techniques/additives that 
would reduce the difficulties encountered with amplification of high GC DNA. The most 
successful, however, would perhaps be to purify th~ protein from B. lactis first, and end-sequence 
it to determine if it is homologous to the other bifidobacterial a-galactosidase proteins. From the 
amino acid sequence determined from the purified protein, appropriate primers could then be 
designed to isolate the gene by PCR. It is entirely possible that the B. lactis enzyme possessing a-
galactosidase activity is different to the B. adolescentis and B. longum enzymes from which the 
PCR primers were designed. Incidentally, sequence analysis of the B. longum genome revealed 
, 
that this organism possesses more than one a-galactosidase gene (262). The B. lactis enzyme, 
might therefore, be similar to the other B. longum a-galactosidase. This could explain the failure 
to isolate the gene by PCR. Hybridisation experiments using probes prepared from the two 
B. longum a-galactosidase genes could be performed to determine if B. lactis also possesses two 
such a-galactosidases. 
Complementation of the B. lactis gene library in E. coli on sucrose resulted in the isolation of a 
sucrose utilisation gene cluster. Three genes, encoding a sucrose phosphorylase (ScrP), a GalR-
Lac! type transcriptional regulator (ScrR), and a sucrose transporter (ScrT), were identified by 
sequence analysis. The scrP gene was expressed constitutively from its own promoter in E. coli 
grown in complete medium, and hydrolysed sucrose in a reaction that was dependent on the 
presence of phosphates. This supported the proposal made on the basis of sequence analysis that 











the product of sucrose hydrolysis, and not glucose-6-phosphate as with hydrolysis by the sucrose-
6-phosphate hydro lases generally associated with sucrose PTS genes. The B. laetis scrR gene 
found identity to sucrose regulators that are all associated with PTS-dependant genes. However, 
this B. laetis sucrose cluster is not likely to be involved in PTS-dependent utilisation of sucrose. 
With regards to regulation of the sucrose utilisation genes isolated, equivalent effects were 
observed at the molecular and physiological levels. The serP, serR and serT genes were 
transcriptionally induced in cells grown in the presence of sucrose or raffinose, but not in glucose. 
Similarly, at the physiological level, sucrase activity in B. laetis was induced in sucrose- or 
raffInose-grown cells. The observed regulation is possibly mediated by at least two mechanisms. 
The serR gene product almost certainly mediates the positive regulation, since deletion of the serR 
gene in plasmid constructs in E. coli resulted in the complete loss of sucrase activity. Furthermore, 
the negative glucose effect on the transcription of the ser genes suggests that they are also 
regulated by catabolite repression. In support of the presence of these two regulatory mechanisms, 
gel shifts were observed with B. laetis protein extract from both sucrose- and glucose-grown cells. 
A possible mechanism by which these ser genes are regulated at the molecular level is proposed 
from the experimental evidence and from the identifIcation of three palindromic sequences in the 
serP-serR promoter region. From their positions relative to the transcriptional starts, identifIed by 
primer extension, and to the potential promoters of the two genes, one can speculate as to how 
both positive and negative regulation could occur. This mechanism is illustrated in Figure 6.1. In 
the presence of glucose, an unidentifIed negative regulatory protein, would bind to the inverted 
repeat sequences proximal to the serP transcription start and to the proposed scrR transcription 
start. This would prevent RNA polymerase from initiating transcription at the two promoters. In 
the presence of sucrose, the repressor would no longer be activated and would not be able to bind 
to the invert repeat sequences. Either sucrose, or a sucrose metabolite, would bind to ScrR, 
changing its conformation to allow it to bind the inverted repeat situated between the proposed -
35 promoters of the scrP and serR genes. As a result, the binding of RNA polymerase and/or the 
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Figure 6.1. Illustration of the proposed mechanism by which the B. lac/is ser genes are regulated. The mechanisms 
are discussed in the text. Coloured arrows indicate the direction of transcription of the serP, serR and serTgenes. The 
black arrow and perpendicular arrows indicate positive and negative controls respectively. TS, transcription start site; 
IR., inverted repeat; -10 and -13, putative promoters for the serP and serR genes. 
This model needs to be proved experimentally. Gel mobility shift assays using purified ScrR, 
possibly fused to the maltose-binding protein would need to be performed. Furthermore, the 
operator sites to which ScrR binds need to be confirmed. This could be analysed by gel shift 
assays with DNA fragments containing the target sites, and DNA footprinting experiments. 
Promoter fusions performed in B. lac tis would also identifY these binding sites, once the genetics 
have been sufficiently developed for such analyses to be carried out in B. lac tis. However, similar 
fusion analyses could be performed in E. coli by providing the scrR in trans. The binding of ScrR 
in a liganded state needs to be shown, and sucrose, glucose, fructose and their phosphorylated 
derivatives need to be tested for their ability to either prevent, or induce, ScrR interaction with its 
operator sites. With regards to the gel shift assays performed with crude extract: antibodies 
produced to the ScrR-His fusion protein could be used to perform a Western hybridisation to 
identifY whether the shift obtained with extract from sucrose-grown cells was due to ScrR 
binding. The involvement of another protein in the negative regulation of these genes in the 
presence of glucose would need to be proved by similar experimental procedures. 
The fmding that E. coli cells with the construct pSuc3 were unable to grow in the presence of 
sucrose, suggests that regulation in response to carbon source could occur in E. coli. Therefore, 
promoter fusions could be used to further investigate this. Evidence was presented to suggest that 
the scrT gene product might also function in the production of ScrP activity. This involvement of 
ScrT could be investigated in E. coli by introducing the scrT gene in trans to establish whether its 
presence in this way would have an effect on the activity of ScrP. Also, uptake studies in E. coli 











In this study, three genes coding for proteins with hydrolytic activity were isolated, which might 
possibly also have transglycosylation activity. These were the B. longum (l- and ~-galactosidases 
and the B. lactis sucrose phosphorylase. Certainly, transglycosylation activity has been 
demonstrated for (l- and ~-galactosidases isolated from bifidobacteria (216). These enzymes could 
be investigated for the enzymatic synthesis of novel prebiotic oligosaccharides, which could 
specifically be used for promoting the growth of the industrially used B. lactis strain, or for 
synbiotic applications. Once transferase activity has been determined, the reaction products 
obtained would need to be analysed and identified. Several methods, such as thin-layer 
chromatography, high performance anion-exchange chromatography, or MALDI-TOF could be 
used for their analysis. Fermentation tests of the oligosaccharides would then be performed to 
determine their effects on bifidobacterial growth rates. 
Two sucrose utilisation clusters were identified in the B. longum genome. One of these is the 
B. lactis scr cluster identified in this study. There is evidence to support that B. lactis also contains 
the second csc sucrose cluster. In both gene clusters there are genes coding for a sucrose-
hydrolysing protein, a transporter protein and a GalR-LacI family regulator. It would be 
interesting to determine if both of these clusters are indispensable for sucrose utilisation. Perhaps 
the csc gene cluster is more specific for the utilisation of inulin-type substrates, considering that 
the sucrase gene shows identity to inulinases and invertases. It would also be interesting to 
determine if the two regulator proteins show cross-reactivity: are they functionally homologous, 
and do they both bind to the promoter regions of the two sucrase genes to mediate regulation? 
Many possibilities could be investigated that would facilitate a better understanding of the 
mechanisms involved in, not only sucrose, but of also other fructose-containing carbohydrates. 
This knowledge, together with the identification of several enzymes which could possibly catalyse 
transglycosylation reactions, would certainly contribute greatly to the development of species-












Bacterial Strains and Plasmids Used in tbis Study 
Strain Genetic characteristic(s) Reference 
Escherichia coli 
JM109 RecAl endAl gyrA96 thi hsdR17 supE44 329 
relAl X LJ(lac-proAB) (F', traD36 proAB 
lacflZdM15) 
Biftdobacterium 
B.lactis Industrial strain used in yoghurt This study 
B. breve NCFB 2257 NCFB, UK 
B. bifidum NCFB 2203 NCFB, UK 
B. longum NCFB 2259 NCFB, UK 
Corynebacterium glutamicum 
ATCC 13032 Nx
R, type strain ABCI, South 
Africa 
Plasmids 
pEcoR251 i AmpR (EcoRI) 336 
pBluescript SK (PSK) AmpR,lacZ' Stratagene 
pMT104 AmpR, 0.15 kb B. fragilis fragment in 320 
pEcoR251 
pGem ® -T Easy • AmpR, lacZ', T -tailed Promega 
pEKplCm Km
R, promoterless cat 70 
i 
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3349 
Figure A.1. Restriction map of pEcoR251 (336). 
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Aat II 20 
Sphl 26 
Neal 37 
pGEMe.y Easy BstZ I 43 
Vector Not I 43 
(3018bp) 
Sac II 49 
EcoRI 52 
~el 64 
coR I 70 
Not I 77 
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Pst I 88 
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Nsil 127 
\. 141 f SP6 












Apt I. ~use 













ACAGGHIICAGW::c: A1'Q 'rca TAl: TAl: CAT CAe CAT CAe CAT CAe au '!'lIe ('.AT A'1'C CXA ACO N!f! OM AlIC C1'Q TAT ft'l' CAIJ"' OCIC oc:c: A1'Q 000 A'l'C 
!WI _I: .R I:yr I:yr iii. iii. b.t' iii. bJ.' bis !!!II! m aft U. OJ! dIr dIr ,1 .. &lOll 1 ... m pi!! '1Il m ala _I: ;11" 11. 
(hUt. !p&cIC nol.oal ..,." proceu. 0:1-.. .iC! 
'fC'CIII I Stu I sa.l I Slrt: I • Z MIl: Z IJlIJp V • I PH Z a.o I sPII I'" .. Z IUad tIl 
---, ...--, ,-, ,..---,,..---, j i .,---,,........--, r----r ...--,...--,...--,...--, 
~~~~OC:C:~~~~~~~~OCIC~ft'l'~A'1'Cm~C1'Q~~~OCIC~~~~~~C1'Q 
~UlI __ al&I:yr~~.~dIr_~~~~~~~ 
Tr'!' Ta'!3 CIlG A1'Q Ala OM GAT ft'l' 
164 
Figure A.4. Restriction map of pProEx™ expression vector (A), and multiple cloning site of 
pProEx HTc (B). The sequence for the His-tag, spacer region and recombinant TEV protease 












B.t. Preparation of Bifidobacterial Media 
B.l.l. Brain Heart Infusion Medium (BHI) 
In grams per litre 
Brain heart infusion (Difco) ................................................ 37 
Yeast extract (Difco) ......................................................... 5 
Cysteine HC!. ................................................................ 0.5 
Rezasurin ..................................................................... 0.001 
Agar ........................................................................... 15 
B.1.2. Basal Medium (BY) 
In grams per litre: 
Tryptone ...................................................................... 10 
Yeast extract (Difco) ........................................................ 2.5 
Tween 80 ..................................................................... 1 
NaC!. .......................................................................... 4.5 
KCl. ........................................................................... 0.25 
MgCh.6H20 .................................................................. 0.15 
KH2P04 •••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••• 0.4 
K2HP04 ....................................................................... 0.2 
~Cl. ........................................................................ 0.4 
Cysteine HCl. ................................................................ 0.5 
Rezasurin ..................................................................... 0.001 











B.1.3. BYG Medium (!!asal + yeast + glucose) 
Basal medium (BY) containing the following in grams per litre: 
Yeast extract (Difco) ........................................................ 2.5 
Glucose ........................................................................ 5 
B.2. C glutamicum LM Medium 
In grams per litre: 
Tryptone ...................................................................... 10 
Yeast Extract ................................................................. 10 
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